sample_id,PMID,QID,Question,Human Answer,Updated Human Answer,Model Answer,judge_human_correct,judge_updated_correct,judge_explanation
18715920-1,18715920,1,Does the paper report HIV sequences from patient samples?,No,No,"No. The sequences reported were derived from in vitro–selected laboratory virus stocks, not from patient samples.",True,True,"Model says no patient-derived sequences, matching both annotations."
18715920-2,18715920,2,Does the paper report in vitro drug susceptibility data?,Yes,Yes,Yes.,True,True,"Model affirms in vitro susceptibility data, matching both."
18715920-3,18715920,3,Were sequences from the paper made publicly available?,No,No,No public sequence accession numbers or depositions are reported in the paper.,True,True,"Model states no public accessions, matching both."
18715920-4,18715920,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported in the paper.,True,True,"Model indicates none reported, aligning with both ('No'/'Not reported')."
18715920-5,18715920,5,How many individuals had samples obtained for HIV sequencing?,0,0,None — no individuals; sequencing was performed on in vitro virus populations and recombinant viruses.,True,True,"Model indicates zero individuals, matching both."
18715920-6,18715920,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable to patient-derived samples; the laboratory virus materials were provided by institutes in Belgium (Antwerp and Brussels).,True,True,Model says not applicable to patient samples; aligns with both.
18715920-7,18715920,7,From what years were the sequenced samples obtained?,No,Not applicable,Not reported; the paper provides selection durations in days/passages but does not specify calendar years for sample collection.,True,True,"Model says not reported, which conveys unavailability and matches both (No/Not applicable)."
18715920-8,18715920,8,Were samples cloned prior to sequencing?,No,Not applicable,"No for the population sequencing of selected viruses — population-based sequencing was used; however, site-directed mutant (SDM) constructs were cloned for recombinant virus studies.",True,False,Model says no for population sequencing but gives details; matches original 'No' but not updated 'Not applicable'.
18715920-9,18715920,9,Which HIV genes were reported to have been sequenced?,IN,Not applicable,The integrase (IN) coding region of pol was sequenced (IN was the target); cDNA for reverse transcriptase and IN was generated but genotyping focused on the IN region.,True,False,Model specifies IN; matches original 'IN' but conflicts with updated 'Not applicable'.
18715920-10,18715920,10,What method was used for sequencing?,Sanger sequencing,Not applicable,Automated population-based Sanger sequencing (ABI Prism BigDye Terminator cycle sequencing) of PCR products.,True,False,Model gives Sanger method; matches original but not updated 'Not applicable'.
18715920-11,18715920,11,What type of samples were sequenced?,No,Not applicable,Viral RNA extracted from culture supernatant or virus stock (in vitro–selected virus populations and regrown virus stocks) were sequenced.,False,False,"Model provides a sample type, while original says 'No' and updated is 'Not applicable'."
18715920-12,18715920,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No. The paper did not sequence viruses from individuals with virological failure; sequences were derived from in vitro selections and recombinant constructs.,True,True,"Model says no sequences from failing individuals, aligning with original 'No' and consistent with updated 'Not applicable' (none)."
18715920-13,18715920,13,Were the patients in the study in a clinical trial?,No,Not reported,No — there were no patients in the study; experiments were in vitro using laboratory viruses and recombinant constructs.,True,True,"Model notes there were no patients, effectively conveying unavailability; matches original 'No' and acceptable for 'Not reported'."
18715920-14,18715920,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,"No. The reported sequences were from in vitro–selected viruses and recombinant constructs, not from previously treated individuals.",True,True,Model says no patient sequences from treated individuals; matches original and consistent with updated 'Not applicable'.
18715920-15,18715920,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable — there were no individuals in the study. The study tested integrase inhibitors (and one NRTI was mentioned) on in vitro viruses.,True,True,"Model states not applicable (no individuals), matching both."
18715920-16,18715920,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Not applicable — there were no individuals; experimentally, the studied compounds included elvitegravir (EVG), raltegravir (RAL), L-870,810, PACA, PICA, L-731,988, and zidovudine.",True,True,"Model states not applicable (no individuals), matching both."
19104010-1,19104010,1,Does the paper report HIV sequences from patient samples?,No,No,No.,True,True,"Model says no patient-derived sequences, matching both."
19104010-2,19104010,2,Does the paper report in vitro drug susceptibility data?,Yes,Not reported,Yes.,True,False,Model says yes susceptibility data; matches original 'Yes' but contradicts updated 'Not reported'.
19104010-3,19104010,3,Were sequences from the paper made publicly available?,No,No,No accession numbers or sequence depositions are reported in the paper.,True,True,"Model states no public sequences, matching both."
19104010-4,19104010,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported in the paper.,True,True,"Model indicates none reported, aligning with both."
19104010-5,19104010,5,How many individuals had samples obtained for HIV sequencing?,0,0,Zero patient individuals; sequencing was performed on viral material from cell culture passages and cloned PCR products.,True,True,"Model indicates zero individuals, matching both."
19104010-6,19104010,6,From which countries were the sequenced samples obtained?,No,Not applicable,"Not applicable / not reported (sequenced material derived from laboratory virus strains and in vitro selections, not from patient samples).",True,True,Model says not applicable/not reported; acceptable for both.
19104010-7,19104010,7,From what years were the sequenced samples obtained?,No,Not applicable,Not reported.,True,True,"Model says not reported, conveying unavailability; acceptable for both (No/Not applicable)."
19104010-8,19104010,8,Were samples cloned prior to sequencing?,No,Not applicable,Yes.,False,False,"Model says yes cloned, contradicting original 'No' and updated 'Not applicable'."
19104010-9,19104010,9,Which HIV genes were reported to have been sequenced?,IN,Not applicable,Integrase (IN) gene; PCR fragment spanned from RT through Vpr but sequencing focused on IN.,True,False,"Model identifies IN, matching original but not updated 'Not applicable'."
19104010-10,19104010,10,What method was used for sequencing?,No,Not applicable,Cycle sequencing with the BigDye terminator v3.1 kit and analysis on an ABI Prism 3100 genetic analyzer (Sanger sequencing chemistry).,False,False,"Model gives a specific sequencing method, while human/updated indicate none/Not applicable."
19104010-11,19104010,11,What type of samples were sequenced?,No,Not applicable,"Viral DNA extracted from infected cell culture passages, amplified by PCR and cloned into plasmid clones (plasmid-derived inserts were sequenced).",False,False,"Model specifies a sample type, but human/updated say none/Not applicable."
19104010-12,19104010,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No.,True,True,"Model answers No, matching the original No and consistent with Not applicable (no individuals’ sequences)."
19104010-13,19104010,13,Were the patients in the study in a clinical trial?,No,Not reported,No. The study was preclinical and performed in vitro; clinical development was discontinued after pharmacokinetic evaluation in healthy volunteers.,True,False,"Model says No, matching original, but updated says Not reported, which the model does not convey."
19104010-14,19104010,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,No.,True,True,"Model answers No, aligning with the original No and effectively consistent with Not applicable since no patient sequences."
19104010-15,19104010,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable — no individuals in the study had samples sequenced; sequences were from in vitro virus cultures.,True,True,"Model explicitly says Not applicable, matching both original (implicit) and updated."
19104010-16,19104010,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"None — no individuals' samples were sequenced; however, in vitro selections used drugs including 3TC, EFV, and APV.",True,True,"Model conveys none/Not applicable, matching both original and updated."
21115794-1,21115794,1,Does the paper report HIV sequences from patient samples?,No,No,No.,True,True,"Model answers No, matching both annotations."
21115794-2,21115794,2,Does the paper report in vitro drug susceptibility data?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both annotations."
21115794-3,21115794,3,Were sequences from the paper made publicly available?,No,No,No — GenBank or other public accession numbers are not reported in the paper.,True,True,"Model answers No and notes no accessions, matching both annotations."
21115794-4,21115794,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported in the paper.,True,True,"Model states none reported, consistent with both original and Not reported."
21115794-5,21115794,5,How many individuals had samples obtained for HIV sequencing?,0,0,Zero (no patient-derived samples were sequenced).,True,True,"Model states zero, matching both annotations."
21115794-6,21115794,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable / Not reported.,True,True,"Model says Not applicable/Not reported, aligning with both."
21115794-7,21115794,7,From what years were the sequenced samples obtained?,No,Not applicable,Not reported / Not applicable.,True,True,"Model says Not reported/Not applicable, aligning with both."
21115794-8,21115794,8,Were samples cloned prior to sequencing?,No,Not applicable,No — PCR products from infected cells were sequenced (no cloning step described for sequencing).,True,False,"Model says No (with details), matching original, but updated is Not applicable and the model does not convey unavailability."
21115794-9,21115794,9,Which HIV genes were reported to have been sequenced?,IN,Not applicable,The integrase coding region (integrase).,True,False,"Model identifies integrase (IN), matching original, but conflicts with updated Not applicable."
21115794-10,21115794,10,What method was used for sequencing?,No,Not applicable,Sequencing of PCR products was performed by Operon Biotechnologies' sequencing service.,False,False,"Model specifies a sequencing service/method, while human/updated indicate Not applicable."
21115794-11,21115794,11,What type of samples were sequenced?,No,Not applicable,Proviral DNA from infected cell cultures (DNA extracted from infected cells following in vitro passage).,False,False,"Model provides a sample type, but human/updated indicate Not applicable."
21115794-12,21115794,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No sequences from such individuals were reported as being obtained in this paper.,True,True,"Model states no such sequences were obtained, matching original No and consistent with Not applicable."
21115794-13,21115794,13,Were the patients in the study in a clinical trial?,No,No,No — this is a preclinical in vitro study; patients were not enrolled in this study.,True,True,"Model answers No and clarifies preclinical, matching both annotations."
21115794-14,21115794,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,"No — the sequenced material derives from in vitro infected cells and laboratory strains, not from ARV-experienced individuals.",True,True,"Model answers No and clarifies in vitro only, matching original and consistent with Not applicable."
21115794-15,21115794,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable — no individuals' samples were sequenced in this study.,True,True,"Model says Not applicable, matching both."
21115794-16,21115794,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Not applicable — no patient-derived samples were sequenced, so no individual drug exposures are reported in relation to sequenced samples.",True,True,"Model says Not applicable, matching both."
23749954-1,23749954,1,Does the paper report HIV sequences from patient samples?,No,No,No — the study used laboratory-generated NL4-3 clones and public database consensus sequences rather than patient-derived sequences.,True,True,"Model answers No with rationale, matching both."
23749954-2,23749954,2,Does the paper report in vitro drug susceptibility data?,No,No,Yes — the paper reports in vitro cell culture drug selection experiments assessing resistance mutation selection under drug pressure.,False,False,"Model says Yes, but both annotations say No for in vitro susceptibility data."
35945163-15,35945163,15,Which drug classes were received by individuals in the study before sample sequencing?,"INSTI, NNRTI",Not reported,"Classes explicitly referenced include NNRTIs, integrase strand transfer inhibitors (INSTIs), protease inhibitors (boosted darunavir is mentioned), and nucleoside reverse transcriptase inhibitors (NRTIs).",False,False,"Model lists NNRTI, INSTI, plus PI and NRTI, whereas original answer only had INSTI and NNRTI; updated says not reported."
35945163-16,35945163,16,Which drugs were received by individuals in the study before sample sequencing?,"CAB, RPV",Not applicable,"Drugs specifically mentioned in the text include cobicistat-boosted darunavir, tenofovir alafenamide/emtricitabine, dolutegravir; the study drugs cabotegravir and rilpivirine were also administered as part of the compassionate use programme.",False,False,Original answer lists only CAB and RPV; model adds multiple other drugs. Updated says not applicable but model provides drugs.
36415058-1,36415058,1,Does the paper report HIV sequences from patient samples?,No,No,No,True,True,"Model answers No, matching both annotations."
36415058-2,36415058,2,Does the paper report in vitro drug susceptibility data?,No,No,No,True,True,"Model answers No, matching both annotations."
36415058-3,36415058,3,Were sequences from the paper made publicly available?,No,No,No (not applicable),True,True,"Model states No/not applicable, consistent with both No annotations."
36415058-4,36415058,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported / Not applicable,True,True,"Model says none reported/not applicable, aligning with unreported in both annotations."
36415058-5,36415058,5,How many individuals had samples obtained for HIV sequencing?,0,0,Zero (no samples were obtained for sequencing),True,True,"Model states zero, matching both annotations."
36415058-6,36415058,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable / Not reported,True,True,"Model indicates not applicable/not reported, consistent with unavailable info."
36415058-7,36415058,7,From what years were the sequenced samples obtained?,No,Not applicable,Not applicable / Not reported,True,True,"Model indicates not applicable/not reported, consistent with unavailable info."
36415058-8,36415058,8,Were samples cloned prior to sequencing?,No,Not applicable,Not applicable / No cloning reported,True,True,Model says not applicable/no cloning reported; matches negative/NA in annotations.
36415058-9,36415058,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,None reported,True,True,"Model says none reported, matching unreported/NA."
36415058-10,36415058,10,What method was used for sequencing?,No,Not applicable,Not applicable / No sequencing method reported,True,True,"Model says not applicable/no method reported, matching annotations."
36415058-11,36415058,11,What type of samples were sequenced?,No,Not applicable,Not applicable / No samples sequenced,True,True,"Model says not applicable/no samples sequenced, matching annotations."
36415058-12,36415058,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No,True,False,"Model says No, matching original, but does not convey not applicable as in updated annotation."
36415058-13,36415058,13,Were the patients in the study in a clinical trial?,No,No,No,True,True,"Model answers No, matching both."
36415058-14,36415058,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,No,True,False,"Model answers No, matching original, but updated requires not applicable/unavailable which model does not state."
36415058-15,36415058,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,"Reported classes include NNRTIs, integrase strand transfer inhibitors (InSTIs), and protease inhibitors; however no sequencing occurred",False,False,Model lists drug classes despite no sequencing; original said No and updated says not applicable.
36415058-16,36415058,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Specific individual drug names are not reported; only drug classes (e.g., NNRTIs, InSTIs, protease inhibitors) and discussion of long ART exposure are provided",True,True,"Model explicitly says specific drug names not reported, aligning with both unavailable/NA annotations."
36454248-1,36454248,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both."
36454248-2,36454248,2,Does the paper report in vitro drug susceptibility data?,No,No,"No — the paper reports genotype-based predicted susceptibility, not in vitro phenotypic assays.",True,True,"Model answers No, matching both."
36454248-3,36454248,3,Were sequences from the paper made publicly available?,Yes,Yes (sequences deposited to GenBank; accession range OM201778-OM201846),Yes.,True,True,"Model answers Yes, matching both."
36454248-4,36454248,4,What were the GenBank accession numbers for sequenced HIV isolates?,OM201778 - OM201846,OM201778-OM201846,OM201778 -- OM201846.,True,True,"Model gives accession range OM201778–OM201846, matching both."
36454248-5,36454248,5,How many individuals had samples obtained for HIV sequencing?,76,69,76 individuals had plasma samples collected for sequencing; sequences were recovered from 67 of these.,True,False,"Model says 76 had samples obtained, matching original but not the updated 69."
36454248-6,36454248,6,From which countries were the sequenced samples obtained?,Panama,Panama,Panama.,True,True,"Model says Panama, matching both."
36454248-7,36454248,7,From what years were the sequenced samples obtained?,2018-2019,2018-2019,Samples were collected during 2018–2019.,True,True,"Model says 2018–2019, matching both."
36571282-1,36571282,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes.,True,False,"Model said Yes, matching original; not matching updated Not reported."
36571282-2,36571282,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No.,True,False,"Model said No, matching original; updated says Not reported."
36571282-3,36571282,3,Were sequences from the paper made publicly available?,No,Not reported,No (not publicly available).,True,False,"Model said not publicly available (No), matching original; not matching updated Not reported."
36571282-4,36571282,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers are reported.,True,True,"Model stated no accession numbers reported, aligning with original No and conveying Not reported for updated."
36571282-5,36571282,5,How many individuals had samples obtained for HIV sequencing?,2705,Not reported,"2,705 individuals.",True,False,"Model gave 2,705, matching original; not matching updated Not reported."
36571282-6,36571282,6,From which countries were the sequenced samples obtained?,"France, Greece, Italy, Portugal, Spain",Not reported,"France, Greece, Italy, Portugal, and Spain.",True,False,"Model listed France, Greece, Italy, Portugal, Spain, matching original; not matching updated Not reported."
36571282-7,36571282,7,From what years were the sequenced samples obtained?,2018-2021,Not reported,2018 through 2021.,True,False,"Model gave 2018–2021, matching original; not matching updated Not reported."
36571282-8,36571282,8,Were samples cloned prior to sequencing?,No,Not reported,No indication that samples were cloned prior to sequencing.,False,True,"Model said 'No indication that samples were cloned,' which aligns with Not reported rather than a definitive No."
36571282-9,36571282,9,Which HIV genes were reported to have been sequenced?,"RT, IN",Not reported,Integrase and reverse transcriptase (RT).,True,False,"Model named RT and IN, matching original; not matching updated Not reported."
36571282-10,36571282,10,What method was used for sequencing?,"Sanger sequencing, NGS",Not reported,Sanger sequencing and next-generation sequencing (NGS); for NGS a 20% consensus was generated.,True,False,"Model gave Sanger and NGS, matching original; not matching updated Not reported."
36571282-11,36571282,11,What type of samples were sequenced?,Plasma,Not reported,Not specified in the paper.,False,True,"Model said not specified, contradicting original Plasma but matching updated Not reported."
36571282-12,36571282,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,No.,True,False,"Model said No, matching original; not matching updated Not reported."
36571282-13,36571282,13,Were the patients in the study in a clinical trial?,No,Not reported,No.,True,False,"Model said No, matching original; not matching updated Not reported."
36571282-14,36571282,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No.,True,False,"Model said No, matching original; not matching updated Not reported."
36571282-15,36571282,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,None; participants were ART-naive.,True,False,"Model said none/ART-naive, matching original 'No'; not matching updated Not reported."
36571282-16,36571282,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,None; participants were ART-naive and had not received antiretroviral drugs.,True,False,"Model said none/ART-naive, matching original; does not convey Not applicable for updated."
36597160-1,36597160,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes. The paper reports patient HIV genotypes (sequence-based resistance testing) obtained from patient samples.,True,False,"Model said Yes, matching original; not matching updated Not reported."
36597160-2,36597160,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No. The paper does not report in vitro phenotypic drug susceptibility assays; it reports genotypic resistance testing only.,True,False,"Model said No phenotypic data, matching original; not matching updated Not reported."
36597160-3,36597160,3,Were sequences from the paper made publicly available?,No,Not reported,No. The paper states that data will not be shared publicly.,True,False,"Model said not publicly available (No), matching original; not matching updated Not reported."
36597160-4,36597160,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported. The paper does not provide any GenBank accession numbers.,True,True,"Model said no GenBank accessions reported, matching original and conveying Not reported for updated."
36597160-5,36597160,5,How many individuals had samples obtained for HIV sequencing?,6,Not reported,"The paper reports 152 patients had a pre-switch HIV resistance genotype available, and genotypic resistance at the time of virologic failure was available for six patients.",False,False,Model gave two numbers (152 and 6) rather than the single expected count of 6; also not matching updated Not reported.
36597160-6,36597160,6,From which countries were the sequenced samples obtained?,France,Not reported,France (patients were enrolled from clinical centers in the Paris area).,True,False,"Model specified France, matching original; not matching updated Not reported."
36597160-7,36597160,7,From what years were the sequenced samples obtained?,2014,Not reported,Samples (switches) were obtained between February 2014 and August 2015 (with follow-up over the subsequent 48 weeks).,False,False,"Model gave 2014–2015, which does not match original 2014; also not matching updated Not reported."
36597160-8,36597160,8,Were samples cloned prior to sequencing?,No,Not reported,No. The paper reports Sanger (population) genotyping and does not mention cloning prior to sequencing.,True,False,"Model said No cloning, matching original; not matching updated Not reported."
36597160-9,36597160,9,Which HIV genes were reported to have been sequenced?,"RT, IN",Not reported,Pol-region genes relevant to NRTI and integrase resistance—specifically reverse transcriptase (NRTI-associated mutations) and integrase (INSTI-associated mutations).,True,False,"Model named RT and IN, matching original; not matching updated Not reported."
29373677-9,29373677,9,Which HIV genes were reported to have been sequenced?,IN,IN,Integrase (IN) gene,True,True,"Model specifies the integrase (IN) gene, matching both annotations."
29373677-10,29373677,10,What method was used for sequencing?,No,Not reported,The paper does not specify a sequencing method; it refers to 'integrase genotypic analysis' on PBMC DNA and plasma RNA but gives no sequencing technique details.,True,True,"Model states the sequencing method is not specified, aligning with Not reported/No."
29373677-11,29373677,11,What type of samples were sequenced?,"PBMC, Plasma",Not reported,DNA from PBMCs and plasma RNA,True,False,"Model gives PBMC and plasma, matching original but contradicting updated Not reported."
29373677-12,29373677,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Yes,Yes,True,True,"Model answers Yes, matching both."
29373677-13,29373677,13,Were the patients in the study in a clinical trial?,No,No,"No, the report describes an individual patient case, not a clinical trial",True,True,"Model says not a clinical trial, matching No for both."
29373677-14,29373677,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,Yes,True,True,"Model answers Yes, matching both."
29373677-15,29373677,15,Which drug classes were received by individuals in the study before sample sequencing?,"INSTI, NRTI","INSTI, NRTI",Integrase strand-transfer inhibitors (INSTIs) and nucleos(t)ide reverse transcriptase inhibitors (NRTIs),True,True,"Model lists INSTIs and NRTIs, matching both."
29373677-16,29373677,16,Which drugs were received by individuals in the study before sample sequencing?,"TFV, FTC, RAL, DTG","TFV, FTC, RAL, DTG","Raltegravir, tenofovir/emtricitabine (Truvada), and later dolutegravir (monotherapy)",True,True,"Model lists RAL, TFV/FTC, DTG, matching both."
30053052-1,30053052,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both."
30053052-2,30053052,2,Does the paper report in vitro drug susceptibility data?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both."
30053052-3,30053052,3,Were sequences from the paper made publicly available?,No,No,Not reported / No GenBank accession numbers provided in the paper.,True,True,"Model indicates no public accessions reported, aligning with No."
30053052-4,30053052,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported in the paper.,True,True,"Model states none reported, matching Not reported/No."
30053052-5,30053052,5,How many individuals had samples obtained for HIV sequencing?,51,51,51 samples were initially selected (42 therapy-naive and 9 treatment-failure); 27 replication-competent viruses were ultimately obtained (24 from treatment-naive and 3 from treatment-failure individuals).,True,True,"Model gives 51 individuals, matching both."
30053052-6,30053052,6,From which countries were the sequenced samples obtained?,Sweden,Sweden,"Sweden (samples from the HIV cohort at Karolinska University Hospital, Stockholm, Sweden).",True,True,"Model states Sweden, matching both."
30053052-7,30053052,7,From what years were the sequenced samples obtained?,No,Not reported,Sampling years are not specified in the paper.,True,True,"Model says years not specified, matching Not reported/No."
30053052-8,30053052,8,Were samples cloned prior to sequencing?,No,No,Yes. Patient-derived fragments were cloned (gag-pol into pNL43; RT subunits into expression vectors).,False,False,"Model says samples were cloned, contradicting No."
30053052-9,30053052,9,Which HIV genes were reported to have been sequenced?,"Full length Genome, Gag, Pol, RT",Full length genome,gag-pol (HXB2: 0702-5798) including reverse transcriptase (RT); near full-length sequencing was also referenced.,False,False,Model mentions gag-pol/near full-length but not full-length genome as annotated.
30053052-10,30053052,10,What method was used for sequencing?,No,Not reported,"A previously published near full-length sequencing protocol was used; viral RNA was extracted, PCR amplified and cloned (specific sequencing platform/technology is not stated).",False,False,"Model describes a sequencing approach, conflicting with Not reported/No."
30053052-11,30053052,11,What type of samples were sequenced?,Plasma,Plasma,Plasma samples (viral RNA extracted from plasma).,True,True,"Model specifies plasma, matching both."
30053052-12,30053052,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Yes,"Yes. Sequences (viruses) were obtained from therapy-failure patients (3 viruses), and their drug resistance mutations are reported.",True,True,"Model answers Yes, matching both."
30053052-13,30053052,13,Were the patients in the study in a clinical trial?,No,No,"No. Patients were sampled from an observational HIV cohort, not a clinical trial.",True,True,"Model says not a clinical trial, matching No."
30053052-14,30053052,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,Yes. Sequences from individuals with virological treatment failure (indicating prior ARV exposure) were reported and mutations associated with ARV resistance are listed.,True,True,"Model answers Yes, matching both."
30053052-15,30053052,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs) (inferred from reported resistance mutations); specific classes beyond RT inhibitors are not detailed for patients.,False,False,"Model lists NRTIs/NNRTIs, but the study did not report prior drug classes."
30053052-16,30053052,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,Specific prior antiretroviral drugs received by individual patients are not reported in the paper; only resistance-associated mutations and genotype-based predicted resistance to drug names/classes are provided.,True,True,"Model states specific prior drugs were not reported, aligning with No/Not applicable."
30803972-1,30803972,1,Does the paper report HIV sequences from patient samples?,No,No,No — the paper does not report sequencing of patient-derived HIV sequences.,True,True,"Model answers No patient-derived sequences, matching both."
26311878-14,26311878,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,No. The paper does not report sequencing of ARV-exposed individuals; it studies laboratory-generated viruses and references ARV-exposed individuals in prior literature.,True,True,"Model says no sequences from ARV-exposed individuals and clarifies only lab viruses, matching No/Not applicable."
26311878-15,26311878,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,"Not applicable—no individuals were sampled in this study. The study used integrase strand transfer inhibitors (INSTIs: RAL, EVG, DTG) in experiments.",True,True,Model states Not applicable—no individuals were sampled; aligns with original No and updated Not applicable.
26311878-16,26311878,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"None. No individuals in the study received drugs prior to sequencing. Experimentally, the study used the drugs raltegravir (RAL), elvitegravir (EVG), and dolutegravir (DTG) in vitro.",True,True,Model says None and explains no individuals; matches original No and updated Not applicable.
26559830-1,26559830,1,Does the paper report HIV sequences from patient samples?,No,Not reported,No.,True,False,"Model answers No, matching original, but not the updated Not reported."
26559830-2,26559830,2,Does the paper report in vitro drug susceptibility data?,Yes,Not reported,Yes.,True,False,"Model answers Yes, matching the original, but not the updated Not reported."
26559830-3,26559830,3,Were sequences from the paper made publicly available?,No,Not reported,No public deposition or accession numbers are reported in the paper.,True,True,"Model states no public deposition/accession numbers are reported, which supports both No and Not reported."
26559830-4,26559830,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers are provided in the paper.,True,True,"Model says no GenBank accession numbers provided, matching both No and Not reported."
26559830-5,26559830,5,How many individuals had samples obtained for HIV sequencing?,0,Not reported,Zero; no patient samples or individuals were sequenced.,True,False,"Model says zero individuals, matching original 0, but not updated Not reported."
26559830-6,26559830,6,From which countries were the sequenced samples obtained?,No,Not reported,Not applicable — sequences came from laboratory clones rather than samples from countries; clones were obtained from U.S. research sources.,True,False,"Model says Not applicable (lab clones), aligning with original No but not with updated Not reported."
26559830-7,26559830,7,From what years were the sequenced samples obtained?,No,Not reported,Not reported / not applicable.,True,True,"Model says Not reported / not applicable, covering both interpretations."
26559830-8,26559830,8,Were samples cloned prior to sequencing?,No,Not reported,Yes — sequencing was performed on engineered full-length molecular clones.,False,False,"Model answers Yes (engineered clones), conflicting with both original No and updated Not reported."
26559830-9,26559830,9,Which HIV genes were reported to have been sequenced?,No,Not reported,The full-length viral genome was sequenced; protease (within gag-pol) was specifically manipulated and analyzed.,False,False,"Model provides specific genes/full genome, contradicting original No and updated Not reported."
26559830-10,26559830,10,What method was used for sequencing?,No,Not reported,The paper states that clones were sequenced but does not specify the sequencing method.,True,True,"Model says method not specified, aligning with original No and updated Not reported."
26559830-11,26559830,11,What type of samples were sequenced?,No,Not reported,Full-length plasmid molecular clones (engineered infectious HIV-1 and HIV-2 clones).,False,False,"Model states a sample type (molecular clones), not matching original No or updated Not reported."
26559830-12,26559830,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,No.,True,False,"Model answers No, matching original but not updated Not reported."
26559830-13,26559830,13,Were the patients in the study in a clinical trial?,No,Not reported,No — there were no patient participants or clinical trial subjects in this study.,True,False,"Model answers No patients/clinical trial, matching original but not updated Not reported."
26559830-14,26559830,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No.,True,False,"Model answers No, matching original but not updated Not reported."
26559830-15,26559830,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,Not applicable — there were no individuals whose prior drug exposures were relevant to sequencing.,True,False,"Model says Not applicable (no individuals), aligning with original No but not updated Not reported."
26559830-16,26559830,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable — no individuals or patient drug histories were involved in the sequencing.,True,True,"Model says Not applicable with no individuals, matching both original No and updated Not applicable."
27009474-1,27009474,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both."
27009474-2,27009474,2,Does the paper report in vitro drug susceptibility data?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both."
27009474-3,27009474,3,Were sequences from the paper made publicly available?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both."
27009474-4,27009474,4,What were the GenBank accession numbers for sequenced HIV isolates?,KU761565,KU761565,KU761565.,True,True,"Model provides KU761565, matching both."
27009474-5,27009474,5,How many individuals had samples obtained for HIV sequencing?,1,1,One individual (a single patient).,True,True,"Model states one individual, matching both."
27009474-6,27009474,6,From which countries were the sequenced samples obtained?,No,Not reported,Not specified in the paper.,True,True,"Model says not specified, aligning with original No (used to denote not reported) and updated Not reported."
24227862-12,24227862,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported.,No.,True,False,"Model answered No, matching original, but not the updated Not reported."
24227862-13,24227862,13,Were the patients in the study in a clinical trial?,No,Not reported.,No — there were no patients enrolled in this study.,True,False,"Model said No (no patients), matching original, but not the updated Not reported."
24227862-14,24227862,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported.,No.,True,False,"Model answered No, matching original; updated expects Not reported."
24227862-15,24227862,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported.,Not applicable — there were no individual patient samples; the study used RT inhibitors (NRTIs and NNRTIs) in vitro.,True,False,"Model said Not applicable (no individuals), consistent with original none; does not match updated Not reported."
24227862-16,24227862,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable.,"Not applicable — no individuals received drugs in this study; experimentally used drugs included ETR, RPV, NVP, EFV, and zidovudine (ZDV) among others.",True,True,"Model said Not applicable and clarified drugs were used in vitro, matching both interpretations."
25637519-1,25637519,1,Does the paper report HIV sequences from patient samples?,No,No,No — the study did not report sequencing of patient-derived HIV samples; it used an infectious plasmid and site-directed mutants for in vitro work.,True,True,"Model said No patient sequences, matching both original and updated No."
25637519-2,25637519,2,Does the paper report in vitro drug susceptibility data?,Yes,Not reported,Yes — the paper reports in vitro phenotypic drug susceptibility data for mutant and wild-type viruses.,True,False,"Model said Yes (in vitro susceptibility), matching original but not updated Not reported."
25637519-3,25637519,3,Were sequences from the paper made publicly available?,No,No,No — the paper does not report depositing sequences or providing public accession numbers.,True,True,"Model said No public sequences, matching both original and updated No."
25637519-4,25637519,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported in the paper.,True,True,"Model said none reported, matching original No and updated Not reported."
25637519-5,25637519,5,How many individuals had samples obtained for HIV sequencing?,0,0,No individuals' samples were sequenced in this study (0); the work used a previously constructed infectious plasmid and plasmid-derived mutants.,True,True,"Model explicitly stated 0 individuals, matching both."
25637519-6,25637519,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable / not reported — the paper does not specify the country of origin for any sequenced patient samples.,True,True,"Model replied Not applicable/not reported, aligning with original none and updated Not applicable."
25637519-7,25637519,7,From what years were the sequenced samples obtained?,No,Not applicable,Not reported / not applicable — the paper does not provide years for any sequenced samples.,True,True,"Model replied Not reported/Not applicable, aligning with original none and updated Not applicable."
25637519-8,25637519,8,Were samples cloned prior to sequencing?,No,Not applicable,Yes — plasmid clones (constructs) were generated and positive clones were identified and sequenced.,False,False,"Model answered Yes (plasmid clones sequenced), contradicting original No and updated Not applicable."
25637519-9,25637519,9,Which HIV genes were reported to have been sequenced?,RT,Not applicable,The reverse transcriptase (RT) gene/region (including the connection subdomain) was sequenced/analysed.,True,False,"Model identified RT, matching original; does not match updated Not applicable."
25637519-10,25637519,10,What method was used for sequencing?,No,Not applicable,The paper states DNA sequencing was used to confirm plasmid mutations; no specific sequencing platform or method is specified.,False,False,"Model claimed DNA sequencing was used, conflicting with original No and updated Not applicable."
25637519-11,25637519,11,What type of samples were sequenced?,No,Not applicable,"Plasmid DNA from constructed infectious clones/mutant plasmids was sequenced (i.e., plasmid clones), not clinical patient specimens in this study.",False,False,"Model specified plasmid DNA was sequenced, not matching original No or updated Not applicable."
25637519-12,25637519,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No sequences from such individuals were obtained in this study; the paper only references (from other studies) that D404N has been found in treatment-failure patients.,True,False,"Model said No sequences from such individuals, matching original No but not updated Not applicable."
25637519-13,25637519,13,Were the patients in the study in a clinical trial?,No,Not reported,No — there were no patients enrolled or treated in a clinical trial in this study; the work was performed using cell lines and plasmid-derived viruses.,True,False,"Model said No (no patients/clinical trial), matching original but not updated Not reported."
25637519-14,25637519,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,No — the study itself did not report sequences from individuals with prior ARV exposure; it only cites other reports where D404N was found in ART-experienced patients.,True,False,"Model said No sequences from ARV-experienced individuals, matching original but not updated Not applicable."
25637519-15,25637519,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable — no individuals were sampled or sequenced in this study. (The study itself tested NNRTIs and NRTIs in vitro.),True,True,"Model said Not applicable (no individuals), matching both."
25637519-16,25637519,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable — no study participants or patient-derived samples were sequenced. (The paper notes externally that D404N has been found in patients receiving nevirapine and efavirenz in other studies.),True,True,"Model said Not applicable (no individuals), matching both."
26246578-1,26246578,1,Does the paper report HIV sequences from patient samples?,No,Not reported,No.,True,False,"Model said No, matching original but not updated Not reported."
26246578-2,26246578,2,Does the paper report in vitro drug susceptibility data?,Yes,Not reported,Yes.,True,False,"Model said Yes, matching original but not updated Not reported."
26246578-3,26246578,3,Were sequences from the paper made publicly available?,No,Not reported,No sequences were reported as being made publicly available.,True,False,"Model said No (not publicly available), matching original but not updated Not reported."
26246578-4,26246578,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model said none reported, matching original No and updated Not reported."
31988104-11,31988104,11,What type of samples were sequenced?,No,Not applicable,Patient-derived clinical isolates from ART-experienced patients.,False,False,"Model gives a specific sample type, but humans indicated no applicable sequencing samples reported."
31988104-12,31988104,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,Not specified.,False,True,"Model says not specified, which aligns with info being unavailable (Not applicable), but not with a definitive No."
31988104-13,31988104,13,Were the patients in the study in a clinical trial?,No,No,No—patient-derived isolates were used for in vitro experiments; clinical trials mentioned are separate referenced studies.,True,True,"Model answers No, matching both annotations."
31988104-14,31988104,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not applicable,Yes.,True,False,"Model says Yes, matching original Yes but not updated Not applicable."
31988104-15,31988104,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,NRTIs (nucleoside/nucleotide reverse transcriptase inhibitors) are implicated based on the mutations described.,False,False,Model lists a drug class despite humans indicating none/applicable not reported.
31988104-16,31988104,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Not explicitly specified; mutations suggest prior exposure to thymidine analogs (e.g., zidovudine/stavudine) and lamivudine/emtricitabine.",False,True,"Model states not explicitly specified (info unavailable), which fits Not applicable, though it speculates examples."
32601157-1,32601157,1,Does the paper report HIV sequences from patient samples?,No,No,No,True,True,"Model says No, matching both."
32601157-2,32601157,2,Does the paper report in vitro drug susceptibility data?,Yes,Yes,Yes,True,True,"Model says Yes, matching both."
32601157-3,32601157,3,Were sequences from the paper made publicly available?,No,No,No (no public sequence accession information is provided),True,True,"Model says No and notes no accessions, matching both."
32601157-4,32601157,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported,True,True,"Model says none reported, matching lack of accession numbers."
32601157-5,32601157,5,How many individuals had samples obtained for HIV sequencing?,0,0,None (0 individuals),True,True,"Model states 0 individuals, matching both."
32601157-6,32601157,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable / None reported,False,True,"Model conveys not applicable/none reported; aligns with updated NA, not with original No."
32601157-7,32601157,7,From what years were the sequenced samples obtained?,No,Not applicable,Not applicable / None reported,False,True,"Model conveys not applicable/none reported; aligns with updated NA, not with original No."
32601157-8,32601157,8,Were samples cloned prior to sequencing?,No,Not applicable,Yes (cloned as plasmid constructs prior to sequencing),False,False,"Model says Yes (cloned), conflicting with both No and Not applicable."
32601157-9,32601157,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,Integrator (IN) coding sequence (HIV-1 integrase gene),False,False,"Model names integrase sequenced, but humans indicated no applicable sequencing reported."
32601157-10,32601157,10,What method was used for sequencing?,No,Not applicable,Not specified beyond 'sequencing' (method/platform not stated),False,True,"Model says not specified (info unavailable), matching updated NA but not original No."
32601157-11,32601157,11,What type of samples were sequenced?,No,Not applicable,Plasmid DNA constructs containing mutant IN coding sequences (cloned IN ORFs),False,False,"Model specifies plasmid constructs, contradicting the NA/No annotations."
32601157-12,32601157,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No,True,False,"Model says No, matching original but not updated Not applicable."
32601157-13,32601157,13,Were the patients in the study in a clinical trial?,No,Not applicable,No (no patients were enrolled; study used in vitro constructs),True,True,"Model says No and clarifies no patients were enrolled, aligning with both and indicating NA context."
32601157-14,32601157,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,No,True,False,"Model says No, matching original but not updated Not applicable."
32601157-15,32601157,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable / None reported,False,True,"Model explicitly says Not applicable/None reported, matching updated NA but not original No."
32601157-16,32601157,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable / None reported,False,True,"Model explicitly says Not applicable/None reported, matching updated NA but not original No."
33855437-1,33855437,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes,True,True,"Model says Yes, matching both."
33855437-2,33855437,2,Does the paper report in vitro drug susceptibility data?,Yes,Not reported,Yes,True,False,"Model says Yes, matching original but not updated Not reported."
33855437-3,33855437,3,Were sequences from the paper made publicly available?,Yes,Yes,Yes,True,True,"Model says Yes, matching both."
35913500-6,35913500,6,From which countries were the sequenced samples obtained?,US,Not reported,"Not applicable — no sequences were reported. The study population was from a single clinic in San Francisco, United States.",False,True,"Model states no sequences were reported (not applicable), contradicting human 'US' but matching updated 'Not reported'."
35913500-7,35913500,7,From what years were the sequenced samples obtained?,2021-2022,Not reported,Not applicable — sequencing dates are not reported. Clinical activity and sample collection occurred between early 2021 and April 2022.,False,True,Model says sequencing dates not reported; human gave 2021–2022. Matches updated 'Not reported'.
35913500-8,35913500,8,Were samples cloned prior to sequencing?,No,Not reported,Not applicable / not reported — the paper does not describe any cloning or sequencing methods.,False,True,"Model: cloning/sequencing not reported. Human said 'No'. Aligns with updated 'Not reported', not original."
35913500-9,35913500,9,Which HIV genes were reported to have been sequenced?,"RT, IN",Not reported,Not applicable — the paper does not report sequencing of genes; it discusses resistance mutations related to integrase and rilpivirine (NNRTI) without presenting gene sequence data.,False,True,"Model: no gene sequencing reported. Human listed RT, IN. Matches updated 'Not reported' only."
35913500-10,35913500,10,What method was used for sequencing?,No,Not reported,Not reported / not applicable — the paper does not describe any sequencing methods.,False,True,Model: sequencing method not reported. Human answered 'No'. Matches updated 'Not reported'.
35913500-11,35913500,11,What type of samples were sequenced?,No,Not reported,"Not applicable — sequencing is not reported; however, the paper indicates blood work was obtained for resistance testing and viral load measurements (ie, plasma/blood samples).",False,True,Model: no sequencing reported (NA); human answered 'No'. Matches updated 'Not reported' despite extra context about blood/plasma.
35913500-12,35913500,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,"The paper does not report sequences, but it does report resistance testing and a baseline N155H mutation in a patient with detectable viremia; resistance testing was planned for those with persistent detectable viral load.",False,True,Model notes sequences not reported; human said 'Yes'. Aligns with updated 'Not reported'.
35913500-13,35913500,13,Were the patients in the study in a clinical trial?,No,Not reported,"No — this was a demonstration project / observational program, not a clinical trial.",True,False,"Model correctly says not a clinical trial, matching human 'No' but not updated 'Not reported'."
35913500-14,35913500,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,"Not applicable — no sequences are reported. The study population included individuals with prior ART exposure and reported resistance mutations (eg, N155H) consistent with prior treatment.",False,True,Model: no sequences reported; human said 'Yes'. Matches updated 'Not reported'.
35913500-15,35913500,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,"The manuscript references nucleoside/nucleotide reverse transcriptase inhibitors (eg, tenofovir/emtricitabine), nonnucleoside reverse transcriptase inhibitors (rilpivirine-associated resistance), and integrase strand transfer inhibitors (INSTIs).",False,False,Model lists prior ARV classes despite sequencing not reported; conflicts with human 'No' and updated 'Not reported'.
35913500-16,35913500,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not reported,Specific drugs mentioned in the manuscript include tenofovir/emtricitabine (a NRTI combination) and references to rilpivirine (RPV) and cabotegravir (CAB) as the LAI regimen; no other individual prior ARV drugs are enumerated or sequencing-specific drug exposures reported.,False,False,Model lists specific drugs; conflicts with human 'No' and updated 'Not reported'.
35945163-1,35945163,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes — the paper reports HIV resistance-associated mutations detected in patient samples.,True,False,"Model says sequences were reported, matching human 'Yes' but not updated 'Not reported'."
35945163-2,35945163,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No — the paper does not report in vitro phenotypic drug susceptibility data.,True,False,"Model says no in vitro susceptibility, matching human 'No' but not updated 'Not reported'."
35945163-3,35945163,3,Were sequences from the paper made publicly available?,No,Not reported,No — the paper does not indicate that sequences were deposited or made publicly available.,True,False,"Model says sequences were not made public, matching human 'No' but not updated 'Not reported'."
35945163-4,35945163,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model: none reported, which aligns with human 'No' and updated 'Not reported'."
35945163-5,35945163,5,How many individuals had samples obtained for HIV sequencing?,6,Not reported,Not explicitly reported — the paper does not state the number of individuals who underwent sequencing.,False,True,Model: number not reported; human gave '6'. Matches updated 'Not reported'.
35945163-6,35945163,6,From which countries were the sequenced samples obtained?,"UK, USA, Belgium, Canada, Netherlands, Switzerland, Portugal, Italy, South Korea, Spain",Not reported,"Samples (participants) were from the UK, USA, Belgium, Canada, Netherlands, Switzerland, Portugal, Italy, South Korea, and Spain.",True,False,Model lists countries matching human list; conflicts with updated 'Not reported'.
35945163-7,35945163,7,From what years were the sequenced samples obtained?,2016-2020,Not reported,From February 2016 through July 2020.,True,False,"Model gives 2016–2020, matching human answer; not updated 'Not reported'."
35945163-8,35945163,8,Were samples cloned prior to sequencing?,No,Not reported,Not reported / No information provided.,False,True,Model says cloning status not reported; human said 'No'. Matches updated 'Not reported'.
35945163-9,35945163,9,Which HIV genes were reported to have been sequenced?,"RT, IN",Not reported,Reverse transcriptase and integrase (mutations in reverse transcriptase/NNRTI-associated sites and integrase were reported).,True,False,"Model identifies RT and IN, matching human; not updated 'Not reported'."
35945163-10,35945163,10,What method was used for sequencing?,No,Not reported,Not reported.,False,True,Model: sequencing method not reported; human answered 'No'. Matches updated 'Not reported'.
35945163-11,35945163,11,What type of samples were sequenced?,Plasma,Not reported,"Not explicitly stated; resistance and viral load data were reported from plasma measurements, so sequencing likely used plasma-derived virus, but the sample type is not explicitly reported.",False,True,Model: sample type not explicitly reported; human said 'Plasma'. Matches updated 'Not reported'.
35945163-12,35945163,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,Yes — sequences (resistance-associated mutations) were reported from individuals who stopped therapy because of incomplete virological response.,False,False,"Model says 'Yes' sequences from virological failure, contradicting human 'No' and updated 'Not reported'."
35945163-13,35945163,13,Were the patients in the study in a clinical trial?,No,Not reported,"No — participants were enrolled in a compassionate use programme, not a clinical trial.",True,False,"Model correctly states not a clinical trial, matching human 'No' but not updated 'Not reported'."
35945163-14,35945163,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,"Yes — many participants had prior ART exposure, and resistance mutations reported relate to prior or study treatment.",True,False,"Model says sequences from previously treated individuals were reported, matching human 'Yes' but not updated 'Not reported'."
30803972-2,30803972,2,Does the paper report in vitro drug susceptibility data?,Yes,Yes,Yes.,True,True,"Model answered Yes, matching both annotations."
30803972-3,30803972,3,Were sequences from the paper made publicly available?,No,No,No — the paper does not report making sequences publicly available.,True,True,"Model said sequences were not made public, matching No."
30803972-4,30803972,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model said none reported, aligning with No/Not reported."
30803972-5,30803972,5,How many individuals had samples obtained for HIV sequencing?,0,0,Not applicable — no patient-derived sequencing was performed.,True,True,"Model stated no sequencing was done, equivalent to 0 individuals."
30803972-6,30803972,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable — no sequences were reported and no country-of-origin for sequenced samples is provided.,True,True,"Model said not applicable due to no sequences, matching both."
30803972-7,30803972,7,From what years were the sequenced samples obtained?,No,Not applicable,"Not applicable — no sequencing was reported, so no sample years are provided.",True,True,"Model said not applicable due to no sequencing, matching both."
30803972-8,30803972,8,Were samples cloned prior to sequencing?,No,Not applicable,"Not applicable — sequencing was not performed; however, the study used molecular clones and constructed site-directed mutants.",True,True,"Model said not applicable (no sequencing), consistent with the intent of the original No and the updated NA."
30803972-9,30803972,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,No genes were reported as sequenced; the study focused on the integrase-encoding region (integrase in pol) for site-directed mutagenesis and phenotypic testing.,True,True,"Model stated no genes were sequenced, matching both."
30803972-10,30803972,10,What method was used for sequencing?,No,Not applicable,Not applicable — the paper does not report any sequencing methods.,True,True,"Model said no sequencing method reported/not applicable, matching both."
30803972-11,30803972,11,What type of samples were sequenced?,No,Not applicable,Not applicable — no samples were sequenced in this study.,True,True,"Model said not applicable—no samples sequenced, matching both."
30803972-12,30803972,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No — the study did not obtain or report sequences from individuals with virological failure on treatment.,True,True,"Model said no sequences from VF individuals, consistent with No/Not applicable."
30803972-13,30803972,13,Were the patients in the study in a clinical trial?,No,No,"No — the paper reports in vitro experiments with virus isolates and clones, not a clinical trial.",True,True,"Model said not a clinical trial, matching No."
30803972-14,30803972,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,No — the isolates tested in this study were from ART-naive individuals.,True,True,"Model answered No (ART‑naive), consistent with No/Not applicable."
30803972-15,30803972,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable — individuals were ART-naive and no sequencing was performed.,True,True,"Model said not applicable/ART‑naive, matching both."
30803972-16,30803972,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,None — the individuals were ART-naive; no sequencing was performed.,True,True,"Model said none/ART‑naive, matching both."
31988104-1,31988104,1,Does the paper report HIV sequences from patient samples?,No,No,Yes.,False,False,"Model said Yes, but both annotations say No."
31988104-2,31988104,2,Does the paper report in vitro drug susceptibility data?,Yes,Yes,Yes.,True,True,"Model answered Yes, matching both."
31988104-3,31988104,3,Were sequences from the paper made publicly available?,No,No,No evidence of public deposition is reported.,True,True,"Model said no public deposition, matching No."
31988104-4,31988104,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,The paper does not report GenBank accession numbers for the study's sequenced HIV isolates.,True,True,"Model said no accession numbers reported, matching No/Not reported."
31988104-5,31988104,5,How many individuals had samples obtained for HIV sequencing?,0,0,14 patient-derived isolates were used.,False,False,"Model said 14, but both annotations say 0."
31988104-6,31988104,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not specified in the paper.,True,True,"Model said not specified, clearly conveying unavailable info; aligns with No/Not applicable."
31988104-7,31988104,7,From what years were the sequenced samples obtained?,No,Not applicable,Not specified in the paper.,True,True,"Model said not specified, clearly conveying unavailable info; aligns with No/Not applicable."
31988104-8,31988104,8,Were samples cloned prior to sequencing?,No,Not applicable,"Yes, patient-derived fragments were cloned into plasmid backbones to create recombinant viruses.",False,False,"Model said Yes to cloning prior to sequencing, contradicting No/Not applicable."
31988104-9,31988104,9,Which HIV genes were reported to have been sequenced?,RT,Not applicable,The reverse transcriptase (RT) region of the pol gene was targeted.,True,False,"Model named RT, matching the original ‘RT’ but not the updated Not applicable."
31988104-10,31988104,10,What method was used for sequencing?,No,Not applicable,The sequencing method is not specified in the paper.,True,True,"Model said sequencing method not specified, conveying unavailability and aligning with No/Not applicable."
33855437-4,33855437,4,What were the GenBank accession numbers for sequenced HIV isolates?,"MW484894, MW484895, MW484893, DQ380549, AF492618","MW484894, MW484895, MW484893, DQ380549, AF492618","MW484894, MW484895, MW484893, DQ380549, AF492618, MW48492 (as printed), AF324493 (pNL4.3)",False,False,"Model added extra/hallucinated accession numbers (e.g., AF324493, malformed MW48492) beyond the listed five."
33855437-5,33855437,5,How many individuals had samples obtained for HIV sequencing?,6 or 7,Not reported,Six individuals (three subtype B and three non-B clinical isolates),False,False,Model states six; original says '6 or 7' and updated says 'Not reported'—does not match either.
33855437-6,33855437,6,From which countries were the sequenced samples obtained?,"Canada, Ethiopia",Canada; Ethiopia,Explicitly stated: Ethiopia (isolate 4742); others obtained from Clinique Actuel (location not specified in the paper) and from the National Institutes of Health (USA).,False,False,Model mentions USA and omits Canada; humans list Canada and Ethiopia.
33855437-7,33855437,7,From what years were the sequenced samples obtained?,No,Not reported,Not reported in the paper.,True,True,"Model clearly states 'Not reported,' matching both 'No' (unavailable) and 'Not reported.'"
33855437-8,33855437,8,Were samples cloned prior to sequencing?,No,No,No evidence of cloning prior to sequencing; genotypic analyses were performed on viral RNA and amplified viruses from culture supernatants.,True,True,"Model indicates no cloning prior to sequencing, matching 'No.'"
33855437-9,33855437,9,Which HIV genes were reported to have been sequenced?,RT,RT,The reverse transcriptase (RT) region (pol gene/RT) was sequenced or genotyped to monitor NNRTI/NRTI-associated mutations.,True,True,"Model specifies RT, matching 'RT.'"
33855437-10,33855437,10,What method was used for sequencing?,No,Not reported,Not specified beyond 'genotypic analyses' of extracted viral RNA and re-genotyping; no sequencing platform or method (e.g. Sanger or NGS) is reported.,True,True,"Model says method not specified, aligning with 'No/Not reported.'"
33855437-11,33855437,11,What type of samples were sequenced?,No,Not reported,Viral RNA from cultured virus—aliquots of cell culture supernatant from serially passaged patient-derived viral isolates (CBMC cultures) were used for genotypic analyses.,False,False,Model asserts a specific sample type; humans indicate it was not reported.
33855437-12,33855437,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,"No clear evidence of sequences from individuals with virological failure; most isolates were from drug‑naive individuals, although one isolate (96USSN20) harboured baseline thymidine analogue mutations.",True,True,"Model conveys no sequences from virological failure, matching 'No.'"
33855437-13,33855437,13,Were the patients in the study in a clinical trial?,No,No,No,True,True,"Model answers 'No,' matching both annotations."
33855437-14,33855437,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,No,"Mostly no — isolates were from drug‑naive individuals; however, one isolate (96USSN20) carried baseline thymidine analogue mutations consistent with prior NRTI exposure.",False,False,"Model hedges ('mostly no') and suggests prior exposure, contradicting a clear 'No.'"
33855437-15,33855437,15,Which drug classes were received by individuals in the study before sample sequencing?,No,nan,Thymidine analogue NRTIs (inferred for isolate 96USSN20); most other individuals were drug‑naive and had not received ARVs.,False,False,"Model infers NRTI class exposure; human original indicates none/not reported, and updated is undefined (nan)."
33855437-16,33855437,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Not specified by drug name; only thymidine-analogue resistance mutations (D67N, T69D, K70R) are reported for one isolate, indicating exposure to thymidine-analogue NRTIs, but specific drug names are not provided.",False,False,Model implies exposure but no drug names; humans indicate none/not applicable.
34516245-1,34516245,1,Does the paper report HIV sequences from patient samples?,No,Yes,No.,True,False,"Model says 'No,' matching original but contradicting updated 'Yes.'"
34516245-2,34516245,2,Does the paper report in vitro drug susceptibility data?,Yes,Not reported,Yes.,True,False,"Model says 'Yes,' matching original but not updated 'Not reported.'"
34516245-3,34516245,3,Were sequences from the paper made publicly available?,Yes,Yes,Yes.,True,True,"Model says 'Yes,' matching both."
34516245-4,34516245,4,What were the GenBank accession numbers for sequenced HIV isolates?,OK263149 to OK263162,OK263149-OK263162,OK263149 to OK263162.,True,True,"Model gives OK263149–OK263162, equivalent formatting to both annotations."
34516245-5,34516245,5,How many individuals had samples obtained for HIV sequencing?,0,Not reported,None (0 individuals); sequences were from laboratory virus stocks and culture supernatants.,True,False,"Model states 0 individuals, matching original; updated says 'Not reported.'"
34516245-6,34516245,6,From which countries were the sequenced samples obtained?,No,Not reported,Not applicable — samples were laboratory-derived (no country of origin for patient samples reported).,True,True,"Model notes not applicable/not reported, aligning with both 'No' and 'Not reported.'"
34516245-7,34516245,7,From what years were the sequenced samples obtained?,No,Not reported,Not reported / not applicable.,True,True,"Model states not reported/not applicable, matching both."
34516245-8,34516245,8,Were samples cloned prior to sequencing?,Yes,Not reported,Yes.,True,False,"Model says 'Yes,' matching original; updated says 'Not reported.'"
34516245-9,34516245,9,Which HIV genes were reported to have been sequenced?,RT,Not reported,The full-length reverse transcriptase (RT) gene.,True,False,"Model identifies RT, matching original; updated says 'Not reported.'"
34516245-10,34516245,10,What method was used for sequencing?,No,Not reported,"Population (double-stranded) sequencing of RT PCR products submitted to ACGT, Inc., and clonal sequencing of RT inserts after cloning into pGEM-T (Sanger-style sequencing).",False,False,Model provides specific methods; humans say not reported.
34516245-11,34516245,11,What type of samples were sequenced?,No,Not reported,"Viral RNA purified from cell culture supernatants (passaged virus), converted to cDNA, PCR-amplified, and cloned PCR products.",False,False,Model specifies sample type; humans indicate not reported.
34516245-12,34516245,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,No.,True,False,"Model answers 'No,' matching original but not the updated 'Not reported.'"
27124362-16,27124362,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable — no patient sequencing was reported; the paper references 3TC or FTC as common regimen components and discusses RPV as an NNRTI.,True,True,Model says Not applicable and explains no patient sequencing; aligns with unavailable info and updated NA.
28559249-1,28559249,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,No.,False,False,"Model answers No, which conflicts with original Yes and does not convey Not reported."
28559249-2,28559249,2,Does the paper report in vitro drug susceptibility data?,Yes,Not reported,Yes.,True,False,"Model answers Yes, matching original; not matching updated Not reported."
28559249-3,28559249,3,Were sequences from the paper made publicly available?,No,Not reported,No — the paper does not report that sequences were made publicly available.,True,False,"Model says No (not publicly available), matching original; not matching updated Not reported."
28559249-4,28559249,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported in this paper.,True,True,"Model states none reported, matching both original No and updated Not reported."
28559249-5,28559249,5,How many individuals had samples obtained for HIV sequencing?,1,Not reported,The paper reports isolates from 10 HIV-1 and 14 HIV-2 strains (24 isolates total) derived from individuals.,False,False,Model provides contradictory counts (24 isolates) not matching original 1 and not indicating Not reported.
28559249-6,28559249,6,From which countries were the sequenced samples obtained?,No,Not reported,Not fully specified; the paper indicates West Africa/Senegal involvement but does not provide a full country list for isolates.,True,True,"Model says not fully specified, effectively Not reported; acceptable for both."
28559249-7,28559249,7,From what years were the sequenced samples obtained?,No,Not reported,Not reported.,True,True,"Model explicitly says Not reported, matching both."
28559249-8,28559249,8,Were samples cloned prior to sequencing?,No,Not reported,Some viral strains used in the study were derived from full-length molecular clones and site-directed/recombinant clones were constructed.,False,False,Model gives cloning context without a clear answer; does not match original No or updated Not reported.
28559249-9,28559249,9,Which HIV genes were reported to have been sequenced?,RT,Not reported,The paper does not report sequencing of genes; it reports analysis of reverse transcriptase (RT) (part of pol) mutations and states pol gene origin for one recombinant.,False,True,"Model says no sequencing of genes was reported, contradicting original RT but matching updated Not reported."
28559249-10,28559249,10,What method was used for sequencing?,No,Not reported,Not reported — no sequencing methods are described in this paper.,True,True,"Model says Not reported for sequencing method, matching both."
28559249-11,28559249,11,What type of samples were sequenced?,No,Not reported,"The study used viral isolates derived from patient samples (clinical isolates) and molecular clones; however, no sequencing of those samples is reported.",True,True,"Model states no sequencing reported, aligning with unavailable info and updated Not reported."
28559249-12,28559249,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,"The paper used a recombinant clone derived from a patient receiving antiretroviral therapy (AZT, 3TC, ritonavir-boosted lopinavir), but it does not state sequencing was performed on that patient's virus within this report.",False,True,"Model indicates it is not stated whether sequences were obtained, mismatching original No but matching updated Not reported."
28559249-13,28559249,13,Were the patients in the study in a clinical trial?,No,Not reported,No indication that the patients providing isolates for this study were participants in a clinical trial.,False,True,"Model says no indication patients were in a clinical trial (i.e., not reported), mismatching original No but matching updated Not reported."
28559249-14,28559249,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,"Yes — the paper includes a recombinant clone (4.7a) derived from a patient who had received ARV drugs (AZT, lamivudine/3TC, and ritonavir-boosted lopinavir), though sequence data are not presented in this paper.",False,False,Model asserts Yes but also says sequences not presented—contradictory; does not cleanly match either annotation.
28559249-15,28559249,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, PI",Not reported,Nucleoside reverse transcriptase inhibitors (NRTIs) and a protease inhibitor (boosted lopinavir).,True,False,"Model lists NRTI and PI, matching original; not matching updated Not reported."
28559249-16,28559249,16,Which drugs were received by individuals in the study before sample sequencing?,"AZT, 3TC, LPV",Not applicable,"AZT (zidovudine), lamivudine (3TC), and ritonavir-boosted lopinavir.",True,False,"Model lists AZT, 3TC, and boosted LPV, matching original; not matching updated Not applicable."
29373677-1,29373677,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes,True,True,"Model answers Yes, matching both original and updated Yes."
29373677-2,29373677,2,Does the paper report in vitro drug susceptibility data?,Yes,Not reported,Yes,True,False,"Model answers Yes, matching original; not matching updated Not reported."
29373677-3,29373677,3,Were sequences from the paper made publicly available?,No,No,Not reported in the paper,False,False,"Model says Not reported, which does not match original or updated No."
29373677-4,29373677,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers are reported,True,True,"Model says no GenBank numbers reported, matching both."
29373677-5,29373677,5,How many individuals had samples obtained for HIV sequencing?,1,Not reported,One individual (a single patient case),True,False,"Model states one individual, matching original; not matching updated Not reported."
29373677-6,29373677,6,From which countries were the sequenced samples obtained?,No,Not reported,Not specified in the paper,True,True,"Model says not specified, aligning with both original No (unavailable) and updated Not reported."
29373677-7,29373677,7,From what years were the sequenced samples obtained?,2008-2015,Not reported,"Samples and genotypic analyses relate to the period 2008–2015, with key events in 2014–2015 (dolutegravir introduced in 2014 and virological failure observed five months later).",True,False,"Model provides 2008–2015, matching original; not matching updated Not reported."
29373677-8,29373677,8,Were samples cloned prior to sequencing?,No,Not reported,No cloning prior to sequencing is described in the paper,True,True,"Model states no cloning prior to sequencing is described, aligning with original No and with updated Not reported phrasing."
26246578-5,26246578,5,How many individuals had samples obtained for HIV sequencing?,0,Not reported,Zero — no individuals were sampled for sequencing.,True,False,"Model gives a specific count (0), matching the original, but not the updated 'Not reported'."
26246578-6,26246578,6,From which countries were the sequenced samples obtained?,No,Not reported,Not applicable — no patient-derived sequences or samples were obtained from any country.,True,True,"Model says not applicable/no countries due to no sequencing, aligning with original 'No' and updated 'Not reported' (info unavailable)."
26246578-7,26246578,7,From what years were the sequenced samples obtained?,No,Not reported,Not applicable — no sequencing of patient samples was performed.,True,True,"Model states not applicable due to no sequencing, consistent with both answers."
26246578-8,26246578,8,Were samples cloned prior to sequencing?,No,Not reported,"Not applicable — no sequencing was performed; however, engineered plasmid clones were generated by site-directed mutagenesis.",True,True,"Model notes not applicable (no sequencing), matching the original 'No' and conveying no info reported."
26246578-9,26246578,9,Which HIV genes were reported to have been sequenced?,IN,Not reported,None — no sequencing was reported; the study focused on the integrase (IN) gene via engineered mutations.,False,True,"Model says none were sequenced, contradicting original 'IN' but consistent with updated 'Not reported'."
26246578-10,26246578,10,What method was used for sequencing?,No,Not reported,Not applicable — no sequencing method is described because no sequencing was reported.,True,True,"Model: not applicable/no method reported, matching 'No' and indicating info not reported."
26246578-11,26246578,11,What type of samples were sequenced?,No,Not reported,"Not applicable — no sequencing of samples was performed; the study used plasmid constructs, recombinant proteins, and cell-culture–derived viruses.",True,True,"Model: not applicable/no samples sequenced, consistent with both answers."
26246578-12,26246578,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,"No — the study did not obtain sequences from any individuals, including those with virological failure.",True,False,"Model answers 'No', matching original, but not the updated 'Not reported' requirement."
26246578-13,26246578,13,Were the patients in the study in a clinical trial?,No,Not reported,No — there were no patients in this study; it was an in vitro laboratory study.,True,False,"Model says 'No' (no patients/clinical trial), matching original but not updated 'Not reported'."
26246578-14,26246578,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No — the paper does not report sequences from such individuals.,True,False,"Model answers 'No', aligning with original but not with updated 'Not reported'."
26246578-15,26246578,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,Not applicable — there were no individuals or sample sequencing; the study used integrase inhibitors (INSTIs) in in vitro assays.,True,True,"Model: not applicable (no individuals/sequencing), matching original and conveying info unavailable."
26246578-16,26246578,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Not applicable — no individuals received drugs and no sample sequencing was done; experimentally, the study used the drugs dolutegravir (DTG), raltegravir (RAL) and elvitegravir (EVG) in vitro.",True,True,"Model: not applicable, matching both original and updated 'Not applicable'."
26311878-1,26311878,1,Does the paper report HIV sequences from patient samples?,No,No,"No. The paper reports sequences from plasmids and tissue-culture viruses, not from patient samples.",True,True,"Model correctly answers 'No' to patient-derived sequences, matching both."
26311878-2,26311878,2,Does the paper report in vitro drug susceptibility data?,Yes,Not reported,"Yes. The paper reports in vitro susceptibility (IC50) measurements to DTG, RAL, and EVG.",True,False,"Model says 'Yes' (in vitro susceptibility reported), matching original but not updated 'Not reported'."
26311878-3,26311878,3,Were sequences from the paper made publicly available?,No,No,"No. The paper does not report any public deposition (e.g., GenBank accession numbers) for sequences generated in this study.",True,True,"Model says sequences not made public, matching both."
26311878-4,26311878,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported in the paper.,True,True,"Model states none reported, aligning with original 'No' and updated 'Not reported'."
26311878-5,26311878,5,How many individuals had samples obtained for HIV sequencing?,0,0,Zero; no individual/patient samples were sequenced in this study.,True,True,"Model says zero individuals, matching both."
26311878-6,26311878,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable; sequenced material was laboratory-derived (plasmids and tissue-culture viruses).,True,True,"Model: not applicable (lab-derived), matching original and updated."
26311878-7,26311878,7,From what years were the sequenced samples obtained?,No,Not applicable,Not reported / not applicable.,True,True,"Model: not reported/not applicable, matching both."
26311878-8,26311878,8,Were samples cloned prior to sequencing?,No,Not applicable,Yes. Plasmids bearing the integrase mutations were generated (cloned) by site-directed mutagenesis and verified by sequencing; replication-competent genetically homogeneous viruses were produced from these plasmids.,False,False,"Model says 'Yes' (cloning prior to sequencing), contradicting both original 'No' and updated 'Not applicable'."
26311878-9,26311878,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,Integrase (IN).,False,False,"Model lists IN as sequenced, contradicting original 'No' and updated 'Not applicable'."
26311878-10,26311878,10,What method was used for sequencing?,No,Not applicable,"Viral RNA was extracted and amplified by RT-PCR, and the PCR products were sequenced; plasmids were also verified by sequencing. The specific sequencing technology (e.g., Sanger or NGS) is not specified.",False,False,"Model provides a sequencing method, contradicting both original 'No' and updated 'Not applicable'."
26311878-11,26311878,11,What type of samples were sequenced?,No,Not applicable,Sequencing was performed on PCR products derived from viral RNA extracted from tissue-culture supernatants and on plasmid DNA used to generate engineered viruses.,False,False,"Model specifies sequenced sample types, contradicting both original 'No' and updated 'Not applicable'."
26311878-12,26311878,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No. The study did not sequence samples from individuals with treatment failure; mentions of such individuals refer to prior reports in the literature.,True,False,"Model answers 'No', matching original but not the updated 'Not applicable' requirement."
26311878-13,26311878,13,Were the patients in the study in a clinical trial?,No,Not reported,"No. The study is an in vitro laboratory study using cell lines, primary cells, and engineered plasmids/viruses, not a clinical trial.",True,False,"Model answers 'No' (not a clinical trial), matching original but not updated 'Not reported'."
27009474-7,27009474,7,From what years were the sequenced samples obtained?,No,Not reported,2014 (patient sample) and 2015 (clones created/characterized).,False,False,"Model gives specific years, whereas both annotations indicate the years are not reported."
27009474-8,27009474,8,Were samples cloned prior to sequencing?,Yes,Yes,"Yes, infectious molecular clones and a recombinant infectious molecular clone from the patient's sample were created.",True,True,"Model affirms cloning, matching the annotated 'Yes'."
27009474-9,27009474,9,Which HIV genes were reported to have been sequenced?,IN,IN,Integrase was sequenced and reported; reverse transcriptase and protease regions were also genotyped (mutations reported).,True,True,Model identifies integrase as sequenced; extra mention of RT/PR as genotyped does not contradict.
27009474-10,27009474,10,What method was used for sequencing?,No,Not reported,The specific sequencing method is not specified in the paper.,True,True,"Model states the sequencing method is not specified, matching not reported."
27009474-11,27009474,11,What type of samples were sequenced?,No,Not reported,Plasma-derived samples (patient's plasma sample) were used.,False,False,"Model specifies plasma samples, contradicting the annotations that the sample type was not reported."
27009474-12,27009474,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,No — the patient whose sample was sequenced was virologically suppressed (plasma HIV-1 RNA <50 copies/ml) on therapy.,True,True,"Model says no sequences from virological failures, matching 'No'."
27009474-13,27009474,13,Were the patients in the study in a clinical trial?,No,No,No; the report describes a single clinical case and does not indicate participation in a clinical trial.,True,True,"Model states not a clinical trial, matching 'No'."
27009474-14,27009474,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,The primary sequence in this study was from a treatment-naive individual with transmitted resistance; the paper also references GenBank sequences from raltegravir-experienced individuals.,True,True,"Model indicates sequences from ARV-experienced individuals (via GenBank) were included, aligning with 'Yes'."
27009474-15,27009474,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, INSTI","NRTI, INSTI",The reported patient was treated with an INSTI-containing regimen and NRTIs (tenofovir and emtricitabine); cobicistat was included as a pharmacoenhancer.,True,True,"Model lists INSTI and NRTIs, matching the annotated classes."
27009474-16,27009474,16,Which drugs were received by individuals in the study before sample sequencing?,"Tenofovir, Emtricitabine, Elvitegravir","Tenofovir (TDF), Emtricitabine (FTC), Elvitegravir (EVG)","Tenofovir, emtricitabine, elvitegravir, and cobicistat.",True,True,"Model lists tenofovir, emtricitabine, and elvitegravir (plus cobicistat), covering the annotated drugs."
27124362-1,27124362,1,Does the paper report HIV sequences from patient samples?,No,No,No.,True,True,"Model answers 'No,' matching both annotations."
27124362-2,27124362,2,Does the paper report in vitro drug susceptibility data?,Yes,Yes,Yes.,True,True,"Model answers 'Yes,' matching both annotations."
27124362-3,27124362,3,Were sequences from the paper made publicly available?,No,No,No sequences or accession numbers are reported in the paper.,True,True,"Model says no sequences/accessions reported, matching 'No'."
27124362-4,27124362,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model states none reported, matching not reported."
27124362-5,27124362,5,How many individuals had samples obtained for HIV sequencing?,0,0,None — no patient sequencing was reported.,True,True,"Model indicates zero individuals sequenced, matching '0'."
27124362-6,27124362,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable — no patient-derived sequences were reported.,True,True,"Model says not applicable due to no sequences, aligning with no country data."
27124362-7,27124362,7,From what years were the sequenced samples obtained?,No,Not applicable,Not applicable — no patient-derived sequencing or sample collection years are reported.,True,True,"Model states not applicable due to no sequences, aligning with no years available."
27124362-8,27124362,8,Were samples cloned prior to sequencing?,No,Not applicable,Not applicable — sequencing of patient samples was not reported.,True,True,"Model says not applicable since no sequencing, consistent with annotations."
27124362-9,27124362,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,The paper reports mutations and analyses of the HIV-1 reverse transcriptase (RT) gene.,False,False,Model mentions RT gene despite no sequenced genes being applicable/reported.
27124362-10,27124362,10,What method was used for sequencing?,No,Not applicable,Not applicable — no sequencing method for patient-derived sequences is described in the paper.,True,True,"Model says not applicable since no sequencing, matching annotations."
27124362-11,27124362,11,What type of samples were sequenced?,No,Not applicable,Not applicable — the study tested laboratory HIV-1 vectors and cell-culture selected viral mutants rather than sequencing clinical samples.,True,True,"Model says not applicable since no clinical samples were sequenced, matching annotations."
27124362-12,27124362,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No — sequences were not obtained from such individuals in this study.,True,True,"Model says no such sequences were obtained, consistent with no/NA."
27124362-13,27124362,13,Were the patients in the study in a clinical trial?,No,Not reported,No — the study did not include patients or a clinical trial.,True,False,"Model answers 'No,' matching the original but not the updated 'Not reported' requirement."
27124362-14,27124362,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,No — the paper does not report sequencing of individuals with prior ARV exposure.,True,True,"Model answers 'No,' consistent with no sequencing and thus NA."
27124362-15,27124362,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,"Not applicable — no individuals were sequenced; however, the paper discusses cART regimens that include NRTIs (e.g., 3TC or FTC) and NNRTIs (RPV).",True,True,"Model states not applicable since no individuals were sequenced, matching annotations."
36659824-3,36659824,3,Were sequences from the paper made publicly available?,No,No,Not reported / No — the paper does not state that HIV sequences or sequence accession numbers were deposited in a public database.,True,True,"Model conveys no public deposition (“Not reported / No”), matching ‘No’."
36659824-4,36659824,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported / Not provided in the paper.,True,True,"Model says no accession numbers reported, matching ‘No’/‘Not reported’."
36659824-5,36659824,5,How many individuals had samples obtained for HIV sequencing?,14,14,Samples for genotyping were collected from the enrolled participants (118 participants were enrolled).,False,False,Model claims sampling from all 118 participants; human says 14.
36659824-6,36659824,6,From which countries were the sequenced samples obtained?,France,France,France.,True,True,"Model lists France, matching human answers."
36659824-7,36659824,7,From what years were the sequenced samples obtained?,2019-2020,2019–2020,Samples were obtained between November 2019 and September 2020 (2019–2020).,True,True,"Model gives 2019–2020, matching human answers."
36659824-8,36659824,8,Were samples cloned prior to sequencing?,No,No,Not reported / No indication of cloning prior to sequencing.,False,False,Human says ‘No’; model hedges ‘Not reported / No indication’ rather than a clear ‘No’.
36659824-9,36659824,9,Which HIV genes were reported to have been sequenced?,"RT, IN","RT, IN",At least reverse transcriptase and integrase regions are implicated (evidenced by detection of M184V in RT and E157Q in integrase).,True,True,"Model identifies RT and IN, matching human answers."
36659824-10,36659824,10,What method was used for sequencing?,No,Not reported,"Not specified — the paper refers to HIV resistance genotyping but does not describe the sequencing or genotyping method (e.g., Sanger or NGS).",True,True,"Model says not specified, matching ‘No’/‘Not reported’."
36659824-11,36659824,11,What type of samples were sequenced?,No,Not reported,"Blood-derived samples (baseline samples collected at the visit; plasma HIV-1 RNA was quantified), i.e. plasma/blood samples.",False,False,"Human says not reported; model asserts plasma/blood, which contradicts."
36659824-12,36659824,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Yes,Yes — resistance genotyping was performed for individuals with virological non-response and the paper reports that no emergent resistance-associated mutations were detected in those who did not achieve viral suppression.,True,True,"Model answers Yes, matching human answers."
36659824-13,36659824,13,Were the patients in the study in a clinical trial?,Yes,Not reported,"Yes — this was a registered clinical study (a national, multicentre, prospective, open-label single-arm study) registered on ClinicalTrials.gov (NCT03858478).",True,False,"Model says Yes (trial), matching original ‘Yes’ but contradicting updated ‘Not reported’."
36659824-14,36659824,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,No — the study population was ART-naive and pretreated individuals were protocol violations and excluded from the main ITT analysis; the paper does not report sequence data specifically from previously treated individuals.,False,False,Human says Yes; model says No—contradiction.
36659824-15,36659824,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, INSTI","NRTI, INSTI",Not reported — the paper does not provide information on antiretroviral drug classes received prior to sequencing for any participants (the study enrolled ART‑naive patients).,False,False,"Human lists NRTI, INSTI; model says not reported—contradiction."
36659824-16,36659824,16,Which drugs were received by individuals in the study before sample sequencing?,"BIC, FTC, TAF","BIC, FTC, TAF",Not reported / None specified — the paper does not list any specific antiretroviral drugs received prior to sequencing.,False,False,"Human lists BIC, FTC, TAF; model says not reported—contradiction."
36660819-1,36660819,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes — the paper reports genotypic (sequence-based) resistance results from participant samples (resistance-associated mutations).,True,True,"Model affirms sequences/genotypic data reported, matching ‘Yes’."
36660819-2,36660819,2,Does the paper report in vitro drug susceptibility data?,No,No,No — the provided content does not present in vitro drug susceptibility (phenotypic) data or susceptibility assay results.,True,True,"Model says no in vitro susceptibility, matching ‘No’."
36660819-3,36660819,3,Were sequences from the paper made publicly available?,No,No,No — the provided paper content does not indicate that sequence data were deposited in a public database; data are available on request to the management group.,True,True,"Model states not publicly available, matching ‘No’."
36660819-4,36660819,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported in the provided paper content.,True,True,Model: none reported; matches ‘No’/‘Not reported’.
36660819-5,36660819,5,How many individuals had samples obtained for HIV sequencing?,8 and 10,Not reported,The paper reports sequencing/genotypic results for participants with confirmed virologic failure — 14 participants with CVF through week 152.,False,False,Human ‘8 and 10’ / updated not reported; model gives 14—mismatch.
36660819-6,36660819,6,From which countries were the sequenced samples obtained?,No,Not reported,Not specified in the provided content.,True,True,"Model says not specified, matching ‘No’/‘Not reported’."
36660819-7,36660819,7,From what years were the sequenced samples obtained?,No,Not reported,Not specified in the provided content (only study timepoints such as week 152 are given).,True,True,"Model says not specified, matching ‘No’/‘Not reported’."
36660819-8,36660819,8,Were samples cloned prior to sequencing?,No,Not reported,Not reported in the provided content.,False,True,"Original says ‘No’; model says not reported (mismatch). Updated is ‘Not reported’, which matches."
36660819-9,36660819,9,Which HIV genes were reported to have been sequenced?,"RT, IN","RT, IN","Reverse transcriptase (RT, associated with rilpivirine resistance) and integrase (INSTI) genes were implicated by the reported resistance mutations.",True,True,"Model identifies RT and IN, matching human answers."
36660819-10,36660819,10,What method was used for sequencing?,No,Not reported,Not reported in the provided content.,True,True,"Model says not reported, matching ‘No’/‘Not reported’."
36660819-11,36660819,11,What type of samples were sequenced?,No,Not reported,Peripheral blood mononuclear cells (baseline PBMCs) and samples from suspected virologic failure (SVF) were used for detection of resistance mutations.,False,False,Human says not reported; model specifies PBMC/SVF samples—contradiction.
36660819-12,36660819,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Yes,Yes — sequences (genotypic resistance data) were obtained from individuals with confirmed virologic failure (CVF) and from suspected virologic failure samples.,True,True,Model agreed that sequences were obtained from virologic failures.
36660819-13,36660819,13,Were the patients in the study in a clinical trial?,Yes,Yes,"Yes — patients were participants in the phase 3b randomized, open-label ATLAS-2M clinical trial.",True,True,Model correctly stated patients were in the ATLAS-2M clinical trial.
36660819-14,36660819,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,"Yes — the study included participants with prior CAB+RPV exposure, and baseline pro-viral RPV resistance-associated mutations were assessed.",True,True,Model affirmed sequences from previously treated individuals.
36660819-15,36660819,15,Which drug classes were received by individuals in the study before sample sequencing?,"NNRTI, INSTI","NNRTI, INSTI",Integrase strand transfer inhibitors (INSTIs) — cabotegravir — and non-nucleoside reverse transcriptase inhibitors (NNRTIs) — rilpivirine — were received by participants prior to sequencing.,True,True,"Model listed INSTI and NNRTI, matching the classes."
36660819-16,36660819,16,Which drugs were received by individuals in the study before sample sequencing?,"CAB, RPV","CAB, RPV",Cabotegravir (CAB) and rilpivirine (RPV) were received by participants prior to the sequencing of resistance mutations.,True,True,"Model named CAB and RPV, matching the drugs received."
36694270-1,36694270,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answered Yes, matching report of patient sample sequences."
36694270-2,36694270,2,Does the paper report in vitro drug susceptibility data?,No,No,"No — only genotypic resistance analysis was reported, not in vitro phenotypic susceptibility testing.",True,True,Model correctly said no in vitro susceptibility data.
36694270-3,36694270,3,Were sequences from the paper made publicly available?,No,No,Not reported / No clear public sequence repository accession information is provided.,True,True,"Model said not reported/no accessions, aligning with not publicly available."
36694270-4,36694270,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model stated none reported, matching lack of GenBank accessions."
36694270-5,36694270,5,How many individuals had samples obtained for HIV sequencing?,62,62,62 individuals.,True,True,"Model gave 62 individuals, matching."
36694270-6,36694270,6,From which countries were the sequenced samples obtained?,China,China,China.,True,True,"Model listed China, matching."
36694270-7,36694270,7,From what years were the sequenced samples obtained?,2019-2022,2019-2022,June 2020 to June 2022.,False,False,"Model gave 2020–2022, but humans reported 2019–2022."
36694270-8,36694270,8,Were samples cloned prior to sequencing?,No,No,No — cloning is not described; PCR products were directly sequenced.,True,True,"Model said no cloning, matching."
36694270-9,36694270,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN","PR, RT, IN","Protease, reverse transcriptase, and integrase.",True,True,"Model listed PR, RT, IN, matching genes sequenced."
36694270-10,36694270,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,One-step RT-PCR followed by nested PCR (nested PCR amplification of viral RNA) and sequencing of the PCR products; specific sequencing platform is not specified.,False,False,Model did not identify Sanger sequencing and said platform unspecified.
36694270-11,36694270,11,What type of samples were sequenced?,"Plasma, CSF","Plasma, CSF",Matched cerebrospinal fluid (CSF) and plasma samples.,True,True,"Model reported CSF and plasma, matching."
36694270-12,36694270,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,Not explicitly reported / Not stated.,False,False,"Model said not stated, while humans answered No."
36694270-13,36694270,13,Were the patients in the study in a clinical trial?,Yes,Yes,No — this was a retrospective observational study of patients admitted to a hospital.,False,False,Model said not a trial; humans said patients were in a clinical trial.
36694270-14,36694270,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,Yes.,True,True,Model agreed sequences were from previously treated individuals.
36694270-15,36694270,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,"NRTIs (mainly), NNRTIs and PIs (patients received regimens including NRTI, NNRTI, and PI classes).",False,False,Model listed drug classes despite humans indicating not reported/No.
36694270-16,36694270,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Specific drugs mentioned in the manuscript include NRTIs 3TC and TDF, the NNRTI efavirenz (EFV), and the protease inhibitor lopinavir/ritonavir (LPV/r).",False,False,Model listed specific drugs despite humans indicating No/Not applicable.
36706364-1,36706364,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answered Yes, matching."
36706364-2,36706364,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,Model correctly answered No.
36706364-3,36706364,3,Were sequences from the paper made publicly available?,No,No,No (not reported).,True,True,"Model said not reported/no public release, aligning with No."
36706364-4,36706364,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model stated none reported, matching lack of accessions."
36706364-5,36706364,5,How many individuals had samples obtained for HIV sequencing?,62 or 3,Not reported,"56 participants had resistance results reported (baseline genotyping performed for all 62 participants retrospectively, but results are reported for 56).",False,False,"Model gives 56 (mentions 62 baseline), not '62 or 3' and not 'Not reported'."
36706364-6,36706364,6,From which countries were the sequenced samples obtained?,South Africa,Not reported,South Africa.,True,False,"Model states South Africa, matching original but not 'Not reported'."
36706364-7,36706364,7,From what years were the sequenced samples obtained?,No,Not reported,Samples were from participants enrolled between August 2019 and July 2020.,False,False,"Model provides specific dates, conflicting with 'No'/'Not reported'."
36706364-8,36706364,8,Were samples cloned prior to sequencing?,No,Not reported,No (not reported).,True,False,"Model answers 'No' (even though it adds 'not reported'), so it matches original 'No' but not updated 'Not reported'."
36706364-9,36706364,9,Which HIV genes were reported to have been sequenced?,"RT, IN",Not reported,Reverse transcriptase (RT) and integrase regions (RT mutations K65R and M184V/I reported; integrase resistance assessed and not detected).,True,False,"Model lists RT and IN, matching original, not 'Not reported'."
36706364-10,36706364,10,What method was used for sequencing?,No,Not reported,The paper reports genotypic resistance testing but does not specify the sequencing method or platform.,True,True,"Model says the sequencing method is not specified, matching 'No/Not reported'."
36706364-11,36706364,11,What type of samples were sequenced?,Plasma,Not reported,Viral load specimens (plasma) associated with elevated VL; genotypic resistance testing was performed on samples with VL >500 copies/mL and on baseline samples.,True,False,"Model identifies plasma, matching original but not 'Not reported'."
36706364-12,36706364,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,Yes.,True,False,"Model says Yes, matching original but not 'Not reported'."
36706364-13,36706364,13,Were the patients in the study in a clinical trial?,Yes,Not reported,Yes.,True,False,"Model says Yes, matching original but not 'Not reported'."
36706364-14,36706364,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes.,True,False,"Model says Yes, matching original but not 'Not reported'."
36706364-15,36706364,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI, INSTI",Not reported,Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs).,False,False,Model gives NRTI and NNRTI only (omits INSTI) and does not indicate 'Not reported'.
36706364-16,36706364,16,Which drugs were received by individuals in the study before sample sequencing?,"TDF, 3TC, FTC, EFV, NVP, DTG",Not applicable,"Tenofovir, lamivudine or emtricitabine (XTC), and efavirenz or nevirapine.",False,False,Model lists TDF/3TC-FTC/EFV-NVP but omits DTG and does not match 'Not applicable'.
36738248-1,36738248,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes,True,True,"Model answers Yes, matching both."
36738248-2,36738248,2,Does the paper report in vitro drug susceptibility data?,No,No,No,True,True,"Model answers No, matching both."
36738248-3,36738248,3,Were sequences from the paper made publicly available?,No,No,Not reported as publicly deposited; sequences were stored in internal databases (SwissHIVGenomeDB and SHCS Drug Resistance Database).,True,True,"Model indicates sequences were not publicly deposited, matching 'No'."
36738248-4,36738248,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers are provided in the paper.,True,True,"Model states no GenBank accessions provided, matching 'No/Not reported'."
36738248-5,36738248,5,How many individuals had samples obtained for HIV sequencing?,527,527,527 individuals contributed the 594 SS/NGS sample pairs included in the analysis.,True,True,"Model states 527 individuals, matching both."
36738248-6,36738248,6,From which countries were the sequenced samples obtained?,Switzerland,Switzerland,Switzerland,True,True,"Model states Switzerland, matching both."
36738248-7,36738248,7,From what years were the sequenced samples obtained?,No,Not reported,Not specifically reported; counts and cohort status are given 'as of August 2021' but specific sample collection years are not detailed.,True,True,"Model says years not specifically reported, matching 'No/Not reported'."
36738248-8,36738248,8,Were samples cloned prior to sequencing?,No,No,No — cloning prior to sequencing is not described.,True,True,"Model says No cloning, matching both."
36738248-9,36738248,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN","PR, RT, IN","pol region (protease [PR], reverse transcriptase [RT], and integrase [IN]); NGS also produced near-whole-genome reads.",True,True,"Model lists PR, RT, IN (pol), matching both."
36738248-10,36738248,10,What method was used for sequencing?,"Sanger sequencing, NGS",Sanger sequencing; NGS,Sanger sequencing (SS) and Illumina next-generation sequencing (MiSeq or HiSeq) were used.,True,True,"Model lists Sanger and NGS, matching both."
36738248-11,36738248,11,What type of samples were sequenced?,Plasma,Plasma,Plasma (viral RNA from blood/plasma samples) was sequenced.,True,True,"Model states plasma, matching both."
36738248-12,36738248,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,Not explicitly reported; virological failure status is not described.,False,False,"Model says not explicitly reported, which does not match 'No'."
36738248-13,36738248,13,Were the patients in the study in a clinical trial?,No,No,"No — patients were enrolled in observational cohort studies (SHCS and ZPHI), not a clinical trial.",True,True,"Model says not a clinical trial, matching both."
36597160-10,36597160,10,What method was used for sequencing?,Sanger sequencing,Not reported,Sanger sequencing (genotypic resistance testing by Sanger).,True,False,"Model states Sanger sequencing, matching original; updated says Not reported."
36597160-11,36597160,11,What type of samples were sequenced?,Plasma,Not reported,Plasma HIV-1 RNA (plasma samples) used for genotypic resistance testing in cases of virologic failure.,True,False,"Model says plasma samples, matching original; updated says Not reported."
36597160-12,36597160,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,"Yes. Genotypic resistance results at the time of virologic failure were obtained for six patients, and five of those had NRTI and INSTI resistance-associated mutations.",True,False,"Model answers Yes, matching original; updated says Not reported."
36597160-13,36597160,13,Were the patients in the study in a clinical trial?,No,Not reported,"No. The study was a retrospective multicenter observational (non-interventional) cohort study, not a clinical trial.",True,False,"Model says not a clinical trial, matching original; updated says Not reported."
36597160-14,36597160,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes. The cohort comprised ART-experienced patients and many had prior antiretroviral exposure; genotypes reported include pre-switch resistance profiles.,True,False,"Model says sequences from ARV-experienced individuals, matching original; updated says Not reported."
36597160-15,36597160,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, PI, NNRTI, INSTI",Not reported,"NRTIs (part of two-NRTI backbones), ritonavir-boosted protease inhibitors (PI/r), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and integrase strand transfer inhibitors (INSTIs).",True,False,"Model lists NRTI, PI/r, NNRTI, INSTI, matching original; updated says Not reported."
36597160-16,36597160,16,Which drugs were received by individuals in the study before sample sequencing?,"TDF,FTC,EVG",Not applicable,"The paper reports prior use of drug classes rather than many specific drug names: individuals were on two NRTIs (including agents associated with M184V and TDF resistance such as emtricitabine [FTC] and tenofovir disoproxil fumarate [TDF] as implied by resistance patterns) plus a third agent that was most commonly a ritonavir-boosted protease inhibitor, an NNRTI, or an INSTI. The regimen they switched to was elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (E/C/F/TDF).",False,False,Model hedges on specific drugs and mentions a switch regimen; does not clearly give TDF/FTC/EVG before sequencing nor say Not applicable.
36645792-1,36645792,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes — the paper reports genotypic sequences from patient plasma (baseline GART performed and numbers of successful baseline GART reported).,True,True,"Model says sequences from patient samples were reported, matching both."
36645792-2,36645792,2,Does the paper report in vitro drug susceptibility data?,No,No,"No — the paper reports genotypic resistance testing and algorithmic drug susceptibility prediction, not in vitro phenotypic (laboratory) drug susceptibility assays.",True,True,"Model says no in vitro susceptibility data, matching both."
36645792-3,36645792,3,Were sequences from the paper made publicly available?,No,Not reported,Not reported — the paper does not state that sequences were deposited in a public database.,False,True,"Model says Not reported for public availability; original says No, updated says Not reported."
36645792-4,36645792,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,Not reported — no GenBank accession numbers are provided in the paper.,True,True,"Model says no GenBank accessions reported, aligning with both (none provided)."
36645792-5,36645792,5,How many individuals had samples obtained for HIV sequencing?,"120 * 76% = 95, or 120 or 129",Not reported,120 participants had successful baseline genotypic testing (successful baseline GART).,True,False,"Model gives 120, which is included in the original’s options; updated says Not reported."
36645792-6,36645792,6,From which countries were the sequenced samples obtained?,South Africa,Not reported,South Africa.,True,False,"Model says South Africa, matching original; updated says Not reported."
36645792-7,36645792,7,From what years were the sequenced samples obtained?,No,Not reported,2020–2021 (participants recruited between 28 August 2020 and 10 November 2021).,False,False,"Model provides years (2020–2021), but both original and updated indicate not reported."
36645792-8,36645792,8,Were samples cloned prior to sequencing?,No,Not reported,Not reported — the paper does not mention cloning of samples prior to sequencing.,False,True,"Model says Not reported about cloning; original says No, updated says Not reported."
36645792-9,36645792,9,Which HIV genes were reported to have been sequenced?,RT,Not reported,"Regions relevant to NRTI and integrase resistance — i.e., reverse transcriptase (NRTI-associated mutations for tenofovir and lamivudine) and integrase (for dolutegravir) were assessed.",False,False,Model lists RT and integrase; original says RT only and updated says Not reported.
36645792-10,36645792,10,What method was used for sequencing?,No,Not reported,"The paper reports genotypic antiretroviral resistance testing (GART) performed at the National Health Laboratory Service Virology Laboratory and drug susceptibility prediction by the Stanford algorithm; the specific sequencing platform/method (e.g., Sanger or NGS) is not specified.",True,True,"Model indicates sequencing method not specified, matching both not reported answers."
36645792-11,36645792,11,What type of samples were sequenced?,Plasma,Not reported,Plasma samples collected at enrollment.,True,False,"Model says plasma, matching original; updated says Not reported."
36645792-12,36645792,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,"Yes — participants were enrolled because they had virologic failure on first-line tenofovir–emtricitabine (or lamivudine)–efavirenz, and baseline genotypes were obtained for these individuals.",True,False,"Model answers Yes for sequences at virologic failure, matching original; updated says Not reported."
36645792-13,36645792,13,Were the patients in the study in a clinical trial?,Yes,Not reported,"Yes — this was a randomized, double-blind, placebo-controlled, phase 2 clinical trial (ARTIST), registered as NCT03991013.",True,False,"Model identifies a clinical trial, matching original; updated says Not reported."
36645792-14,36645792,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes — sequences were obtained from individuals who had been on first-line antiretroviral therapy (tenofovir + emtricitabine/lamivudine + efavirenz) and were experiencing virologic failure.,True,False,"Model says sequences from previously treated individuals, matching original; updated says Not reported."
36645792-15,36645792,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI",Not reported,Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) and a nonnucleoside reverse transcriptase inhibitor (NNRTI).,True,False,"Model lists NRTI and NNRTI, matching original; updated says Not reported."
36645792-16,36645792,16,Which drugs were received by individuals in the study before sample sequencing?,"TDF, 3TC, EFV",Not applicable,"Tenofovir, emtricitabine (or lamivudine), and efavirenz.",True,False,"Model lists tenofovir + (FTC or 3TC) + efavirenz, equivalent to TDF/3TC/EFV; updated says Not applicable."
36659824-1,36659824,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes — the paper reports that HIV resistance genotyping was performed on patient samples.,True,True,"Model says patient sample sequences were reported, matching both."
36659824-2,36659824,2,Does the paper report in vitro drug susceptibility data?,No,No,No — the paper does not report in vitro susceptibility testing of patient isolates; it only references a literature value for an in vitro protein-adjusted IC95.,True,True,"Model says no in vitro susceptibility data, matching both."
36795586-16,36795586,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Abacavir, tenofovir, zidovudine (as NRTI backbones), lamivudine (as part of TLD), and patients previously received NNRTI- and PI-based regimens (specific NNRTI/PI drugs not detailed).",False,False,"Model lists specific drugs/regimens, whereas annotation indicates none/not applicable."
36851704-1,36851704,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both annotations."
36851704-2,36851704,2,Does the paper report in vitro drug susceptibility data?,No,No,"No; the paper reports genotypic resistance predictions from sequences, not in vitro phenotypic susceptibility assays.",True,True,"Model states no in vitro susceptibility, matching both."
36851704-3,36851704,3,Were sequences from the paper made publicly available?,No,No,No — the paper does not report public sequence deposition; data are available on request from the corresponding author.,True,True,"Model says sequences not publicly deposited, matching both."
36851704-4,36851704,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers are reported in the paper.,True,True,"Model explicitly says no GenBank accessions reported, aligning with not reported."
36851704-5,36851704,5,How many individuals had samples obtained for HIV sequencing?,206,206,206 individuals had samples obtained; genotyping success rates were 204/206 for protease and reverse transcriptase and 205/206 for integrase.,True,True,"Model reports 206 individuals, matching both."
36851704-6,36851704,6,From which countries were the sequenced samples obtained?,Uruguay,Uruguay,Samples were obtained from participants in Uruguay; plasma specimens were shipped to Mexico for testing.,True,True,Model identifies Uruguay; shipping detail doesn’t conflict.
36851704-7,36851704,7,From what years were the sequenced samples obtained?,2018-2019,2018–2019,Samples were obtained from October 2018 to October 2019.,True,True,"Model gives Oct 2018–Oct 2019, consistent with 2018–2019."
36851704-8,36851704,8,Were samples cloned prior to sequencing?,No,No,No — samples were PCR amplified and Sanger sequenced; cloning is not described.,True,True,"Model says no cloning, matching both."
36851704-9,36851704,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN","PR, RT, IN","Protease, reverse transcriptase, and integrase genes were sequenced.",True,True,"Model lists PR, RT, IN, matching both."
36851704-10,36851704,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,Sanger sequencing was used (performed on an Applied Biosystems 3730xl Genetic Analyser).,True,True,"Model states Sanger sequencing, matching both."
36851704-11,36851704,11,What type of samples were sequenced?,Whole Blood,Whole Blood,Plasma specimens (HIV RNA extracted from 1 mL of plasma) derived from whole blood were sequenced.,False,False,"Model says plasma was sequenced, contradicting ‘Whole Blood’ in both annotations."
36851704-12,36851704,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,No — participants were adults initiating or reinitiating ART (not described as experiencing on-treatment virological failure); all had viral load >1000 copies/mL at enrolment.,True,True,"Model says no sequences from on-treatment virological failure, matching both."
36851704-13,36851704,13,Were the patients in the study in a clinical trial?,No,No,"No — the study was a nationally representative cross-sectional survey, not a clinical trial.",True,True,"Model identifies it as a survey, not a clinical trial, matching both."
36851704-14,36851704,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,"Yes — 35.6% of participants reported previous exposure to antiretroviral drugs, and sequences include participants with and without prior exposure.",True,True,"Model confirms sequences from previously exposed individuals, matching both."
36851704-15,36851704,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI, PI, INSTI","NRTI, NNRTI, PI, INSTI","The paper does not provide a comprehensive list of ARV drug classes previously received; prior exposures are described as prior ART (unspecified), pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), and prevention of mother-to-child transmission (PMTCT). It also notes that those with INSTI resistance did not report receiving INSTI-based ART.",False,False,"Model claims classes not provided; annotations list NRTI, NNRTI, PI, INSTI."
36851704-16,36851704,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not reported,"The paper does not list specific drug names received prior to sequencing; it classifies prior exposures (prior ART, PrEP, PEP, PMTCT) but does not provide a comprehensive list of specific drugs administered before sampling.",True,True,"Model clearly states specific drugs not listed, aligning with ‘No/Not reported’."
36851760-1,36851760,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both."
36851760-2,36851760,2,Does the paper report in vitro drug susceptibility data?,No,No,No — only genotypic (sequence-based) resistance analysis was reported; no phenotypic in vitro susceptibility assays are described.,True,True,"Model says no phenotypic susceptibility, matching both."
36851760-3,36851760,3,Were sequences from the paper made publicly available?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both."
36851760-4,36851760,4,What were the GenBank accession numbers for sequenced HIV isolates?,OQ435656-OQ435729,OQ435656-OQ435729,OQ435656–OQ435729.,True,True,"Model lists accession range OQ435656–OQ435729, matching both."
36851760-5,36851760,5,How many individuals had samples obtained for HIV sequencing?,107,Not reported,DBSs were obtained from 107 HIV-1-infected children; sequencing was successful for 75 of those samples.,True,False,"Model gives 107 individuals, matching original but contradicting updated ‘Not reported’."
36851760-6,36851760,6,From which countries were the sequenced samples obtained?,"Mali, Benin",Not reported,Benin and Mali.,True,False,"Model lists Benin and Mali, matching original but not updated ‘Not reported’."
36851760-7,36851760,7,From what years were the sequenced samples obtained?,2015-2020,Not reported,"Samples were collected between 2015–2016 (Benin, ART-treated children) and 2018–2020 (Mali, ART-naïve children).",True,False,"Model provides years (2015–2016; 2018–2020), matching original but not updated ‘Not reported’."
36851760-8,36851760,8,Were samples cloned prior to sequencing?,No,Not reported,No evidence of cloning; samples were amplified by RT-PCR and nested PCR and directly Sanger-sequenced.,True,False,"Model states no cloning, matching original but not updated ‘Not reported’."
36738248-14,36738248,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,Yes,True,True,"Model answered Yes, matching both original and updated answers."
36738248-15,36738248,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,"Protease inhibitors (PIs), nucleoside/nucleotide reverse-transcriptase inhibitors (NRTIs), non-nucleoside reverse-transcriptase inhibitors (NNRTIs), and integrase inhibitors (INSTIs) are referenced.",False,False,"Model listed ARV classes, but humans indicated the information was not reported."
36738248-16,36738248,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,Specific individual ARV drug names received by participants are not listed in the manuscript text.,True,False,Model said specific drugs were not listed (aligns with original 'No' as not reported) but not with updated 'Not applicable'.
36751650-1,36751650,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes.,True,False,"Model said Yes, matching original but not updated 'Not reported'."
36751650-2,36751650,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No.,True,False,"Model said No, matching original but not updated 'Not reported'."
36751650-3,36751650,3,Were sequences from the paper made publicly available?,No,Not reported,Not reported / No evidence of public deposition in the paper.,False,True,"Model stated not reported/no evidence, which conflicts with original 'No' but matches updated 'Not reported'."
36751650-4,36751650,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,Not reported.,True,True,"Model said not reported for accessions, matching both original and updated."
36751650-5,36751650,5,How many individuals had samples obtained for HIV sequencing?,1653,Not reported,1653 individuals (samples) were sequenced.,True,False,"Model gave 1653, matching original but not updated 'Not reported'."
36751650-6,36751650,6,From which countries were the sequenced samples obtained?,China,Not reported,"China (Guangxi, China).",True,False,"Model answered China, matching original but not updated 'Not reported'."
36751650-7,36751650,7,From what years were the sequenced samples obtained?,2016-2020,Not reported,From January 2016 to December 2020 (2016–2020).,True,False,"Model gave 2016–2020, matching original but not updated 'Not reported'."
36751650-8,36751650,8,Were samples cloned prior to sequencing?,No,Not reported,No (no cloning step described).,True,False,"Model said No cloning, matching original but not updated 'Not reported'."
36751650-9,36751650,9,Which HIV genes were reported to have been sequenced?,Pol,Not reported,A fragment of the pol gene (encoding protease and the first 299 residues of reverse transcriptase).,True,False,"Model identified pol, matching original but not updated 'Not reported'."
36751650-10,36751650,10,What method was used for sequencing?,Sanger sequencing,Not reported,Sanger sequencing of nested PCR products.,True,False,"Model gave Sanger sequencing, matching original but not updated 'Not reported'."
36751650-11,36751650,11,What type of samples were sequenced?,Plasma,Not reported,Plasma-derived viral RNA from peripheral blood samples.,True,False,"Model said plasma, matching original but not updated 'Not reported'."
36751650-12,36751650,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,No.,True,False,"Model said No, matching original but not updated 'Not reported'."
36751650-13,36751650,13,Were the patients in the study in a clinical trial?,No,Not reported,No (they were recruited from voluntary counseling and testing centers; no clinical trial is reported).,True,False,"Model said No clinical trial, matching original but not updated 'Not reported'."
36751650-14,36751650,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No.,True,False,"Model said No prior ARVs, matching original but not updated 'Not reported'."
36751650-15,36751650,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,None; participants had not received antiretroviral therapy.,True,False,"Model said None (no ARV classes), matching original 'No' but not updated 'Not reported'."
36751650-16,36751650,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,None; no antiretroviral drugs were received prior to sequencing.,True,False,"Model said none were received, matching original 'No' but not updated 'Not applicable'."
36779485-1,36779485,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes.,True,False,"Model said Yes, matching original but not updated 'Not reported'."
36779485-2,36779485,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No (the paper reports genotypic predictions rather than in vitro phenotypic susceptibility assays).,True,False,"Model said No, matching original but not updated 'Not reported'."
36779485-3,36779485,3,Were sequences from the paper made publicly available?,No,Not reported,Not reported / not specified in this paper.,False,True,"Model said not reported/not specified, conflicting with original 'No' but matching updated 'Not reported'."
36779485-4,36779485,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers are reported in the paper.,True,True,"Model noted no GenBank accessions reported, matching both original and updated."
36779485-5,36779485,5,How many individuals had samples obtained for HIV sequencing?,1649,Not reported,Genotypic sequence data were reported from 277 patients initiating ART and 1372 patients experiencing NNRTI-treatment failure (total 1649 individuals).,True,False,"Model gave 1649, matching original but not updated 'Not reported'."
36779485-6,36779485,6,From which countries were the sequenced samples obtained?,South Africa,Not reported,South Africa.,True,False,"Model said South Africa, matching original but not updated 'Not reported'."
36779485-7,36779485,7,From what years were the sequenced samples obtained?,No,Not reported,Not specified in this paper.,True,True,"Model says years not specified, matching original 'No' (not reported) and updated 'Not reported'."
36779485-8,36779485,8,Were samples cloned prior to sequencing?,No,Not reported,Not reported / no indication that samples were cloned prior to sequencing.,True,True,"Model states not reported/no indication of cloning, matching both original 'No' and updated 'Not reported'."
36779485-9,36779485,9,Which HIV genes were reported to have been sequenced?,Pol,Not reported,pol (HIV pol gene).,True,False,"Model identifies pol gene, matching original 'Pol' but contradicting updated 'Not reported'."
36779485-10,36779485,10,What method was used for sequencing?,No,Not reported,Not specified in this paper (referred to as genotypic sequence data; methods described previously).,True,True,"Model says sequencing method not specified, aligning with original 'No' and updated 'Not reported'."
36779485-11,36779485,11,What type of samples were sequenced?,Plasma,Not reported,"Not explicitly specified (sequences derive from viremic patients, including those failing NNRTI-based ART).",False,True,"Model says sample type not specified, contradicting original 'Plasma' but matching updated 'Not reported'."
36779485-12,36779485,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,Yes.,True,False,"Model answers 'Yes', matching original but not the updated 'Not reported'."
36779485-13,36779485,13,Were the patients in the study in a clinical trial?,No,Not reported,"No; this was a retrospective analysis of a South African cohort, not a clinical trial.",True,False,"Model answers 'No' (not a clinical trial), matching original but not updated 'Not reported'."
36779485-14,36779485,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes; sequences include individuals failing NNRTI-based ART who had prior ARV exposure.,True,False,"Model says yes, prior ARV exposure, matching original but contradicting updated 'Not reported'."
36779485-15,36779485,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI",Not reported,Non-nucleoside reverse transcriptase inhibitors (NNRTIs) — specifically patients failing NNRTI-based ART.,False,False,"Model lists only NNRTIs, omitting NRTIs; contradicts original 'NRTI, NNRTI' and updated 'Not reported'."
36779485-16,36779485,16,Which drugs were received by individuals in the study before sample sequencing?,RPV,Not reported,Specific drug names are not reported in this paper; only that patients were on NNRTI-based regimens.,False,True,"Model says specific drugs not reported, contradicting original 'RPV' but matching updated 'Not reported'."
36795586-1,36795586,1,Does the paper report HIV sequences from patient samples?,No,No,No.,True,True,"Model says no sequences reported, matching both original and updated 'No'."
36795586-2,36795586,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,"Model says no in vitro susceptibility data, matching both original and updated 'No'."
36795586-3,36795586,3,Were sequences from the paper made publicly available?,No,No,No — no sequence data were reported or made available.,True,True,"Model says no sequences made available, matching both original and updated 'No'."
36795586-4,36795586,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported / Not applicable.,True,True,"Model states none reported/not applicable, aligning with original 'No' and updated 'Not reported'."
36795586-5,36795586,5,How many individuals had samples obtained for HIV sequencing?,0,0,Not reported / Not specified.,False,False,Correct answer is 0; model says not reported/not specified.
36795586-6,36795586,6,From which countries were the sequenced samples obtained?,No,Not applicable,"Not reported; study COEs were located in Botswana, Eswatini, Lesotho, Malawi, Tanzania (Mbeya and Mwanza) and Uganda.",True,False,Model conveys not reported and lists study countries; matches original 'No' but not updated 'Not applicable'.
36795586-7,36795586,7,From what years were the sequenced samples obtained?,No,Not applicable,Not reported; the study period was January 2017 to December 2020.,True,False,Model conveys not reported and mentions study period; aligns with original 'No' but not updated 'Not applicable'.
36795586-8,36795586,8,Were samples cloned prior to sequencing?,No,Not applicable,Not reported / No information provided.,True,False,"Model says not reported, matching original 'No' but not updated 'Not applicable'."
36795586-9,36795586,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,Not reported / Not specified.,True,False,"Model says not reported, matching original 'No' but not updated 'Not applicable'."
36795586-10,36795586,10,What method was used for sequencing?,No,Not applicable,Not reported / Not specified.,True,False,"Model says not reported, matching original 'No' but not updated 'Not applicable'."
36795586-11,36795586,11,What type of samples were sequenced?,No,Not applicable,Not reported / Not specified.,True,False,"Model says not reported, matching original 'No' but not updated 'Not applicable'."
36795586-12,36795586,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,Yes — targeted HIV genotype testing was sporadically available for CALHIV failing second-line ART.,False,False,"Model says yes sequences from failures, contradicting both original 'No' and updated 'Not applicable'."
36795586-13,36795586,13,Were the patients in the study in a clinical trial?,No,Not applicable,"No — this was a retrospective cohort (real-world) study, not a clinical trial.",True,False,"Model answers 'No' (not a trial), matching original but not updated 'Not applicable'."
36795586-14,36795586,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,"No sequences are reported; however, genotype testing was sporadically performed on ART-experienced (failing second-line) individuals.",True,False,"Model says no sequences reported, matching original 'No' but not updated 'Not applicable'."
36795586-15,36795586,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,"Nucleoside reverse transcriptase inhibitors (NRTIs), nonnucleoside reverse transcriptase inhibitors (NNRTIs), and protease inhibitors (PIs).",False,False,Model lists ARV classes despite no sequencing; contradicts original 'No' and updated 'Not applicable'.
36931676-2,36931676,2,Does the paper report in vitro drug susceptibility data?,No,No,No — the paper reports predicted phenotypic sensitivity but does not report in vitro phenotypic susceptibility assays.,True,True,"Model says no in vitro susceptibility data, matching both annotations."
36931676-3,36931676,3,Were sequences from the paper made publicly available?,No,Not reported,No — the paper does not state that sequences were made publicly available; data are available only upon reasonable request.,True,False,Model asserts no public availability; updated says not reported.
36931676-4,36931676,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported in the paper.,True,True,"Model states no accession numbers reported, matching both."
36931676-5,36931676,5,How many individuals had samples obtained for HIV sequencing?,0,Not reported,Not specified in the paper.,False,True,Model says not specified; original says 0.
36931676-6,36931676,6,From which countries were the sequenced samples obtained?,Sweden,Not reported,Sweden (samples derive from the national InfCareHIV cohort of people with diagnosed HIV in Sweden).,True,False,Model gives Sweden; updated says not reported.
36931676-7,36931676,7,From what years were the sequenced samples obtained?,No,Not reported,Not specified for sequencing; the cohort was established in 2003 with national coverage since 2008 and data are current to August 2022.,True,True,"Model indicates years not specified, aligning with both annotations."
36931676-8,36931676,8,Were samples cloned prior to sequencing?,No,No,Not reported.,False,False,Model says not reported; both annotations say no.
36931676-9,36931676,9,Which HIV genes were reported to have been sequenced?,RT,Not reported,pol gene sequences are reported.,False,False,Model says pol; original says RT and updated says not reported.
36931676-10,36931676,10,What method was used for sequencing?,No,Not reported,Not specified in the paper.,True,True,"Model says not specified, matching both annotations."
36931676-11,36931676,11,What type of samples were sequenced?,"Plasma, CSF, PBMC",Not reported,"Not explicitly specified for sequencing; the paper reports that blood plasma/serum/liquor, PBMCs, HIV isolates and CSF are collected in biobanks and that HIV-RNA (plasma and CSF) data are included.",False,True,"Model says not explicitly specified (and lists biobank types), matching updated but not original list."
36931676-12,36931676,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,"Yes — the cohort includes sequences associated with acquired drug resistance, implying sequences from individuals with treatment failure.",True,False,Model says yes; updated says not reported.
36931676-13,36931676,13,Were the patients in the study in a clinical trial?,No,Not reported,"No — this is a registry-based cohort study, not a clinical trial.",True,False,Model says not a clinical trial; updated says not reported.
36931676-14,36931676,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes.,True,False,Model says yes; updated says not reported.
36931676-15,36931676,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI, PI, INSTI",Not reported,"Nucleoside reverse transcriptase inhibitors (NRTIs), protease inhibitors (PIs), and integrase strand transfer inhibitors (INSTIs; e.g., dolutegravir) are mentioned.",False,False,"Model lists NRTI, PI, INSTI but omits NNRTI; updated says not reported."
36931676-16,36931676,16,Which drugs were received by individuals in the study before sample sequencing?,DTG,Not applicable,"Dolutegravir is explicitly named; in addition, individuals received nucleoside reverse transcriptase inhibitor regimens and protease inhibitor-based regimens (specific other drug names are not provided).",True,False,Model names dolutegravir; updated says not applicable.
36961945-1,36961945,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model says sequences are reported, matching both."
36961945-2,36961945,2,Does the paper report in vitro drug susceptibility data?,No,No,No — the paper reports genotypic resistance (sequence-based DRMs) but does not report phenotypic/in vitro drug susceptibility assays.,True,True,"Model says no in vitro susceptibility, matching both."
36961945-3,36961945,3,Were sequences from the paper made publicly available?,No,No,Not reported / No accession numbers or public deposition are reported in the paper.,True,True,"Model indicates no public deposition reported, aligning with both 'No' annotations."
36961945-4,36961945,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,Not reported.,True,True,"Model says not reported, matching both."
36961945-5,36961945,5,How many individuals had samples obtained for HIV sequencing?,190,190,190 individuals.,True,True,"Model gives 190 individuals, matching both."
36961945-6,36961945,6,From which countries were the sequenced samples obtained?,USA,USA,United States (San Diego cohort).,True,True,"Model gives USA, matching both."
36961945-7,36961945,7,From what years were the sequenced samples obtained?,2005-2020,2005-2020,Samples were collected from January 2005 to February 2020.,True,True,"Model gives 2005–2020, matching both."
36961945-8,36961945,8,Were samples cloned prior to sequencing?,No,No,No — cloning is not described; PCR and nested PCR were used to generate amplicons for sequencing.,True,True,"Model says no cloning, matching both."
36961945-9,36961945,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN","PR, RT, IN","Protease (PR), reverse transcriptase (RT), and integrase (IN) (partial pol; RT specifically in plasma genotyping).",True,True,"Model lists PR, RT, IN, matching both."
36961945-10,36961945,10,What method was used for sequencing?,Illumina sequencing,Illumina sequencing,Next-Generation Sequencing (deep sequencing / NGS) of proviral DNA and bulk (consensus) genotyping (GeneSeq or ViroSeq) of plasma (standard Sanger-based genotyping).,False,False,Model mentions NGS and Sanger but not Illumina as specified by both annotations.
37039023-6,37039023,6,From which countries were the sequenced samples obtained?,Brazil,Brazil,"Brazil (specifically Rio de Janeiro, RJ, and Rio Grande do Sul, RS).",True,True,"Model specifies Brazil (with states), matching both answers."
37039023-7,37039023,7,From what years were the sequenced samples obtained?,2016-2018,2016–2018,Samples from Rio de Janeiro were collected between February 2016 and November 2018; samples from Rio Grande do Sul were collected between August and December 2017.,True,True,Collection windows fall within 2016–2018.
37039023-8,37039023,8,Were samples cloned prior to sequencing?,No,No,No.,True,True,Model states no cloning.
37039023-9,37039023,9,Which HIV genes were reported to have been sequenced?,"NFLG, PR, RT, IN, Env",Near full length genome (NFLG),"Near full-length genome (NFLG) sequences were obtained; analyses specifically included protease, reverse transcriptase (including RNaseH and connection subdomains), integrase and envelope (env) regions.",True,True,Model reports NFLG and lists regions analyzed; aligns with original list and includes NFLG per updated.
37039023-10,37039023,10,What method was used for sequencing?,Illumina sequencing,NGS (Illumina),High-throughput sequencing on the Illumina MiSeq platform with Nextera XT library preparation and a paired-end 2×251 protocol.,True,True,Illumina MiSeq NGS matches both annotations.
37039023-11,37039023,11,What type of samples were sequenced?,PBMC,PBMC,"DNA from peripheral blood cells containing archived integrated HIV proviral genomes (i.e., proviral DNA from blood cells / PBMC reservoir).",True,True,PBMC/proviral DNA matches PBMC.
37039023-12,37039023,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,No.,True,True,Model says no sequences from virological failure; matches.
37039023-13,37039023,13,Were the patients in the study in a clinical trial?,No,No,No.,True,True,Model says not a clinical trial; matches.
37039023-14,37039023,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,Yes. All study participants were on antiretroviral therapy (first- or second-line) and had been receiving ART prior to sampling.,True,True,Model confirms sequences from previously treated individuals.
37039023-15,37039023,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI","NRTI, NNRTI","Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and protease inhibitors (PIs).",False,False,Model adds PIs; humans list only NRTI and NNRTI.
37039023-16,37039023,16,Which drugs were received by individuals in the study before sample sequencing?,"TDF, 3TC, EFV","TDF, 3TC, EFV","Specifically reported drugs include tenofovir disoproxil fumarate (TDF), lamivudine (3TC), efavirenz (EFV); at least one protease inhibitor mentioned in context was atazanavir/ritonavir (ATV/r). Dolutegravir (DTG) is mentioned as a later recommended first-line drug but most patients received TDF+3TC+EFV.",False,False,"Model mentions ATV/r and DTG; humans list only TDF, 3TC, EFV."
37042390-1,37042390,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both."
37042390-2,37042390,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,"Model answers No, matching both."
37042390-3,37042390,3,Were sequences from the paper made publicly available?,No,No,No (the paper does not report depositing sequences or providing accession numbers).,True,True,Model says not publicly available; matches both.
37042390-4,37042390,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model states none reported, matching 'No/Not reported'."
37042390-5,37042390,5,How many individuals had samples obtained for HIV sequencing?,85,85,"At baseline, 40 individuals had the integrase gene sequenced and 38 individuals had the protease and reverse transcriptase genes sequenced.",False,False,"Model gives per-gene counts (40, 38) instead of total 85 individuals."
37042390-6,37042390,6,From which countries were the sequenced samples obtained?,India,India,India.,True,True,"Model specifies India, matching both."
37042390-7,37042390,7,From what years were the sequenced samples obtained?,2016-2019,2016–2019,Samples were obtained from patients started on third-line ART between July 2016 and December 2019 (sequencing done at the start of third-line therapy).,True,True,"Model’s years span 2016–2019, matching both."
37042390-8,37042390,8,Were samples cloned prior to sequencing?,No,No,"No, samples were PCR-amplified, gel-purified and directly sequenced; no cloning step is described.",True,True,Model states no cloning; matches.
37042390-9,37042390,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN","PR, RT, IN","Integrase (IN), reverse transcriptase (RT) and protease (PR) genes (regions of the pol gene).",True,True,"Model lists PR, RT, IN; matches both."
37042390-10,37042390,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,Sanger sequencing on an Applied Biosystems 3730xl DNA Analyzer following RT-PCR and nested PCR (gel-purified PCR products).,True,True,Model specifies Sanger sequencing; matches.
37042390-11,37042390,11,What type of samples were sequenced?,Plasma,Plasma,Plasma-derived viral RNA (plasma separated from whole blood in EDTA tubes) was extracted and sequenced.,True,True,Model indicates plasma RNA; matches plasma.
37042390-12,37042390,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Yes,"Yes. Genotyping/sequencing was performed for patients who did not attain virological suppression after 12 months; among 13 patients who did not attain suppression, sequencing was done on multiple samples.",True,True,Model confirms sequences from virological failure cases; matches.
37042390-13,37042390,13,Were the patients in the study in a clinical trial?,No,No,"No — this was a single-centre observational study in programmatic conditions, not a clinical trial.",True,True,"Model says observational, not a clinical trial; matches."
37042390-14,37042390,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,Yes.,True,True,Model confirms sequences from previously treated individuals; matches.
36851760-9,36851760,9,Which HIV genes were reported to have been sequenced?,IN,Not reported,The integrase gene of HIV-1.,True,False,"Model states integrase (IN), matching original; contradicts updated ‘Not reported’."
36851760-10,36851760,10,What method was used for sequencing?,Sanger sequencing,Not reported,Sanger sequencing following RT-PCR and nested PCR.,True,False,"Model gives Sanger sequencing, matching original; conflicts with updated ‘Not reported’."
36851760-11,36851760,11,What type of samples were sequenced?,DBS,Not reported,Dried blood spots (DBSs) collected on Whatman 903 filter paper.,True,False,"Model says dried blood spots (DBS), matching original; conflicts with updated ‘Not reported’."
36851760-12,36851760,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,Yes — sequences include samples from ART-treated children with virological failure.,True,False,"Model answers Yes, matching original; conflicts with updated ‘Not reported’."
36851760-13,36851760,13,Were the patients in the study in a clinical trial?,No,Not reported,No indication that patients were enrolled in a clinical trial; samples were collected during a study and routine early diagnosis/follow-up activities.,True,False,"Model indicates not a clinical trial, matching original; conflicts with updated ‘Not reported’."
36851760-14,36851760,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes.,True,False,"Model answers Yes, matching original; conflicts with updated ‘Not reported’."
36851760-15,36851760,15,Which drug classes were received by individuals in the study before sample sequencing?,"NNRTI, NRTI, PI",Not reported,Primarily non-nucleoside reverse transcriptase inhibitors (NNRTIs); some received nucleoside reverse transcriptase inhibitors (NRTIs) and protease inhibitors (PIs) in combination.,True,False,"Model lists NNRTI, NRTI, PI, matching original; conflicts with updated ‘Not reported’."
36851760-16,36851760,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"The paper reports ART regimens by drug class (NNRTIs, NRTIs, PIs) but does not list specific drug names for the participants; all children were INI‑naïve.",True,False,"Model says no specific drug names reported, aligning with original ‘No’; not ‘Not applicable’ per updated."
36920025-1,36920025,1,Does the paper report HIV sequences from patient samples?,No,No,No,True,True,"Model answers No, matching both original and updated."
36920025-2,36920025,2,Does the paper report in vitro drug susceptibility data?,Yes,Not reported,Yes,True,False,"Model answers Yes, matching original; conflicts with updated ‘Not reported’."
36920025-3,36920025,3,Were sequences from the paper made publicly available?,Yes,No,Yes,True,False,"Model answers Yes, matching original; conflicts with updated ‘No’."
36920025-4,36920025,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers are reported in the paper.,True,True,"Model states no GenBank accessions reported, matching original ‘No’ and conveying ‘Not reported’."
36920025-5,36920025,5,How many individuals had samples obtained for HIV sequencing?,0,0,None (no human individuals); sequencing was performed on laboratory virus cultures.,True,True,"Model says none/0 individuals, matching both original and updated."
36920025-6,36920025,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable / not reported (samples were laboratory-derived).,True,True,"Model says not applicable/not reported, aligning with original ‘No’ (none) and updated ‘Not applicable’."
36920025-7,36920025,7,From what years were the sequenced samples obtained?,No,Not applicable,Not reported / not applicable,True,True,"Model says not reported/not applicable, aligning with original ‘No’ and updated ‘Not applicable’."
36920025-8,36920025,8,Were samples cloned prior to sequencing?,No,Not applicable,"Yes; PCR products were either directly sequenced or cloned prior to sequencing, and Primer ID NGS was also used.",False,False,Model says cloning was done; original says No and updated says Not applicable.
36920025-9,36920025,9,Which HIV genes were reported to have been sequenced?,PR,Not applicable,The protease coding domain (PR) and Gag protease cleavage sites were sequenced.,True,False,"Model includes PR (protease), matching original PR; conflicts with updated ‘Not applicable’."
36920025-10,36920025,10,What method was used for sequencing?,Illumina sequencing,Not applicable,Next-generation sequencing using Primer ID on the Illumina MiSeq (300 bp paired-end) and Sanger/clone-based sequencing of PCR products.,True,False,"Model includes Illumina sequencing (and Sanger), matching original; conflicts with updated ‘Not applicable’."
36920025-11,36920025,11,What type of samples were sequenced?,No,Not applicable,Viral RNA (for Primer-ID MiSeq libraries) and total cellular DNA from infected cell pellets (PCR-amplified protease coding region); PCR products were sometimes cloned prior to sequencing.,False,False,"Model specifies sample types, whereas original says ‘No’ and updated is ‘Not applicable’."
36920025-12,36920025,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No,True,False,"Model answers No, matching original; not ‘Not applicable’ as updated."
36920025-13,36920025,13,Were the patients in the study in a clinical trial?,No,Not reported,No,True,False,"Model answers No, matching original; conflicts with updated ‘Not reported’."
36920025-14,36920025,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,No,True,False,"Model answers No, matching original; not ‘Not applicable’ as updated."
36920025-15,36920025,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable; no individuals contributed samples (laboratory viruses only).,True,True,"Model says Not applicable, consistent with original ‘No’ (none) and updated ‘Not applicable’."
36920025-16,36920025,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable; no human individuals received drugs for this study.,True,True,Model says Not applicable; matches original ‘No’ (none) and updated ‘Not applicable’.
36931676-1,36931676,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both original and updated."
37017009-13,37017009,13,Were the patients in the study in a clinical trial?,No,Not reported,"No. The study was a cross-sectional, facility-based survey, not a clinical trial.",True,False,"Model said No, matching original, but not matching updated Not reported."
37017009-14,37017009,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes. All participants were on ART for at least one year and the study collected data on current and previous regimens and PMTCT exposure.,True,False,"Model said Yes, matching original, but not updated Not reported."
37017009-15,37017009,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI, PI",Not reported,"Protease inhibitors (PIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs).",True,False,"Model listed NRTI/NNRTI/PI, matching original; not matching updated Not reported."
37017009-16,37017009,16,Which drugs were received by individuals in the study before sample sequencing?,"LPV, ATV, EFV, NVP, 3TC, ABC, AZT, FTC, D4T, TDF",Not reported,"Specific drugs included ritonavir-boosted lopinavir and ritonavir-boosted atazanavir (PIs); efavirenz and nevirapine (NNRTIs); lamivudine, abacavir, zidovudine, emtricitabine, stavudine and tenofovir disoproxil fumarate (NRTIs).",True,False,Model listed the same drugs as original; not matching updated Not reported.
37029656-1,37029656,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes — the paper reports genotypic resistance testing (sequencing) performed on patient samples.,True,False,"Model said Yes, matching original; not matching updated Not reported."
37029656-2,37029656,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,"No — the paper reports genotypic interpretation of resistance, not in vitro phenotypic susceptibility assays.",True,False,"Model said No phenotypic data, matching original; not matching updated Not reported."
37029656-3,37029656,3,Were sequences from the paper made publicly available?,No,Not reported,Not reported — the paper does not state that sequence data were deposited in public databases.,False,True,"Model said Not reported, which conflicts with original No but matches updated Not reported."
37029656-4,37029656,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers are reported in the paper.,True,True,"Model stated no accession numbers reported, matching both original No and updated Not reported."
37029656-5,37029656,5,How many individuals had samples obtained for HIV sequencing?,1223,Not reported,1223 individuals.,True,False,"Model gave 1223, matching original; not matching updated Not reported."
37029656-6,37029656,6,From which countries were the sequenced samples obtained?,Italy,Not reported,Samples were obtained in Italy (single-centre study; many participants of Italian origin).,True,False,"Model said Italy, matching original; not matching updated Not reported."
37029656-7,37029656,7,From what years were the sequenced samples obtained?,2009-2019,Not reported,Samples were obtained over the period 2009–2019.,True,False,"Model gave 2009–2019, matching original; not matching updated Not reported."
37029656-8,37029656,8,Were samples cloned prior to sequencing?,No,Not reported,Not reported; the paper describes direct Sanger sequencing and does not mention cloning.,False,True,"Model said Not reported (re cloning), which conflicts with original No but matches updated Not reported."
37029656-9,37029656,9,Which HIV genes were reported to have been sequenced?,IN,Not reported,"The integrase gene (INSTI-associated mutations) was sequenced; genotypic resistance testing also assessed resistance to NRTI, NNRTI and PI drug classes (implying sequencing of relevant pol regions), but integrase is explicitly reported.",True,False,"Model identified integrase (IN), matching original; not matching updated Not reported."
37029656-10,37029656,10,What method was used for sequencing?,Sanger sequencing,Not reported,Sanger sequencing using an ABI PRISM 3130xl Genetic Analyzer (Applied Biosystems).,True,False,"Model said Sanger sequencing, matching original; not matching updated Not reported."
37029656-11,37029656,11,What type of samples were sequenced?,Plasma,Not reported,Clinical pre-ART patient samples used for genotypic resistance testing (immediate pre-ART GRT in newly diagnosed people).,False,False,Original says plasma; model gave a vague sample description without specifying plasma and did not state Not reported.
37029656-12,37029656,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,"No — sequences were obtained from ART-naive individuals before initiation of therapy, not from people with virological failure on treatment.",True,False,"Model said No (ART-naive), matching original; not matching updated Not reported."
37029656-13,37029656,13,Were the patients in the study in a clinical trial?,No,Not reported,"No — the study was an observational time-trend, single-centre study of ART-naive people living with HIV.",True,False,"Model said No trial, matching original; not matching updated Not reported."
37029656-14,37029656,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No — the paper reports sequences from ART-naive individuals who had not previously received antiretroviral therapy.,True,False,"Model said No prior ARVs, matching original; not matching updated Not reported."
37029656-15,37029656,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,None — individuals were ART-naive and had not received antiretroviral drug classes prior to sequencing.,True,False,"Model said None, matching original No; not matching updated Not reported."
37029656-16,37029656,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,None — participants were antiretroviral therapy–naive and had not received specific antiretroviral drugs prior to sequencing.,True,False,"Model said None, matching original No; does not convey Not applicable per updated."
37039023-1,37039023,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model said Yes, matching both original and updated."
37039023-2,37039023,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,"Model said No, matching both original and updated."
37039023-3,37039023,3,Were sequences from the paper made publicly available?,Yes,No,Yes (raw reads deposited to SRA under BioProject PRJNA419915).,True,False,"Model said Yes (SRA available), matching original; contradicts updated No."
37039023-4,37039023,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,The paper does not report GenBank accession numbers for the study isolates; only the HXB2 reference accession NC_001802 is cited and raw reads were deposited to SRA (PRJNA419915).,True,True,"Model said no GenBank accessions reported, matching both original No and updated Not reported."
37039023-5,37039023,5,How many individuals had samples obtained for HIV sequencing?,86,86,86 individuals.,True,True,"Model gave 86, matching both original and updated."
36454248-8,36454248,8,Were samples cloned prior to sequencing?,No,No,No.,True,True,"Model answered No, matching both annotations."
36454248-9,36454248,9,Which HIV genes were reported to have been sequenced?,Pol,Pol,"Protease (PR), reverse transcriptase (RT), and integrase (IN) regions of the pol gene.",True,True,"Model specified PR/RT/IN regions of pol, equivalent to Pol."
36454248-10,36454248,10,What method was used for sequencing?,No,Not reported,RT-PCR and nested PCR amplification of HIV-1 pol PCR amplicons which were purified and sequenced by Macrogen Inc.; sequences assembled and edited with Lasergene.,False,False,"Model provided specific sequencing methods, but both annotations say not reported."
36454248-11,36454248,11,What type of samples were sequenced?,Plasma,Plasma,Plasma samples (HIV-1 RNA extracted from plasma).,True,True,"Model stated plasma samples, matching both."
36454248-12,36454248,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Yes,Yes; sequences were obtained from treated individuals who were in virological failure (VL >50 copies/mL).,True,True,Model said Yes and specified virological failure; matches both.
36454248-13,36454248,13,Were the patients in the study in a clinical trial?,No,No,"No; patients were under clinical follow-up/clinical monitoring, not enrolled in a clinical trial.",True,True,"Model said not a clinical trial, matching both."
36454248-14,36454248,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,Yes.,True,True,"Model answered Yes, matching both."
36454248-15,36454248,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI, PI, INSTI","NRTI, NNRTI, PI, INSTI","Nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside RT inhibitors (NNRTIs), protease inhibitors (PIs), and integrase strand transfer inhibitors (INSTIs).",True,True,"Model listed NRTI, NNRTI, PI, INSTI; matches both."
36454248-16,36454248,16,Which drugs were received by individuals in the study before sample sequencing?,"3TC, AZT, LPV, EFV, RAL","3TC, AZT, LPV, EFV, RAL","Reported drugs included lamivudine and zidovudine (often combined), lopinavir/ritonavir, efavirenz; tenofovir and emtricitabine (used in combinations), darunavir and raltegravir were used as rescue regimens; prophylaxis included zidovudine and zidovudine+lamivudine (and one case efavirenz+lamivudine).",False,False,"Model listed additional drugs (e.g., TDF/FTC/DRV) beyond the annotated set (3TC, AZT, LPV, EFV, RAL)."
36519389-1,36519389,1,Does the paper report HIV sequences from patient samples?,No,Not reported,No — the paper does not report HIV sequences from patient samples.,True,True,"Model said the paper does not report sequences, aligning with No/Not reported."
36519389-2,36519389,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No — the paper does not report any in vitro drug susceptibility data.,True,True,"Model said no in vitro susceptibility data, aligning with No/Not reported."
36519389-3,36519389,3,Were sequences from the paper made publicly available?,No,Not reported,No — the paper does not report any HIV sequences or state that sequences were made publicly available.,True,True,"Model said no sequences/public release reported, aligning with both."
36519389-4,36519389,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported / Not applicable — no GenBank accession numbers are provided.,True,True,"Model said none reported/not applicable, matching both."
36519389-5,36519389,5,How many individuals had samples obtained for HIV sequencing?,0,Not reported,Not applicable / Not reported — the paper does not report any HIV sequencing or number of individuals sequenced.,False,True,"Model said not reported; original annotation was 0, updated was Not reported."
36519389-6,36519389,6,From which countries were the sequenced samples obtained?,No,Not reported,"Not applicable — no sequenced samples were reported. Study participants were from South Africa and several neighbouring countries (Zimbabwe, Malawi, Mozambique, and others).",True,True,Model stated not applicable (no sequenced samples); matches No/Not reported.
36519389-7,36519389,7,From what years were the sequenced samples obtained?,No,Not reported,Not applicable / Not reported — no sequencing was performed or dated. Enrollment occurred from July to November 2022.,True,True,Model stated not applicable/not reported for years; matches both.
36519389-8,36519389,8,Were samples cloned prior to sequencing?,No,Not reported,Not reported / Not applicable — cloning prior to sequencing is not described.,False,True,"Model said not reported/not applicable; original said No, updated Not reported."
36519389-9,36519389,9,Which HIV genes were reported to have been sequenced?,No,Not reported,Not applicable / Not reported — no HIV genes or sequencing targets are described.,True,True,Model said no genes/targets described; matches both.
36519389-10,36519389,10,What method was used for sequencing?,No,Not reported,Not applicable / Not reported — no sequencing methods are provided in the paper.,True,True,Model said no sequencing methods reported; matches both.
36519389-11,36519389,11,What type of samples were sequenced?,No,Not reported,"Not applicable / Not reported — no sequencing was performed, so no sample types for sequencing are given.",True,True,Model said no sequencing/sample type reported; matches both.
36519389-12,36519389,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,No sequences were reported. The paper does report virologic elevations in some participants but does not report sequencing from those individuals.,True,True,Model said no sequences reported (including from failures); matches both.
36519389-13,36519389,13,Were the patients in the study in a clinical trial?,Yes,Not reported,Yes — participants were part of the CHARACTERISE study and had previously been part of the randomized ADVANCE trial.,True,False,"Model said Yes (clinical trial), matching original Yes but not updated Not reported."
36519389-14,36519389,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,"No — the paper does not report HIV sequences. Participants had previously received antiretroviral regimens, but no sequences are presented.",True,True,Model said no sequences from previously treated individuals; aligns with both.
36519389-15,36519389,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,"Not applicable to sequencing (no sequences reported). The participants had received nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), a non-nucleoside reverse transcriptase inhibitor (NNRTI), and an integrase strand transfer inhibitor (INSTI).",True,True,"Model stated not applicable (no sequencing), satisfying No/Not reported."
36519389-16,36519389,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not reported,"Not applicable to sequencing (no sequences reported). Participants received tenofovir alafenamide (TAF), tenofovir disoproxil fumarate (TDF), emtricitabine (FTC), lamivudine (3TC), dolutegravir (DTG), and efavirenz (EFV).",True,True,"Model stated not applicable (no sequencing), satisfying No/Not reported."
36982978-4,36982978,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model says none reported, matching original ‘No’ and updated ‘Not reported’."
36982978-5,36982978,5,How many individuals had samples obtained for HIV sequencing?,0,0,None — the paper did not obtain or sequence samples from individuals.,True,True,"Model indicates zero samples obtained, matching ‘0’ for both annotations."
36982978-6,36982978,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable — no sequencing of samples was reported in this paper.,True,True,"Model states not applicable due to no sequencing, aligning with original ‘No’ and updated ‘Not applicable’."
36982978-7,36982978,7,From what years were the sequenced samples obtained?,No,Not applicable,Not applicable — the paper does not report sequenced samples or sampling years.,True,True,"Model notes not applicable; no sequencing years reported, matching both annotations."
36982978-8,36982978,8,Were samples cloned prior to sequencing?,No,Not applicable,Not applicable — no sequencing experiments or cloning are described in this paper.,True,True,"Model says not applicable since no sequencing/cloning, consistent with original ‘No’ and updated ‘Not applicable’."
36982978-9,36982978,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,None — the paper does not report sequencing of HIV genes in original samples.,True,True,"Model reports no genes sequenced, matching original ‘No’ and updated ‘Not applicable’."
36982978-10,36982978,10,What method was used for sequencing?,No,Not applicable,Not applicable — no sequencing methods are described in this review.,True,True,"Model states not applicable/no methods described, aligning with both annotations."
36982978-11,36982978,11,What type of samples were sequenced?,No,Not applicable,Not applicable — the paper does not report sequencing of any samples.,True,True,"Model says not applicable; no samples sequenced, matching both annotations."
36982978-12,36982978,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No — this paper did not obtain or report original sequences from such individuals.,True,True,"Model answers No sequences from such individuals, consistent with original ‘No’ and effectively not applicable for updated."
36982978-13,36982978,13,Were the patients in the study in a clinical trial?,No,Not reported,Not applicable — this is a review article and does not report enrollment of patients in a trial by the authors.,True,True,"Model indicates not applicable (review), aligning with original ‘No’ and updated ‘Not reported’ as unavailable."
36982978-14,36982978,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,No — the paper does not present original HIV sequences from treated individuals.,True,True,"Model says no original sequences from treated individuals, matching both annotations."
36982978-15,36982978,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable — no samples were sequenced in this study and no pre-sequencing drug exposures are reported.,True,True,"Model answers not applicable since no sequencing, matching both annotations."
36982978-16,36982978,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable — the paper did not sequence samples and thus does not list individual patients' prior drugs.,True,True,"Model states not applicable as no sequencing, matching both annotations."
37017009-1,37017009,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes.,True,False,"Model says Yes, matching original; updated says Not reported, which conflicts."
37017009-2,37017009,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,"No — the paper reports genotypic resistance predictions, not in vitro phenotypic susceptibility testing.",True,False,"Model says No phenotypic data, matching original; updated is Not reported, so mismatch."
37017009-3,37017009,3,Were sequences from the paper made publicly available?,No,Not reported,Not reported / No evidence of public deposition is provided in the paper.,False,True,"Model says Not reported/no evidence, which does not match original ‘No’ but matches updated ‘Not reported’."
37017009-4,37017009,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model says none reported, matching original ‘No’ and updated ‘Not reported’."
37017009-5,37017009,5,How many individuals had samples obtained for HIV sequencing?,809 or 899,Not reported,899 participants had specimens included for analysis; genotyping and sequencing was successful for 809 of these.,True,False,"Model provides 899 total, 809 successful—matches original ‘809 or 899’; conflicts with updated ‘Not reported’."
37017009-6,37017009,6,From which countries were the sequenced samples obtained?,South Africa,Not reported,South Africa.,True,False,"Model says South Africa, matching original; updated says Not reported."
37017009-7,37017009,7,From what years were the sequenced samples obtained?,2017-2019,Not reported,Samples were obtained between March 2017 and March 2019.,True,False,"Model gives 2017–2019 timeframe, matching original; updated says Not reported."
37017009-8,37017009,8,Were samples cloned prior to sequencing?,No,Not reported,No — samples were PCR-amplified and libraries prepared for direct sequencing; cloning is not mentioned.,True,False,"Model says No cloning, matching original; updated says Not reported."
37017009-9,37017009,9,Which HIV genes were reported to have been sequenced?,"PR, RT",Not reported,The protease gene and the first 250 amino acids of the reverse transcriptase gene (a 1.5 kb segment of pol).,True,False,"Model lists PR and RT (first 250 aa), matching original; updated says Not reported."
37017009-10,37017009,10,What method was used for sequencing?,"Sanger sequencing, Illumina sequencing",Not reported,Next-generation sequencing on the Illumina MiSeq (MiSeq V3 kit) with Nextera XT library preparation; Sanger sequencing was used for some smaller amplicons when needed.,True,False,"Model reports Illumina (MiSeq) and some Sanger, matching original; updated says Not reported."
37017009-11,37017009,11,What type of samples were sequenced?,Whole Blood,Not reported,Plasma-derived total nucleic acid from blood samples (viral RNA/DNA extracted from plasma).,False,False,"Model says plasma-derived nucleic acid, which does not match original ‘Whole Blood’; also contradicts updated ‘Not reported’."
37017009-12,37017009,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,Yes. All sequenced samples came from children on ART with evidence of virological failure (VL 1000 copies/mL).,True,False,"Model says Yes, matching original; updated says Not reported."
37104815-1,37104815,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answered Yes, matching both original and updated."
37104815-2,37104815,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,"Model answered No, matching both original and updated."
37104815-3,37104815,3,Were sequences from the paper made publicly available?,No,No,No (not reported).,True,True,"Model said No (not publicly available), aligning with both annotations of No."
37104815-4,37104815,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported in the paper.,True,True,"Model stated none reported, matching original ‘No’/updated ‘Not reported’."
37104815-5,37104815,5,How many individuals had samples obtained for HIV sequencing?,121 or 10,Not reported,Ten individuals (10 VFs).,True,False,"Model gave 10, which matches one of the original values (121 or 10), but contradicts updated ‘Not reported’."
37104815-6,37104815,6,From which countries were the sequenced samples obtained?,France,Not reported,Not specified in the paper.,False,True,Original says France; model says not specified. Matches updated ‘Not reported’ only.
37104815-7,37104815,7,From what years were the sequenced samples obtained?,2017-2019,Not reported,Samples were collected during the trial period between 2017 and 2019 (screening 7 Sep 2017 to 22 Jan 2018; W48 data up to 4 Apr 2019).,True,False,"Model provided 2017–2019, matching original but not updated ‘Not reported’."
37104815-8,37104815,8,Were samples cloned prior to sequencing?,No,Not reported,No indication of cloning; cloning is not reported.,False,True,"Model said cloning not reported/no indication, which does not affirm ‘No’ but aligns with updated ‘Not reported’."
37104815-9,37104815,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN",Not reported,"Reverse transcriptase (RT), protease (PR) and integrase (INT) regions.",True,False,"Model listed PR/RT/IN, matching original but not updated ‘Not reported’."
37104815-10,37104815,10,What method was used for sequencing?,"Sanger sequencing, Illumina sequencing",Not reported,Sanger sequencing and ultra-deep sequencing (UDS) using Illumina technology.,True,False,"Model gave Sanger and Illumina UDS, matching original but contradicting updated ‘Not reported’."
37104815-11,37104815,11,What type of samples were sequenced?,"Whole Blood, Semen",Not reported,Plasma RNA at failure and cellular (HIV) DNA at baseline (D0).,False,False,"Model said plasma RNA and cellular DNA, conflicting with original (whole blood, semen) and not ‘Not reported’."
37104815-12,37104815,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,Yes.,True,False,"Model answered Yes, matching original but not updated ‘Not reported’."
37104815-13,37104815,13,Were the patients in the study in a clinical trial?,Yes,Not reported,Yes — they were participants in the ANRS 170 QUATUOR Phase III randomized clinical trial.,True,False,"Model answered Yes (clinical trial), matching original but not updated ‘Not reported’."
37104815-14,37104815,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes.,True,False,"Model answered Yes, matching original but not updated ‘Not reported’."
37104815-15,37104815,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI, PI, INSTI",Not reported,"Integrase strand transfer inhibitors (INSTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), and nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) as backbone (tenofovir/FTC or TAF/FTC, abacavir/lamivudine).",True,False,"Model listed INSTI, NNRTI, PI, NRTI, matching original classes but not updated ‘Not reported’."
37104815-16,37104815,16,Which drugs were received by individuals in the study before sample sequencing?,"TDF, FTC, ABC, 3TC",Not applicable,"NRTI backbones included tenofovir/emtricitabine or tenofovir alafenamide/emtricitabine and abacavir/lamivudine; third agents included drugs from INSTI and NNRTI classes and some PIs — specific drugs mentioned in the paper include rilpivirine, raltegravir, elvitegravir/cobicistat and dolutegravir (among others).",True,False,"Model included TDF/FTC, TAF/FTC, ABC/3TC (covers TDF, FTC, ABC, 3TC), matching original but not updated ‘Not applicable’."
37112971-1,37112971,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answered Yes, matching both."
37112971-2,37112971,2,Does the paper report in vitro drug susceptibility data?,No,No,"No — the paper reports genotypic sequencing and interpretation, not primary in vitro phenotypic susceptibility testing.",True,True,"Model answered No, matching both."
37112971-3,37112971,3,Were sequences from the paper made publicly available?,No,No,"No, the sequence data are not publicly available; they are available on request from the corresponding author.",True,True,"Model answered No (not publicly available), matching both."
37112971-4,37112971,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers for the sequenced isolates are reported.,True,True,"Model stated no GenBank accessions reported, matching both."
37112971-5,37112971,5,How many individuals had samples obtained for HIV sequencing?,4481,4481,Samples from 4481 treatment-naïve individuals were obtained; integrase sequences were available for 844 of them.,True,True,"Model gave 4481, matching both."
37112971-6,37112971,6,From which countries were the sequenced samples obtained?,Russia,Russia,All sequenced samples were obtained in Russia (from different regions/federal districts of Russia).,True,True,"Model specified Russia, matching both."
37112971-7,37112971,7,From what years were the sequenced samples obtained?,2006-2022,2006-2022,Blood sampling years ranged from 2006 to 2022.,True,True,"Model gave 2006–2022, matching both."
37112971-8,37112971,8,Were samples cloned prior to sequencing?,No,No,No — there is no indication that samples were cloned; sequencing was performed directly from plasma RNA using genotyping kits and Sanger or NGS methods.,True,True,"Model explicitly said No (no indication of cloning), matching both."
37112971-9,37112971,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN","PR, RT, IN","Protease (PR), part of reverse transcriptase (RT) (PR-RT region), and integrase (INT).",True,True,"Model listed PR, RT, IN, matching both."
37112971-10,37112971,10,What method was used for sequencing?,"Sanger sequencing, NGS","Sanger sequencing, NGS","Sanger-based or next-generation sequencing (NGS) with a 20% detection threshold, using commercial genotyping kits and in-house methods.",True,True,"Model states Sanger and NGS, matching both annotations."
37112971-11,37112971,11,What type of samples were sequenced?,Plasma,Plasma,Blood plasma samples (RNA extracted from blood plasma).,True,True,"Model specifies blood plasma, matching ‘Plasma’."
37112971-12,37112971,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,"No — all sequences were from treatment-naïve patients, so not from individuals with virological failure on therapy.",True,True,"Model answers No, consistent with treatment-naïve only."
37112971-13,37112971,13,Were the patients in the study in a clinical trial?,No,No,"No — the sequences were obtained from routine HIV DR testing, research and clinical projects, and outbreak investigations; there is no indication patients were enrolled in a clinical trial.",True,True,"Model says not a clinical trial, matching No."
37112971-14,37112971,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,No,"No — the study population consisted of treatment-naïve individuals (i.e., they had not previously received antiretroviral drugs).",True,True,"Model says no prior ARVs, matching No."
37112971-15,37112971,15,Which drug classes were received by individuals in the study before sample sequencing?,No,nan,None — individuals were treatment-naïve and had not received antiretroviral drug classes prior to sampling.,True,False,"Model indicates none; original ‘No’ matches, but updated answer is missing (nan)."
37112971-16,37112971,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,None — no specific antiretroviral drugs were received prior to sampling because all participants were treatment-naïve.,True,True,Model says none received; matches original ‘No’ and aligns with ‘Not applicable’.
37147875-1,37147875,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model says Yes, matching both."
37147875-2,37147875,2,Does the paper report in vitro drug susceptibility data?,Yes,Not reported,No (the paper does not present new in vitro susceptibility experiments; it cites prior in vitro work).,False,True,Model says no in vitro data; conflicts with original ‘Yes’ but matches updated ‘Not reported’.
37147875-3,37147875,3,Were sequences from the paper made publicly available?,No,No,Not reported / No indication that sequences were made publicly available.,False,False,"Model says not reported/no indication, not a clear ‘No’ as in both annotations."
37147875-4,37147875,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model says none reported, matching ‘No’/‘Not reported’."
37147875-5,37147875,5,How many individuals had samples obtained for HIV sequencing?,1,Not reported,One individual (a single 22-year-old man).,True,False,Model says one individual; matches original ‘1’ but not updated ‘Not reported’.
37147875-6,37147875,6,From which countries were the sequenced samples obtained?,France,Not reported,France.,True,False,Model gives France; matches original but not updated ‘Not reported’.
37147875-7,37147875,7,From what years were the sequenced samples obtained?,2022,Not reported,2022 (April 2022).,True,False,Model gives 2022; matches original but not updated ‘Not reported’.
37147875-8,37147875,8,Were samples cloned prior to sequencing?,No,Not reported,No indication that samples were cloned prior to sequencing.,False,True,"Model says no indication of cloning (i.e., not reported), not a clear ‘No’; matches updated ‘Not reported’."
37147875-9,37147875,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN",Not reported,"Reverse transcriptase (RT), protease, and integrase.",True,False,Model lists PR/RT/IN; matches original but contradicts updated ‘Not reported’.
37147875-10,37147875,10,What method was used for sequencing?,"Sanger sequencing, Illumina sequencing",Not reported,Sanger-based sequencing (SBS) and next-generation sequencing (NGS) using the Illumina MiSeq platform (data analysed with PASeq).,True,False,"Model provides Sanger and Illumina; matches original, not updated ‘Not reported’."
37147875-11,37147875,11,What type of samples were sequenced?,Plasma,Not reported,Not specified in the paper.,False,True,"Model says not specified, contradicting original ‘Plasma’ but matches updated ‘Not reported’."
37147875-12,37147875,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,"No — the sequences reported were from a newly infected, treatment-naive individual; sequences were not reported from the partner who had adherence difficulties.",True,False,Model answers No; matches original but not updated ‘Not reported’.
37147875-13,37147875,13,Were the patients in the study in a clinical trial?,No,Not reported,"No — this is a case report/research letter, not a clinical trial.",True,False,Model answers No; matches original but not updated ‘Not reported’.
37147875-14,37147875,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No — the reported sequences are from an individual who had not yet started antiretroviral therapy prior to sequencing.,True,False,Model answers No prior ARVs; matches original but not updated ‘Not reported’.
37147875-15,37147875,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,None — the sequenced individual had not received antiretroviral drugs prior to sequencing.,True,False,Model says none; matches original ‘No’ but not updated ‘Not reported’.
37147875-16,37147875,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,None — the sequenced individual had not received any specific antiretroviral drugs prior to sequencing.,True,True,Model says none; matches original ‘No’ and aligns with ‘Not applicable’.
37272233-1,37272233,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model says Yes, matching both."
37272233-2,37272233,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,"Model says No, matching both."
37071019-8,37071019,8,Were samples cloned prior to sequencing?,No,Not applicable,No (no patient samples); plasmids were generated by site-directed mutagenesis and amplified in bacteria prior to Sanger sequencing,True,False,"Model said 'No' (matches original), but updated is 'Not applicable' which the model did not state."
37071019-9,37071019,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,Integrase (IN) coding region,False,False,"Model named IN, which does not match original 'No' nor updated 'Not applicable'."
37071019-10,37071019,10,What method was used for sequencing?,No,Not applicable,Sanger sequencing,False,False,Model gave 'Sanger sequencing'; original said 'No' and updated 'Not applicable'.
37071019-11,37071019,11,What type of samples were sequenced?,No,Not applicable,Plasmid DNA from engineered proviral constructs (site-directed mutagenesis products) amplified in bacteria,False,False,Model described plasmid DNA; original said 'No' and updated 'Not applicable'.
37071019-12,37071019,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No,True,False,"Model answered 'No' (matches original), but updated is 'Not applicable'."
37071019-13,37071019,13,Were the patients in the study in a clinical trial?,No,Not reported,No — there were no patients in this study,True,False,"Model said 'No—no patients', matching original 'No' but not updated 'Not reported'."
37071019-14,37071019,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,No,True,False,Model 'No' matches original; updated is 'Not applicable' which was not conveyed.
37071019-15,37071019,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable — no individuals were sequenced in this study,False,True,"Model explicitly said 'Not applicable'; original was 'No', updated was 'Not applicable'."
37071019-16,37071019,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable — no individuals were sequenced; in vitro the study used dolutegravir (DTG) and bictegravir (BIC),False,True,"Model stated 'Not applicable' (with extra context); original was 'No', updated 'Not applicable'."
37085698-1,37085698,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes,True,True,Model 'Yes' matches both.
37085698-2,37085698,2,Does the paper report in vitro drug susceptibility data?,No,No,No,True,True,Model 'No' matches both.
37085698-3,37085698,3,Were sequences from the paper made publicly available?,Yes,Yes,Yes,True,True,Model 'Yes' matches both.
37085698-4,37085698,4,What were the GenBank accession numbers for sequenced HIV isolates?,MW560010 to MW560058,MW560010–MW560058,MW560010 to MW560058,True,True,Accession range matches exactly (dash vs 'to' equivalent).
37085698-5,37085698,5,How many individuals had samples obtained for HIV sequencing?,49,49,49 individuals,True,True,Model '49 individuals' matches both.
37085698-6,37085698,6,From which countries were the sequenced samples obtained?,Ethiopia,Ethiopia,Ethiopia,True,True,Model 'Ethiopia' matches both.
37085698-7,37085698,7,From what years were the sequenced samples obtained?,2018,2018,2018 (June to December 2018),True,True,Model '2018' (with months) matches both.
37085698-8,37085698,8,Were samples cloned prior to sequencing?,No,No,No,True,True,Model 'No' matches both.
37085698-9,37085698,9,Which HIV genes were reported to have been sequenced?,IN,IN,The HIV-1 integrase (IN) gene region (first 263 codons),True,True,Model identified IN region; matches 'IN'.
37085698-10,37085698,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,Sanger DNA sequencing using the BigDye Terminator v3.1 kit on an ABI PRISM 3500 xL automated Genetic Analyzer,True,True,Model specified Sanger sequencing; matches both.
37085698-11,37085698,11,What type of samples were sequenced?,Plasma,Plasma,Plasma-derived viral RNA from EDTA blood samples,True,True,Model 'Plasma-derived RNA' equals plasma.
37085698-12,37085698,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,No,True,True,Model 'No' matches both.
37085698-13,37085698,13,Were the patients in the study in a clinical trial?,No,No,No,True,True,Model 'No' matches both.
37085698-14,37085698,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,No,No,True,True,Model 'No' matches both.
37085698-15,37085698,15,Which drug classes were received by individuals in the study before sample sequencing?,No,nan,None; participants were ARV-naive,True,False,"Model said 'None/ARV-naive' (semantically matches original 'No'); updated answer is 'nan' (unspecified), so not matchable."
37085698-16,37085698,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,None; participants had not received any antiretroviral drugs,True,False,"Model 'None' matches original 'No'; updated is 'Not applicable', which the model did not state."
37042390-15,37042390,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, PI, INSTI","NRTI, PI, INSTI","Nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and protease inhibitors (PIs); most were integrase inhibitor (INSTI)-naive prior to third-line therapy.",False,False,"Model listed NNRTI and said INSTI-naive, contradicting expected NRTI, PI, INSTI exposure."
37042390-16,37042390,16,Which drugs were received by individuals in the study before sample sequencing?,"RAL, DRV","RAL, DRV","The paper does not list specific prior first- or second-line drug names; it reports drug classes (NRTIs, NNRTIs, PIs) and specifies the standardized third-line regimen used in the programme was raltegravir + darunavir + ritonavir (later raltegravir replaced by dolutegravir).",False,False,"Model claimed specific prior drugs were not listed and gave regimen details; it did not clearly answer RAL, DRV as prior drugs before sequencing."
37052343-1,37052343,1,Does the paper report HIV sequences from patient samples?,No,No,No.,True,True,"Model answered No, matching both."
37052343-2,37052343,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No.,True,False,"Model said No, which matches original but not the updated Not reported."
37052343-3,37052343,3,Were sequences from the paper made publicly available?,No,No,No.,True,True,"Model answered No, matching both."
37052343-4,37052343,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None / Not applicable.,True,True,"Model said None/Not applicable, clearly conveying no accessions."
37052343-5,37052343,5,How many individuals had samples obtained for HIV sequencing?,0,0,None / Not applicable.,True,True,Model indicated 0 individuals (none).
37052343-6,37052343,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable — no sequences were obtained.,True,True,"Model said Not applicable due to no sequences, aligning with no countries/NA."
37052343-7,37052343,7,From what years were the sequenced samples obtained?,No,Not applicable,Not applicable — no sequences were obtained.,True,True,"Model said Not applicable due to no sequences, aligning with both."
37052343-8,37052343,8,Were samples cloned prior to sequencing?,No,Not applicable,Not applicable — no sequencing was performed.,True,True,"Model said Not applicable since no sequencing, aligning with both."
37052343-9,37052343,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,None / Not applicable.,True,True,Model conveyed None/Not applicable for sequenced genes.
37052343-10,37052343,10,What method was used for sequencing?,No,Not applicable,Not applicable — no sequencing method reported.,True,True,Model said Not applicable—no sequencing method reported.
37052343-11,37052343,11,What type of samples were sequenced?,No,Not applicable,Not applicable — the paper does not report sequencing; plasma HIV-1 RNA measurements were used for virological outcomes.,True,True,Model said Not applicable—no sequencing performed.
37052343-12,37052343,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No — no sequences were obtained or reported.,True,True,"Model said No sequences obtained, effectively NA."
37052343-13,37052343,13,Were the patients in the study in a clinical trial?,No,Not reported,No; they were participants in an observational cohort study (RESPOND).,True,False,"Model said No (observational cohort), matching original but not the updated Not reported."
37052343-14,37052343,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,"No — participants were treatment-naive, and the paper does not report sequences.",True,True,Model said No sequences reported; aligns with both (effectively NA).
37052343-15,37052343,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable — participants were treatment-naive (no prior ARV exposure) and no sequencing was performed.,True,True,Model said Not applicable—no prior ARVs and no sequencing.
37052343-16,37052343,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Not applicable — participants were treatment-naive (no prior ARV drugs before baseline sequencing, and no sequencing was performed).",True,True,Model said Not applicable—no prior ARV drugs and no sequencing.
37071019-1,37071019,1,Does the paper report HIV sequences from patient samples?,No,No,No,True,True,"Model answered No, matching both."
37071019-2,37071019,2,Does the paper report in vitro drug susceptibility data?,Yes,Yes,Yes,True,True,"Model answered Yes, matching both."
37071019-3,37071019,3,Were sequences from the paper made publicly available?,No,No,No,True,True,"Model answered No, matching both."
37071019-4,37071019,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported,True,True,"Model said None reported, clearly conveying unavailability."
37071019-5,37071019,5,How many individuals had samples obtained for HIV sequencing?,0,0,None (0 individuals),True,True,Model gave 0 individuals.
37071019-6,37071019,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable — no patient-derived samples or sequences,True,True,Model said Not applicable—no samples/sequences.
37071019-7,37071019,7,From what years were the sequenced samples obtained?,No,Not applicable,Not applicable — no patient-derived samples or sequences,True,True,Model said Not applicable—no samples/sequences.
37279764-12,37279764,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,No.,True,True,"Model answered No, matching both annotations."
37279764-13,37279764,13,Were the patients in the study in a clinical trial?,No,No,"No — they were newly diagnosed patients, not participants in a clinical trial as described.",True,True,"Model answered No, matching both annotations."
37279764-14,37279764,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,No,No.,True,True,"Model answered No, matching both annotations."
37279764-15,37279764,15,Which drug classes were received by individuals in the study before sample sequencing?,No,nan,None — participants were treatment naive.,True,False,Model said none/treatment-naive (aligns with human 'No'); updated answer is 'nan' so cannot match it.
37279764-16,37279764,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,None — participants were treatment naive.,True,True,"Model said none/treatment-naive, aligning with human 'No' and updated 'Not applicable'."
37327289-1,37327289,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes,True,True,"Model answered Yes, matching both annotations."
37327289-2,37327289,2,Does the paper report in vitro drug susceptibility data?,No,No,No,True,True,"Model answered No, matching both annotations."
37327289-3,37327289,3,Were sequences from the paper made publicly available?,Yes,Yes,Yes,True,True,"Model answered Yes, matching both annotations."
37327289-4,37327289,4,What were the GenBank accession numbers for sequenced HIV isolates?,LC723952-LC724015,LC723952-LC724015,The pol sequences were archived in DDBJ under accessions LC723952–LC724015.,True,True,Accession range LC723952–LC724015 matches annotations (INSDC/DDBJ equivalent to GenBank).
37327289-5,37327289,5,How many individuals had samples obtained for HIV sequencing?,157,157,64 individuals,False,False,Model said 64; annotations say 157.
37327289-6,37327289,6,From which countries were the sequenced samples obtained?,Kenya,Kenya,Kenya,True,True,"Model answered Kenya, matching both."
37327289-7,37327289,7,From what years were the sequenced samples obtained?,2020-2021,2020-2021,Samples were obtained between November 2020 and April 2021 (2020–2021).,True,True,"Model gave 2020–2021, matching both."
37327289-8,37327289,8,Were samples cloned prior to sequencing?,No,No,No,True,True,"Model answered No, matching both."
37327289-9,37327289,9,Which HIV genes were reported to have been sequenced?,Pol,Pol,pol gene (primary); env V3 loop sequences were used for tropism determination (env attempted).,False,False,Model added env V3; annotations report only pol.
37327289-10,37327289,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,"Sanger sequencing (Thermo Fisher HIV Genotyping kit, run on an Applied Biosystems 3500xL DX genetic analyzer).",True,True,"Model identified Sanger sequencing, matching both."
37327289-11,37327289,11,What type of samples were sequenced?,Plasma,Plasma,Plasma samples (HIV-1 RNA extracted from plasma).,True,True,"Model answered plasma, matching both."
37327289-12,37327289,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,No,True,True,"Model answered No, matching both."
37327289-13,37327289,13,Were the patients in the study in a clinical trial?,No,No,No,True,True,"Model answered No, matching both."
37327289-14,37327289,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,No,No,True,True,"Model answered No, matching both."
37327289-15,37327289,15,Which drug classes were received by individuals in the study before sample sequencing?,No,nan,None (participants were treatment-naive).,True,False,Model said none/treatment-naive (aligns with human 'No'); updated answer is 'nan' so cannot match it.
37327289-16,37327289,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,None (no specific ARV drugs were received; participants were treatment-naive).,True,True,"Model said none/treatment-naive, aligning with human 'No' and updated 'Not applicable'."
37340869-1,37340869,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,"Yes — the paper reports genotypic (sequence-based) data from participants (e.g., RPV resistance-associated mutations and HIV-1 subtypes).",True,True,"Model answered Yes, matching both."
37340869-2,37340869,2,Does the paper report in vitro drug susceptibility data?,No,No,No — the paper does not present in vitro drug susceptibility (phenotypic) results in the main text.,True,True,"Model answered No, matching both."
37340869-3,37340869,3,Were sequences from the paper made publicly available?,No,No,Not reported — the paper does not state that sequence data were deposited in public databases.,False,False,Model said 'Not reported' whereas both annotations say 'No' (not deposited).
37340869-4,37340869,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,Not reported — no GenBank accession numbers are provided in the paper.,True,True,"Model said 'Not reported', matching that no accession numbers are provided."
37272233-3,37272233,3,Were sequences from the paper made publicly available?,No,No,Not reported / No indication of public deposition.,False,False,Model said 'not reported/no indication' rather than a clear 'No' to public availability.
37272233-4,37272233,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model stated 'none reported,' matching that accession numbers were not provided."
37272233-5,37272233,5,How many individuals had samples obtained for HIV sequencing?,248,248,248 individuals were included in the analysis (sequencing results reviewed for these patients).,True,True,"Model gave 248, matching both annotations."
37272233-6,37272233,6,From which countries were the sequenced samples obtained?,South Korea,South Korea,Korea (patients diagnosed and treated at a Korean hospital).,True,True,Model’s 'Korea' aligns with 'South Korea' in context.
37272233-7,37272233,7,From what years were the sequenced samples obtained?,2012-2020,2012-2020,From patients diagnosed between January 2010 and December 2020 (study period).,False,False,"Model gave 2010–2020, but annotated years are 2012–2020."
37272233-8,37272233,8,Were samples cloned prior to sequencing?,No,No,Not reported / No indication of cloning prior to sequencing.,False,False,Model said 'not reported' instead of a clear 'No' for cloning.
37272233-9,37272233,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN","PR, RT, IN","Genes corresponding to drug targets for NRTI and NNRTI (reverse transcriptase), PI (protease), and INSTI (integrase) were sequenced.",True,True,"Model identified protease, reverse transcriptase, and integrase (PR, RT, IN)."
37272233-10,37272233,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,PCR-based sequencing using an AB 3500xL Dx genetic analyzer (Applied Biosystems).,True,True,"Model description implies Sanger sequencing (AB 3500xL Dx), matching 'Sanger'."
37272233-11,37272233,11,What type of samples were sequenced?,Plasma,Plasma,Not explicitly specified in the paper (sequencing is described only as HIV drug resistance mutation sequencing from patients).,False,False,Model said sample type not specified; annotation says plasma.
37272233-12,37272233,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,Not clearly reported; the paper does not state sequences were from individuals identified as having virological failure.,False,False,Model said not clearly reported; annotation says 'No' virological failure sequences.
37272233-13,37272233,13,Were the patients in the study in a clinical trial?,No,No,No.,True,True,"Model answered 'No,' matching both."
37272233-14,37272233,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,No,Yes — some participants had prior ART exposure and some underwent ART before resistance testing.,False,False,"Model said 'Yes' prior ARV exposure, contradicting 'No'."
37272233-15,37272233,15,Which drug classes were received by individuals in the study before sample sequencing?,No,nan,Not specified in detail; the paper reports prior ART use generally but does not enumerate which ARV classes individual patients received before sequencing.,False,False,Model claimed not specified and implied prior ART; original says 'No' and updated is missing.
37272233-16,37272233,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,Not specified in the report.,False,False,"Model said 'Not specified,' which does not match 'No' or 'Not applicable.'"
37279764-1,37279764,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answered 'Yes,' matching both."
37279764-2,37279764,2,Does the paper report in vitro drug susceptibility data?,No,No,No — the paper reports genotypic resistance inference rather than in vitro phenotypic susceptibility assays.,True,True,Model correctly stated no phenotypic susceptibility data.
37279764-3,37279764,3,Were sequences from the paper made publicly available?,Yes,Yes,Yes.,True,True,"Model said 'Yes,' matching both."
37279764-4,37279764,4,What were the GenBank accession numbers for sequenced HIV isolates?,"MW947591–MW957968, OP058117–OP058658","MW947591–MW957968, OP058117–OP058658",MW947591–MW957968 and OP058117–OP058658.,True,True,Accession ranges match exactly.
37279764-5,37279764,5,How many individuals had samples obtained for HIV sequencing?,12320,Not reported,"12,320 individuals.",True,False,"Model gave 12,320 matching original, but updated says not reported."
37279764-6,37279764,6,From which countries were the sequenced samples obtained?,China,China,China.,True,True,"Model answered 'China,' matching both."
37279764-7,37279764,7,From what years were the sequenced samples obtained?,2011-2019,2011-2019,2011 to 2019.,True,True,Years 2011–2019 match both.
37279764-8,37279764,8,Were samples cloned prior to sequencing?,No,No,No cloning is reported.,True,True,'No cloning is reported' aligns with 'No.'
37279764-9,37279764,9,Which HIV genes were reported to have been sequenced?,Pol,Pol,A partial HIV-1 pol gene.,True,True,'Partial pol gene' matches pol.
37279764-10,37279764,10,What method was used for sequencing?,No,Not Reported,PCR amplification and sequencing as performed according to previously described methods.,True,True,"Model indicates method not specified, matching 'No/Not reported.'"
37279764-11,37279764,11,What type of samples were sequenced?,Whole Blood,Whole Blood,Blood samples.,True,True,'Blood samples' matches whole blood in this context.
37520425-11,37520425,11,What type of samples were sequenced?,Plasma,Plasma,Blood plasma samples.,True,True,"Model states blood plasma, matching Plasma."
37520425-12,37520425,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both."
37520425-13,37520425,13,Were the patients in the study in a clinical trial?,No,No,No.,True,True,"Model answers No, matching both."
37520425-14,37520425,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,No; the study focused on treatment-naive individuals and excluded treatment-experienced patients.,False,False,"Model says no prior ARVs, contradicting human Yes."
37520425-15,37520425,15,Which drug classes were received by individuals in the study before sample sequencing?,INSTI,INSTI,"Integrase strand transfer inhibitor (INSTI) via dolutegravir-based regimens, nonnucleoside reverse transcriptase inhibitors (NNRTIs), and nucleoside reverse transcriptase inhibitor (NRTI) backbone drugs co-administered with DTG.",False,False,Model adds NNRTI/NRTI classes; humans list only INSTI.
37520425-16,37520425,16,Which drugs were received by individuals in the study before sample sequencing?,DTG,Dolutegravir (DTG),Dolutegravir (DTG) and NNRTI-based regimens (specific NNRTI drugs not named); participants also received co-administered NRTIs as backbone therapy.,False,False,Model adds other drugs/classes beyond DTG; humans specify DTG only.
37537871-1,37537871,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model says Yes, matching both."
37537871-2,37537871,2,Does the paper report in vitro drug susceptibility data?,No,No,"No — the paper reports genotypic resistance (sequence-based) interpretation, not in vitro phenotypic susceptibility assays.",True,True,"Model says No in vitro phenotypic assays, matching both."
37537871-3,37537871,3,Were sequences from the paper made publicly available?,No,No,No public deposition of patient sequences is reported in the paper.,True,True,"Model states no public deposition, matching No."
37537871-4,37537871,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None are provided in the paper.,True,True,"Model says none provided, matching not reported/none."
37537871-5,37537871,5,How many individuals had samples obtained for HIV sequencing?,77,77,77 individuals (77 plasma samples).,True,True,"Model gives 77, matching both."
37537871-6,37537871,6,From which countries were the sequenced samples obtained?,Hong Kong,Hong Kong,Hong Kong.,True,True,"Model lists Hong Kong, matching both."
37537871-7,37537871,7,From what years were the sequenced samples obtained?,2002-2014,2002-2014,Between 2002 and 2014.,True,True,"Model gives 2002–2014, matching both."
37537871-8,37537871,8,Were samples cloned prior to sequencing?,No,No,No — samples were directly sequenced from viral RNA extracted from plasma (no cloning of patient samples is described).,True,True,"Model says no cloning, matching both."
37537871-9,37537871,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN","PR, RT, IN","Protease, reverse transcriptase (RT), and integrase (i.e., the pol region were covered by the long amplicon).",True,True,"Model lists PR, RT, IN (pol genes), matching both."
37537871-10,37537871,10,What method was used for sequencing?,"Sanger sequencing, Illumina sequencing, Oxford nanopore","Sanger sequencing, Illumina sequencing, Oxford nanopore","Long-read Oxford Nanopore (ONT) sequencing on GridION was the primary method, with Sanger sequencing and Illumina MiSeq used for comparison/validation.",True,True,"Model mentions ONT, Sanger, and Illumina, matching both."
37537871-11,37537871,11,What type of samples were sequenced?,Plasma,Plasma,Plasma samples (viral RNA extracted from plasma).,True,True,"Model states plasma, matching both."
37537871-12,37537871,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Yes,Not reported / clinical virological failure status was not determined for the sequenced individuals.,False,False,"Model says not reported, but humans say Yes virological failure."
37537871-13,37537871,13,Were the patients in the study in a clinical trial?,No,No,No — samples were collected from a hospital cohort and no clinical trial is mentioned.,True,True,"Model says No clinical trial, matching both."
37537871-14,37537871,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,Not specified in the paper.,False,False,"Model says not specified, but humans say Yes prior ARVs."
37537871-15,37537871,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,Not reported / not specified.,False,True,"Model says not reported; original says No (implying none), updated says Not reported."
37537871-16,37537871,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,Not reported / not specified.,False,True,"Model says not reported; original says No, updated says Not applicable (unavailable)."
37540331-1,37540331,1,Does the paper report HIV sequences from patient samples?,No,Not reported,No,True,False,Model says No; updated says Not reported (requires explicit unavailability).
37540331-2,37540331,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No,True,False,Model says No; updated says Not reported (model doesn’t indicate unavailability).
37540331-3,37540331,3,Were sequences from the paper made publicly available?,No,Not reported,No,True,False,"Model says No; updated says Not reported (model asserts absence, not unavailability)."
37515146-2,37515146,2,Does the paper report in vitro drug susceptibility data?,No,No,No,True,True,"Model said No, matching both original and updated answers."
37515146-3,37515146,3,Were sequences from the paper made publicly available?,Yes,Yes,Yes,True,True,"Model said Yes, matching both annotations."
37515146-4,37515146,4,What were the GenBank accession numbers for sequenced HIV isolates?,"MK702015-MK702057, MK867695-MK867757, MK995397-MK995457","MK702015-MK702057, MK867695-MK867757, MK995397-MK995457","GenBank MK702015-MK702057, MK867695-MK867757, and MK995397-MK995457",True,True,Accession ranges match exactly.
37515146-5,37515146,5,How many individuals had samples obtained for HIV sequencing?,379,167,379 individuals,True,False,"Model gave 379, which matches the original but not the updated value of 167."
37515146-6,37515146,6,From which countries were the sequenced samples obtained?,Cameroon,Cameroon,Cameroon,True,True,"Country listed as Cameroon, matching both."
37515146-7,37515146,7,From what years were the sequenced samples obtained?,2014-2019,2014-2019,December 2014 to June 2019,True,True,Model’s date range (Dec 2014–Jun 2019) matches 2014–2019.
37515146-8,37515146,8,Were samples cloned prior to sequencing?,No,No,No,True,True,"Model said No, matching both."
37515146-9,37515146,9,Which HIV genes were reported to have been sequenced?,Pol,Pol,pol gene — protease and reverse transcriptase regions,True,True,"Model specified pol (PR/RT regions), consistent with pol."
37515146-10,37515146,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,Sanger (capillary) sequencing of PCR-amplified pol region products on an ABI 3500 genetic analyzer following RT‑PCR and semi-nested PCR,True,True,"Model described Sanger sequencing, matching both."
37515146-11,37515146,11,What type of samples were sequenced?,Plasma,Plasma,Plasma samples (derived from venous blood),True,True,"Model said plasma, matching both."
37515146-12,37515146,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,No,True,True,"Model said No, matching both."
37515146-13,37515146,13,Were the patients in the study in a clinical trial?,No,No,No,True,True,"Model said No, matching both."
37515146-14,37515146,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,No,No,True,True,"Model said No prior ARVs, matching both."
37515146-15,37515146,15,Which drug classes were received by individuals in the study before sample sequencing?,No,nan,None — participants were ART‑naive (no prior antiretroviral drug classes received),True,False,"Model stated None/ART-naive, matching the original “No”; updated answer is nan (no specific value to match)."
37515146-16,37515146,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,None — participants had not received any antiretroviral drugs prior to sampling,True,True,"Model stated None, consistent with original “No” and updated “Not applicable.”"
37520425-1,37520425,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model said Yes, matching both."
37520425-2,37520425,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,"Model said No, matching both."
37520425-3,37520425,3,Were sequences from the paper made publicly available?,Yes,Yes,Yes.,True,True,"Model said Yes, matching both."
37520425-4,37520425,4,What were the GenBank accession numbers for sequenced HIV isolates?,OQ627458-OQ627474,OQ627458-OQ627474,OQ627458-OQ627474.,True,True,Accession numbers exactly match.
37520425-5,37520425,5,How many individuals had samples obtained for HIV sequencing?,25 or 30,Not reported,Sequences were successfully obtained from 16 individuals.,False,False,"Model gave 16 (successfully sequenced), which does not match original “25 or 30” and contradicts updated “Not reported.”"
37520425-6,37520425,6,From which countries were the sequenced samples obtained?,Tanzania,Tanzania,Tanzania.,True,True,"Model said Tanzania, matching both."
37520425-7,37520425,7,From what years were the sequenced samples obtained?,"2016-2017, 2019-2020",2016-2017; 2019-2020,Samples derive from patients initiating ART in two time periods: NNRTI cohort 16 December 2016 to 15 December 2017 and DTG cohort 16 March 2019 to 15 September 2020.,True,True,Model’s detailed periods map to 2016–2017 and 2019–2020.
37520425-8,37520425,8,Were samples cloned prior to sequencing?,No,No,No.,True,True,"Model said No, matching both."
37520425-9,37520425,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN","PR, RT, IN",Protease and reverse transcriptase (and testing included integrase/INSTI resistance assessment).,True,True,"Model covered PR and RT and indicated integrase resistance testing, aligning with PR, RT, IN."
37520425-10,37520425,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,Direct Sanger sequencing following RT-PCR amplification using the HIV-1 Genotyping Kit Amplification Module and analysis with BioEdit 7.2.,True,True,"Model described Sanger sequencing, matching both."
37381002-7,37381002,7,From what years were the sequenced samples obtained?,2017-2020,2017-2020,From 2017 to 2020.,True,True,"Model states 2017–2020, matching both annotations."
37381002-8,37381002,8,Were samples cloned prior to sequencing?,No,No,No — cloning is not described; PCR products were directly sequenced (Sanger) or pooled and NGS-sequenced.,True,True,"Model clearly says no cloning, matching both."
37381002-9,37381002,9,Which HIV genes were reported to have been sequenced?,"NFLG, Pol","NFLG, Pol",Partial pol gene (protease and first 300 amino acids of reverse transcriptase) and near full-length genomes covering gag to nef.,True,True,"Model describes partial pol and near full-length genomes, equivalent to Pol and NFLG."
37381002-10,37381002,10,What method was used for sequencing?,"Sanger sequencing, Illumina sequencing","Sanger sequencing, Illumina sequencing",Sanger sequencing for the partial pol fragments and next-generation sequencing (Illumina iSeq) for near full-length genomes.,True,True,"Model gives Sanger and Illumina, matching both."
37381002-11,37381002,11,What type of samples were sequenced?,Plasma,Plasma,Plasma samples (EDTA-anticoagulated blood/plasma).,True,True,"Model specifies plasma, matching both."
37381002-12,37381002,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Yes,Yes — sequences were from individuals with antiretroviral therapy (ART) failure (viral load ≥ 1000 copies/ml).,True,True,"Model affirms sequences from virological failure cases, matching both."
37381002-13,37381002,13,Were the patients in the study in a clinical trial?,No,No,"No — the study is described as a retrospective observational study, not a clinical trial.",True,True,"Model says not a clinical trial, matching both."
37381002-14,37381002,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,Yes — individuals had received antiretroviral therapy for more than one year prior to being identified as treatment failures.,True,True,"Model confirms prior ARV exposure, matching both."
37381002-15,37381002,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,Primarily nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs); protease inhibitors (PIs) are also discussed though first-line exposure was mainly NRTI + NNRTI.,False,False,"Humans say drug classes not reported; model asserts NRTI/NNRTI (and PI), contradicting."
37381002-16,37381002,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"The paper states the most common first-line drugs/regimen included TDF (tenofovir) or AZT (zidovudine), plus 3TC (lamivudine), and EFV (efavirenz) or NVP (nevirapine).",False,False,"Humans indicate not provided/NA; model lists specific drugs, contradicting."
37439411-1,37439411,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes,True,False,Original says Yes and model says Yes; updated says Not reported.
37439411-2,37439411,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,"No — only genotypic susceptibility interpretations were reported, not in vitro phenotypic assays.",True,False,Original says No and model says No; updated says Not reported.
37439411-3,37439411,3,Were sequences from the paper made publicly available?,No,Not reported,Not reported / Not specified,False,True,Original says No but model says Not reported; updated is Not reported.
37439411-4,37439411,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,Not reported,True,True,"Accession numbers not provided; model says Not reported, matching both (original ‘No’ implies none reported)."
37439411-5,37439411,5,How many individuals had samples obtained for HIV sequencing?,9387,Not reported,"15,369 individuals (5,982 treatment-naïve and 9,387 treatment-experienced)",False,False,"Human: 9,387; model: 15,369. Updated says Not reported; model gives numbers."
37439411-6,37439411,6,From which countries were the sequenced samples obtained?,Italy,Not reported,Italy (samples originated from Italian centres); patients included some born outside Italy but sequencing was from Italian cohort centres,True,False,Original Italy matches model; updated says Not reported.
37439411-7,37439411,7,From what years were the sequenced samples obtained?,2000-2020,Not reported,2000 to 2020,True,False,Original 2000–2020 matches model; updated says Not reported.
37439411-8,37439411,8,Were samples cloned prior to sequencing?,No,Not reported,Not reported / No indication of cloning prior to sequencing,False,True,Original says No cloning; model says Not reported/no indication. Updated is Not reported.
37439411-9,37439411,9,Which HIV genes were reported to have been sequenced?,"PR, RT",Not reported,Protease and reverse transcriptase (parts of the pol gene),True,False,"Model lists PR and RT, matching original; updated says Not reported."
37439411-10,37439411,10,What method was used for sequencing?,No,Not reported,Population genotypic sequencing of HIV-1 RNA (genotyping); specific laboratory sequencing platform/method not specified,True,True,"Model indicates method not specified, matching original ‘No’ and updated Not reported."
37439411-11,37439411,11,What type of samples were sequenced?,No,Not reported,"HIV-1 RNA (viral RNA) samples (i.e., RNA genotypes); biological source (e.g. plasma) not explicitly stated",True,True,"Model notes biological source not explicitly stated, matching original ‘No’ and updated Not reported."
37439411-12,37439411,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,Yes,False,False,Original says No and updated Not reported; model says Yes.
37439411-13,37439411,13,Were the patients in the study in a clinical trial?,Yes,Not reported,No — they were part of an observational cohort,False,False,Original says Yes; model says No. Updated says Not reported; model asserts No.
37439411-14,37439411,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes,True,False,Original Yes matches model; updated says Not reported.
37439411-15,37439411,15,Which drug classes were received by individuals in the study before sample sequencing?,NNRTI,Not reported,NNRTIs are explicitly reported as a prior exposure class; other classes are discussed but prior exposure to other specific classes is not explicitly reported as predictors.,True,False,Original NNRTI matches model; updated says Not reported.
37439411-16,37439411,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Specific individual drugs received prior to sequencing are not detailed; only prior exposure to NNRTIs as a class is reported. The paper does discuss NNRTI drugs (e.g., RPV, ETR, NVP, EFV, DOR) when reporting susceptibility but does not specify which of these were received by participants.",True,True,"Model states specific drugs not detailed, aligning with original 'No' and updated 'Not applicable' (only class-level exposure reported)."
37495103-1,37495103,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes,True,True,"Model answered Yes, matching both annotations."
37495103-2,37495103,2,Does the paper report in vitro drug susceptibility data?,No,No,No,True,True,"Model answered No, matching both annotations."
37495103-3,37495103,3,Were sequences from the paper made publicly available?,No,No,Not reported / No evidence of public deposition,True,True,"Model said 'Not reported / No evidence of public deposition,' effectively equivalent to No."
37495103-4,37495103,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers reported,True,True,"Model clearly states no GenBank accessions reported, matching both."
37495103-5,37495103,5,How many individuals had samples obtained for HIV sequencing?,271,271,237 individuals (sequences/subtyping reported for 237 patients),False,False,"Model gave 237, but the correct number is 271."
37495103-6,37495103,6,From which countries were the sequenced samples obtained?,Russia,Russia,Russia,True,True,"Model identified Russia, matching both."
37495103-7,37495103,7,From what years were the sequenced samples obtained?,2018-2022,2018-2022,March 2018 through August 2022,True,True,"Model gave March 2018–August 2022, consistent with 2018–2022."
37495103-8,37495103,8,Were samples cloned prior to sequencing?,No,No,No,True,True,"Model answered No, matching both."
37495103-9,37495103,9,Which HIV genes were reported to have been sequenced?,"PR, RT","PR, RT",HIV-1 pol gene (specifically the PR-RT fragment: protease and reverse transcriptase),True,True,"Model specified PR-RT fragment (protease and reverse transcriptase), matching PR, RT."
37495103-10,37495103,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,RT-PCR followed by Sanger sequencing on an ABI PRISM 3130xl DNA Analyser,True,True,"Model indicated Sanger sequencing (with RT-PCR), matching both."
37495103-11,37495103,11,What type of samples were sequenced?,Plasma,Plasma,Plasma (HIV-1 RNA isolated from plasma),True,True,"Model specified plasma, matching both."
37495103-12,37495103,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Yes,Yes,True,True,"Model answered Yes, matching both."
37495103-13,37495103,13,Were the patients in the study in a clinical trial?,No,No,No,True,True,"Model answered No, matching both."
37495103-14,37495103,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,Yes,True,True,"Model answered Yes, matching both."
37495103-15,37495103,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI, PI, INSTI","NRTI, NNRTI, PI, INSTI","Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), and integrase strand transfer inhibitors (INSTIs)",True,True,"Model listed NRTI, NNRTI, PI, INSTI, matching both."
37495103-16,37495103,16,Which drugs were received by individuals in the study before sample sequencing?,"TDF, FTC, EFV, ABC, 3TC, DTG, LPV, Elsulfavirine, RAL, DRV, AZT","TDF, FTC, EFV, ABC, 3TC, DTG, LPV, Elsulfavirine, RAL, DRV, AZT","Drugs included tenofovir (TDF), lamivudine (3TC), efavirenz (EFV), abacavir (ABC), dolutegravir (DTG), lopinavir/ritonavir (LPV/r), elsulfavirine (ESV), raltegravir (RAL), darunavir/ritonavir (DRV/r), and PhAZT (phosphoside).",False,False,Model omitted FTC and replaced AZT with 'PhAZT'; includes a likely hallucination and does not match the full list.
37498738-1,37498738,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answered Yes, matching both."
37498738-2,37498738,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,"Model answered No, matching both."
37498738-3,37498738,3,Were sequences from the paper made publicly available?,No,No,Not stated in the main text; data availability is referenced in the Supplementary Appendix 6.,False,False,Model said not stated and referenced a supplement rather than clearly saying No.
37498738-4,37498738,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers are provided in the main text.,True,True,"Model explicitly states no GenBank accession numbers provided, aligning with not reported/none."
37498738-5,37498738,5,How many individuals had samples obtained for HIV sequencing?,43 or 101,Not reported,Sequencing was attempted for 101 participants; consensus sequences were obtained from samples overall and a focused analysis included 43 participants with successful sequences at three time points; single-genome sequencing was performed on 10 participants.,True,False,"Model provided the 101 attempted and 43 subset figures, aligning with '43 or 101,' but not with updated 'Not reported.'"
37498738-6,37498738,6,From which countries were the sequenced samples obtained?,Switzerland,Switzerland,Switzerland.,True,True,"Model answered Switzerland, matching both."
37498738-7,37498738,7,From what years were the sequenced samples obtained?,No,Not reported,"Calendar years are not specified; samples are described by study-relative time points (ART start, 1 year after ART start, ESS week 0, ESS week 48).",True,True,"Model clearly states years not specified, matching 'No/Not reported.'"
37498738-8,37498738,8,Were samples cloned prior to sequencing?,No,No,No; samples were not cloned—sequencing was performed on near full-length PCR amplicons and single-genome dilutions with whole-genome amplification rather than cloning.,True,True,"Model answered No cloning, matching both."
37498738-9,37498738,9,Which HIV genes were reported to have been sequenced?,NFLG,Near full-length genome,"Near full-length proviral genomes were sequenced, with specific analysis of gag, pol (including protease and reverse transcriptase), env, and integrase.",True,True,Model states near full-length genomes (NFLG); matches both answers.
37498738-10,37498738,10,What method was used for sequencing?,"Sanger sequencing, Illumina sequencing",Not reported,Near full-length PCR amplification followed by next-generation sequencing (NGS); consensus assembly used SmaltAlign.,False,False,"Model gives NGS/SmaltAlign, not Sanger+Illumina and not ‘Not reported’."
37498738-11,37498738,11,What type of samples were sequenced?,PBMC,PBMC,Peripheral blood mononuclear cells (PBMCs) or co-culture virus derived from PBMCs.,True,True,Model includes PBMCs (extra co-culture note does not contradict PBMC).
37498738-12,37498738,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,No sequences were reported from individuals with virological failure; participants demonstrated sustained virological suppression over 48 weeks.,True,True,Model says no sequences from virological failure; matches ‘No’.
37498738-13,37498738,13,Were the patients in the study in a clinical trial?,Yes,Yes,"Yes; participants were enrolled in the Early Simplified Study (ESS), a randomized clinical trial (NCT00537966).",True,True,Model answers Yes (clinical trial); aligns with both.
37498738-14,37498738,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,Yes.,True,True,Model answers Yes; matches both.
37498738-15,37498738,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, INSTI",NRTI; INSTI,Participants received combination antiretroviral therapy (cART) and dolutegravir (an integrase inhibitor) was used in monotherapy; analyses also reference reverse transcriptase and protease drug-resistance contexts (indicating exposure to RT-targeting and protease-targeting drugs in cART).,False,False,Model implies additional classes beyond NRTI/INSTI and is not a clear match.
37498738-16,37498738,16,Which drugs were received by individuals in the study before sample sequencing?,DTG,Dolutegravir (DTG),Dolutegravir (DTG) is explicitly mentioned; the paper refers generally to combination antiretroviral therapy (cART) but does not list specific other drug names in the main text provided.,True,True,Model specifies dolutegravir (DTG); matches both.
37515095-1,37515095,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,Model answers Yes; matches both.
37515095-2,37515095,2,Does the paper report in vitro drug susceptibility data?,No,No,"No — only genotypic resistance profiling from sequences was reported, not in vitro phenotypic susceptibility assays.",True,True,Model says no phenotypic susceptibility data; matches both.
37515095-3,37515095,3,Were sequences from the paper made publicly available?,No,No,No.,True,True,Model says no public sequences; matches both.
37515095-4,37515095,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported in the paper.,True,True,Model says none reported; matches ‘No’/‘Not reported’.
37515095-5,37515095,5,How many individuals had samples obtained for HIV sequencing?,968 or 1004,Not reported,1004 participants provided blood samples for the study; after processing and removal of duplicates the final sequencing dataset comprised 968 HIV-1 sequences.,True,False,"Model gives 1004 and 968, matching human but not ‘Not reported’."
37515095-6,37515095,6,From which countries were the sequenced samples obtained?,Kazakhstan,Not reported,Kazakhstan.,True,False,Model states Kazakhstan; contradicts ‘Not reported’.
37515095-7,37515095,7,From what years were the sequenced samples obtained?,2017-2020,Not reported,2017 to 2020.,True,False,Model gives 2017–2020; contradicts ‘Not reported’.
37515095-8,37515095,8,Were samples cloned prior to sequencing?,No,Not reported,No evidence of cloning; samples were processed by RT-PCR and directly sequenced.,True,False,Model indicates no cloning; contradicts ‘Not reported’.
37515095-9,37515095,9,Which HIV genes were reported to have been sequenced?,Pol,Not reported,Partial pol gene: protease and the 5′-end of reverse transcriptase (positions 2253 to 3337 on HXB2).,True,False,Model specifies partial pol; contradicts ‘Not reported’.
37515095-10,37515095,10,What method was used for sequencing?,Sanger sequencing,Not reported,RT-PCR followed by Sanger sequencing using the AmpliSens® HIV-Resist-Seq kit and an Applied Biosystems Genetic Analyzer 3130.,True,False,Model specifies Sanger; contradicts ‘Not reported’.
37515095-11,37515095,11,What type of samples were sequenced?,Whole Blood,Not reported,mRNA purified from blood samples.,False,False,"Model says mRNA from blood, not whole blood, and not ‘Not reported’."
37515095-12,37515095,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,Not explicitly reported; virological failure status is not specified in the paper.,False,True,Model says status not specified; matches ‘Not reported’ but not ‘No’.
37515095-13,37515095,13,Were the patients in the study in a clinical trial?,No,Not reported,No.,True,False,Model answers No trial; contradicts ‘Not reported’.
37515095-14,37515095,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes — most sequences were from ART-experienced individuals; only 7 individuals were not undergoing ART.,True,False,Model answers Yes prior ARVs; contradicts ‘Not reported’.
37515095-15,37515095,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI",Not reported,"Nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), and integrase strand transfer inhibitors (INSTIs).",False,False,"Model lists extra classes (PI, INSTI) beyond NRTI/NNRTI and not ‘Not reported’."
37515095-16,37515095,16,Which drugs were received by individuals in the study before sample sequencing?,"3TC, ABC, AZT, D4T, DDI, FTC, TDF, ETR, EFV, NVP, RPV",Not applicable,"Reported drugs included AZT (zidovudine), DDI (didanosine), D4T (stavudine), 3TC (lamivudine), ABC (abacavir), TDF (tenofovir), FTC (emtricitabine), NVP (nevirapine), EFV (efavirenz), ETR (etravirine), RPV (rilpivirine), DRV/r and DRV/c (darunavir with ritonavir or cobicistat), LPV/r (lopinavir/ritonavir), and DTG (dolutegravir). The most common regimen was FTC + TDF + EFV.",False,False,Model lists additional drugs beyond human list and not ‘Not applicable’.
37515146-1,37515146,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes,True,True,Model answers Yes; matches both.
36961945-11,36961945,11,What type of samples were sequenced?,"Plasma, PBMC","Plasma, PBMC",Peripheral blood mononuclear cells (PBMCs) for proviral DNA (NGS) and blood plasma for bulk HIV RNA genotyping.,True,True,"Model lists PBMC and plasma, matching 'Plasma, PBMC'."
36961945-12,36961945,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,No — no participants experienced virologic failure during follow-up after ART initiation.,True,True,Model says no virologic failure sequences; matches 'No'.
36961945-13,36961945,13,Were the patients in the study in a clinical trial?,No,No,"No — participants were enrolled in the San Diego PIRC cohort (observational study), not described as part of a clinical trial.",True,True,Model states not a clinical trial; matches 'No'.
36961945-14,36961945,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,No,"No — the study was conducted in antiretroviral (ART)-naïve individuals, so sequences are from ART-naïve persons prior to ART initiation.",True,True,Model says sequences from ART-naïve individuals; matches 'No' prior ARVs.
36961945-15,36961945,15,Which drug classes were received by individuals in the study before sample sequencing?,No,nan,None — participants were ART-naïve at the time of sequencing.,True,False,"Model says none (ART-naïve), matching original 'No'. Updated answer is missing (nan)."
36961945-16,36961945,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,None — no antiretroviral drugs were received prior to the baseline sequencing (participants were ART-naïve).,True,True,Model says no drugs received; consistent with 'No' and 'Not applicable'.
36967989-1,36967989,1,Does the paper report HIV sequences from patient samples?,No,Not reported.,No — the paper did not report new HIV sequences from patient samples; it analyzed existing genotype-phenotype data from a public database.,True,False,Model says no new patient sequences; matches original 'No' but not 'Not reported'.
36967989-2,36967989,2,Does the paper report in vitro drug susceptibility data?,No,Not reported.,Yes — the paper used phenotypic (in vitro) drug susceptibility data (fold-change and IC50) from the Stanford PhenoSense assay and external datasets.,False,False,"Model says Yes, contradicting both 'No' and 'Not reported'."
36967989-3,36967989,3,Were sequences from the paper made publicly available?,No,Not reported.,"No novel sequences were reported; however, all data and code used in the study were made publicly available on GitHub and Zenodo.",True,False,Model implies no sequences to share (aligns with 'No'); does not convey 'Not reported'.
36967989-4,36967989,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported.,None reported.,True,True,"Model says none reported, matching both 'No' (none) and 'Not reported'."
36967989-5,36967989,5,How many individuals had samples obtained for HIV sequencing?,0,Not reported.,"Not applicable — the authors did not obtain or sequence clinical samples; they analyzed existing genotype-phenotype records (11,803 genotype-phenotype data points, with isolates counts per PI reported).",True,True,"Model conveys not applicable/zero clinical samples, matching '0' and indicating unreported."
36967989-6,36967989,6,From which countries were the sequenced samples obtained?,No,Not reported.,Not applicable / not reported.,True,True,Model says not applicable/not reported; matches both.
36967989-7,36967989,7,From what years were the sequenced samples obtained?,No,Not reported.,Not applicable / not reported.,True,True,Model says not applicable/not reported; matches both.
36967989-8,36967989,8,Were samples cloned prior to sequencing?,No,Not reported.,Not applicable / not reported.,True,True,Model says not applicable/not reported; matches both.
36967989-9,36967989,9,Which HIV genes were reported to have been sequenced?,No,Not reported.,Protease (HIV-1 protease) — the analysis focused on protease gene mutations associated with protease inhibitor susceptibility.,False,False,"Model claims protease was sequenced, contradicting 'No'/'Not reported'."
36967989-10,36967989,10,What method was used for sequencing?,No,Not reported.,Not applicable / not reported — the paper did not perform sequencing and thus does not describe any sequencing method.,True,True,Model says no sequencing method (not applicable/not reported); matches both.
36967989-11,36967989,11,What type of samples were sequenced?,No,Not reported.,Not applicable / not directly sequenced; the analysis used genotype-fold change measurements from viral isolates (population-level virus samples) in the Stanford database.,True,True,Model indicates no samples were directly sequenced; matches 'No'/'Not reported'.
36967989-12,36967989,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported.,Not specified / not reported.,False,True,Model says not reported; original says No; updated is Not reported.
36967989-13,36967989,13,Were the patients in the study in a clinical trial?,No,Not reported.,No — the study did not involve patients in a clinical trial; it analyzed retrospective genotype-phenotype data from public databases.,True,False,Model says not a clinical trial; matches original 'No' but not 'Not reported'.
36967989-14,36967989,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported.,Not specified / not reported.,False,True,Model says not reported; original says No; updated is Not reported.
36967989-15,36967989,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported.,Not reported.,False,True,Model says Not reported; original says No; updated is Not reported.
36967989-16,36967989,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable.,Not reported.,False,True,"Model says Not reported; updated says Not applicable, which is acceptable as conveying unavailability."
36982978-1,36982978,1,Does the paper report HIV sequences from patient samples?,No,No,No.,True,True,Model says No; matches both.
36982978-2,36982978,2,Does the paper report in vitro drug susceptibility data?,No,No,Yes — the paper summarizes and reports in vitro susceptibility data from published studies.,False,False,Model says Yes; both human and updated say No.
36982978-3,36982978,3,Were sequences from the paper made publicly available?,No,No,No — the paper does not present new sequences and does not provide public sequence accession information.,True,True,Model says No sequences and no accessions; matches both 'No' responses.
37541705-13,37541705,13,Were the patients in the study in a clinical trial?,Yes,Not reported,"Yes — participants were enrolled in an international phase I/II clinical trial (IMPAACT 2019, NCT03760458).",True,False,"Model explicitly said patients were in a clinical trial, matching original Yes but not updated Not reported."
37541705-14,37541705,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not applicable,No — the paper does not report any HIV sequences; however most participants (95%) were treatment-experienced prior to study entry.,False,True,"Model said no sequences were reported, contradicting original Yes but aligning with Not applicable."
37541705-15,37541705,15,Which drug classes were received by individuals in the study before sample sequencing?,"PI, INSTI",Not applicable,"Protease inhibitor (lopinavir/ritonavir) and integrase strand transfer inhibitors (dolutegravir, raltegravir) were used by participants prior to study entry.",True,False,"Model listed PI and INSTI, matching original classes; not compatible with Not applicable."
37541705-16,37541705,16,Which drugs were received by individuals in the study before sample sequencing?,"LPV, DTG, RAL, ABC, 3TC",Not applicable,"Specific drugs reported as prior anchor medications were lopinavir/ritonavir, dolutegravir, and raltegravir.",False,False,"Model listed only LPV/r, DTG, RAL and omitted ABC, 3TC; also not Not applicable."
37546367-1,37546367,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answered Yes, matching both."
37546367-2,37546367,2,Does the paper report in vitro drug susceptibility data?,No,No,"No — the paper reports genotypic resistance inference, not in vitro phenotypic susceptibility assays.",True,True,"Model answered No and clarified genotypic only, matching both."
37546367-3,37546367,3,Were sequences from the paper made publicly available?,Yes,Yes,Yes.,True,True,"Model answered Yes, matching both."
37546367-4,37546367,4,What were the GenBank accession numbers for sequenced HIV isolates?,OQ886077 - OQ888150,OQ886077–OQ888150,OQ886077 - OQ888150.,True,True,Accession range matches exactly.
37546367-5,37546367,5,How many individuals had samples obtained for HIV sequencing?,2074,2074,"Sequences were obtained from 2,074 individuals (out of 3,274 samples collected).",True,True,"Model gave 2,074, matching both."
37546367-6,37546367,6,From which countries were the sequenced samples obtained?,China,China,"China (Guangdong Province, China).",True,True,"Model identified China, matching both."
37546367-7,37546367,7,From what years were the sequenced samples obtained?,2011-2022,2011–2022,Samples were obtained from 2011 to 2022.,True,True,"Model gave 2011–2022, matching both."
37546367-8,37546367,8,Were samples cloned prior to sequencing?,No,No,No evidence of cloning; PCR products were purified and directly Sanger-sequenced.,True,True,"Model indicated no cloning, matching No."
37546367-9,37546367,9,Which HIV genes were reported to have been sequenced?,"PR, RT, Pol","PR, RT (Pol)",Partial HIV-1 pol gene (HXB2 nt 2253–3252).,True,True,"Model described partial pol (HXB2 2253–3252), which covers PR and RT, matching PR, RT (Pol)."
37546367-10,37546367,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,Sanger sequencing of RT-PCR/nested-PCR amplified products after ultracentrifugation-based concentration of plasma.,True,True,"Model specified Sanger sequencing, matching both."
37546367-11,37546367,11,What type of samples were sequenced?,Plasma,Plasma,Plasma samples (derived from EDTA blood) concentrated by ultracentrifugation.,True,True,"Model stated plasma samples, matching both."
37546367-12,37546367,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Yes,"No — sequences were obtained from ART-experienced individuals with low-level viremia (200–1000 copies/mL), not specifically described as virological failure.",False,False,"Model said No (low-level viremia), contradicting both humans’ Yes."
37546367-13,37546367,13,Were the patients in the study in a clinical trial?,No,No,"No — this was a retrospective observational study of routine samples, not a clinical trial.",True,True,"Model stated it was not a clinical trial, matching both No."
37546367-14,37546367,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,Yes — all participants had received antiretroviral therapy for at least 6 months.,True,True,"Model confirmed ART-experienced participants, matching both Yes."
37546367-15,37546367,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI, PI","NRTI, NNRTI, PI","NRTIs (nucleoside reverse-transcriptase inhibitors), NNRTIs (non-nucleoside reverse-transcriptase inhibitors), and PIs (protease inhibitors).",True,True,"Model listed NRTI, NNRTI, PI, matching both."
37546367-16,37546367,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not Reported,"The paper references common NRTIs (AZT, ABC, FTC, 3TC, TDF, D4T, DDI), NNRTIs (NVP, EFV, ETR, RPV, DOR) and PIs (e.g., NFV/r, DRV/r) in the analyses and discussion, indicating these drugs were relevant to regimens/exposures.",False,False,"Model listed multiple drugs, contradicting original No and updated Not reported."
37554471-1,37554471,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,No.,False,True,"Model answered No, which conveys that sequences were not reported, aligning with updated Not reported but not original Yes."
37554471-2,37554471,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,Yes — for non-HIV pathogens (MAI) and HBV drug resistance testing; no HIV phenotypic susceptibility data are reported.,False,False,"Model answered Yes (for non-HIV), conflicting with original No and not conveying Not reported."
37554471-3,37554471,3,Were sequences from the paper made publicly available?,No,Not reported,No — the paper does not report making any sequences publicly available.,True,False,"Model said No (not made public), matching original No but not updated Not reported."
37554471-4,37554471,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported / not applicable.,True,True,"Model stated none reported/not applicable, matching both no accessions and Not reported."
37554471-5,37554471,5,How many individuals had samples obtained for HIV sequencing?,1,Not reported,None — no HIV sequencing was reported; the paper describes a single patient case.,False,False,"Model said none (0) due to no sequencing, conflicting with original 1 and not matching updated Not reported."
37573167-15,37573167,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI, PI, INSTI",Not reported,"NRTIs, NNRTIs, PIs, and INSTIs (antiretroviral classes).",True,False,"Model lists NRTI, NNRTI, PI, INSTI matching original; updated says not reported."
37573167-16,37573167,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,Specific individual drug names are not reported; only antiretroviral drug classes and regimen types are described.,True,True,"Model states drugs not reported, aligning with original 'No' and updated 'Not applicable' (information unavailable)."
37574435-1,37574435,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes — the paper reports HIV genotypic resistance data (mutations) from patient samples.,True,True,"Model says Yes, matching both."
37574435-2,37574435,2,Does the paper report in vitro drug susceptibility data?,No,No,No — the paper does not report in vitro (phenotypic) drug susceptibility assays.,True,True,"Model says No in vitro data, matching both."
37574435-3,37574435,3,Were sequences from the paper made publicly available?,No,No,No — the paper does not report that sequences were deposited or made publicly available.,True,True,"Model says not publicly available, matching both."
37574435-4,37574435,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model says none reported, matching both 'No' and 'Not reported'."
37574435-5,37574435,5,How many individuals had samples obtained for HIV sequencing?,70 or 79,Not reported,70 of 79 participants had available genotypic resistance data prior to the switch.,False,False,"Model gives '70 of 79', not matching original '70 or 79' and contradicts updated 'Not reported'."
37574435-6,37574435,6,From which countries were the sequenced samples obtained?,Taiwan,Taiwan,Taiwan (single-center study at National Taiwan University Hospital).,True,True,"Model states Taiwan, matching both."
37574435-7,37574435,7,From what years were the sequenced samples obtained?,2016-2022,Not reported,Samples/reports were from the study period between 1 January 2016 and 30 March 2022.,True,False,"Model gives 2016–2022, matching original but not updated 'Not reported'."
37574435-8,37574435,8,Were samples cloned prior to sequencing?,No,No,Not reported / not specified.,False,False,"Model says not reported, while both annotations say No."
37574435-9,37574435,9,Which HIV genes were reported to have been sequenced?,RT,RT,"Regions associated with NRTI and INSTI resistance — i.e., reverse transcriptase (NRTI-related RAMs) and integrase (INSTI-related RAMs) regions.",False,False,Model lists RT and integrase; humans specify RT only.
37574435-10,37574435,10,What method was used for sequencing?,No,Not reported,Not specified in the paper.,True,True,"Model says not specified, matching both 'No/Not reported'."
37574435-11,37574435,11,What type of samples were sequenced?,No,Not reported,"Not explicitly specified; the study references plasma HIV RNA load and genotypic resistance reports, implying plasma-derived viral RNA but the sample type for sequencing is not explicitly stated.",True,True,"Model indicates sample type not specified, aligning with both 'No/Not reported'."
37574435-12,37574435,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Yes,Yes — genotypic resistance data were available for participants who had viral rebound (virologic failure) prior to switching regimens.,True,True,"Model says Yes for sequences from virological failure, matching both."
37574435-13,37574435,13,Were the patients in the study in a clinical trial?,No,No,"No — the study was a single-center, retrospective cohort study, not a clinical trial.",True,True,"Model identifies retrospective cohort, not a trial, matching both."
37574435-14,37574435,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,Yes — all participants were antiretroviral-experienced and the paper reports archived resistance mutations from these individuals.,True,True,"Model says sequences from ARV-experienced individuals, matching both."
37574435-15,37574435,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, INSTI","NRTI, INSTI","Classes explicitly mentioned as prior regimens include non-nucleoside reverse-transcriptase inhibitor (NNRTI)-based regimens, first-generation integrase strand-transfer inhibitor (INSTI)-based regimens, and nucleos(t)ide reverse-transcriptase inhibitors (NRTIs).",False,False,"Model includes NNRTI in addition to NRTI and INSTI; humans list only NRTI, INSTI."
37574435-16,37574435,16,Which drugs were received by individuals in the study before sample sequencing?,"DTG, BIC, FTC, TAF","DTG, BIC, FTC, TAF",Specific drugs mentioned as prior exposures include first-generation INSTIs raltegravir and cobicistat-boosted elvitegravir; tenofovir is also mentioned in the context of resistance (K65R).,False,False,"Model lists RAL, EVG/c, and tenofovir instead of DTG, BIC, FTC, TAF."
37585352-1,37585352,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes,True,True,"Model says Yes, matching both."
37585352-2,37585352,2,Does the paper report in vitro drug susceptibility data?,Yes,Not reported,No,False,False,"Model says No, while original says Yes and updated says Not reported."
37585352-3,37585352,3,Were sequences from the paper made publicly available?,No,Not reported,"Yes, available on request through the PANGEA consortium",False,False,"Model says Yes available, contradicting original 'No' and updated 'Not reported'."
37585352-4,37585352,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,Not reported / no GenBank accession numbers provided,True,True,"Model says not reported, matching both."
37585352-5,37585352,5,How many individuals had samples obtained for HIV sequencing?,5805,Not reported,5805 participants (sequences),True,False,"Model gives 5805, matching original; updated says Not reported."
37585352-6,37585352,6,From which countries were the sequenced samples obtained?,Botswana,Not reported,Botswana,True,False,"Model says Botswana, matching original; updated says Not reported."
37585352-7,37585352,7,From what years were the sequenced samples obtained?,2013-2018,Not reported,2013,False,False,Model gives 2013 only; original says 2013–2018 and updated says Not reported.
37554471-6,37554471,6,From which countries were the sequenced samples obtained?,No,Not reported,Not applicable — no sequenced samples were reported.,True,True,"Model indicates no sequencing (not applicable), aligning with original 'No' and updated 'Not reported'."
37554471-7,37554471,7,From what years were the sequenced samples obtained?,No,Not reported,Not applicable — no sequencing or dates for sequencing are reported.,True,True,"Model states no sequencing/dates reported, matching 'No' and 'Not reported'."
37554471-8,37554471,8,Were samples cloned prior to sequencing?,No,Not reported,Not applicable — no sequencing or cloning methods are reported.,True,True,"Model says cloning not applicable because no sequencing, consistent with original 'No' and updated 'Not reported'."
37554471-9,37554471,9,Which HIV genes were reported to have been sequenced?,RT,Not reported,None — no HIV genes were reported as sequenced.,False,True,"Human said 'RT', but model says no genes were sequenced. Updated says 'Not reported', which the model conveys."
37554471-10,37554471,10,What method was used for sequencing?,No,Not reported,Not applicable — no sequencing method is reported.,True,True,"Model notes no sequencing method reported (not applicable), matching both 'No' and 'Not reported'."
37554471-11,37554471,11,What type of samples were sequenced?,No,Not reported,Not applicable — no samples were reported as sequenced.,True,True,"Model says no samples were sequenced (not applicable), consistent with both annotations."
37554471-12,37554471,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,No — no sequences were obtained or reported.,True,True,"Model answers 'No' due to no sequences being obtained, aligning with original 'No' and effectively conveying unavailability for the updated 'Not reported'."
37554471-13,37554471,13,Were the patients in the study in a clinical trial?,No,Not reported,"No — this report is a single-case clinical report, not a clinical trial participant.",True,False,"Model says 'No' (not a clinical trial), matching original 'No' but not the updated 'Not reported'."
37554471-14,37554471,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No — the paper does not report any HIV sequences; the described patient had prior ARV exposure.,True,False,"Model says no sequences were reported, matching original 'No' but not updated 'Not reported'."
37554471-15,37554471,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,"Reportedly received antiretroviral agents spanning multiple classes: non-nucleotide reverse transcriptase inhibitors (NNRTIs), integrase strand transfer inhibitor (INSTI), protease inhibitor (with pharmacologic booster), and nucleoside/tide reverse transcriptase inhibitors (NRTIs).",False,False,"Model lists drug classes, contradicting original 'No' and updated 'Not reported'."
37554471-16,37554471,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"The patient had been prescribed etravirine, dolutegravir, darunavir and ritonavir; prior resistance testing showed mutations to tenofovir, lamivudine, emtricitabine, abacavir and efavirenz. He later received cabotegravir/rilpivirine long‑acting injections and was started on emtricitabine/tenofovir alafenamide for HBV when reactivation was detected.",False,False,"Model lists specific drugs, conflicting with original 'No' and updated 'Not applicable'."
37573167-1,37573167,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes.,True,False,"Model says 'Yes', matching original but not updated 'Not reported'."
37573167-2,37573167,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,"No — the paper reports genotypic resistance and genotypic susceptibility scores, not in vitro (phenotypic) susceptibility assays.",True,False,"Model says no in vitro susceptibility, matching original 'No' but not updated 'Not reported'."
37573167-3,37573167,3,Were sequences from the paper made publicly available?,No,Not reported,Not reported / No indication of public sequence deposition.,False,True,"Model says 'Not reported', which conflicts with original 'No' but matches updated 'Not reported'."
37573167-4,37573167,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers are reported in the paper.,True,True,"Model states no GenBank accessions reported, aligning with original 'No' and updated 'Not reported'."
37573167-5,37573167,5,How many individuals had samples obtained for HIV sequencing?,1126,Not reported,1126 individuals.,True,False,"Model gives '1126', matching original but not updated 'Not reported'."
37573167-6,37573167,6,From which countries were the sequenced samples obtained?,Italy,Not reported,Italy.,True,False,"Model says 'Italy', matching original but not updated 'Not reported'."
37573167-7,37573167,7,From what years were the sequenced samples obtained?,2010-2021,Not reported,From 2010 to 2021.,True,False,"Model provides '2010–2021', matching original but not updated 'Not reported'."
37573167-8,37573167,8,Were samples cloned prior to sequencing?,No,Not reported,No — the study used standard Sanger sequencing without mention of cloning.,True,False,"Model says 'No' cloning, matching original but not updated 'Not reported'."
37573167-9,37573167,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN",Not reported,Protease/reverse transcriptase (PR/RT) and integrase.,True,False,"Model lists PR/RT and IN, matching original but not updated 'Not reported'."
37573167-10,37573167,10,What method was used for sequencing?,Sanger sequencing,Not reported,Sanger sequencing.,True,False,"Model states Sanger sequencing, matching original but not updated 'Not reported'."
37573167-11,37573167,11,What type of samples were sequenced?,PBMC,Not reported,HIV-1 DNA extracted from whole blood and lymphomonocytic cells (PBMCs) separated from peripheral blood.,True,False,"Model mentions PBMCs (plus whole blood), which matches the original PBMC answer but not updated 'Not reported'."
37573167-12,37573167,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,No — sequences were obtained from virologically suppressed individuals at the time of sampling.,True,False,"Model answers 'No', matching original but not updated 'Not reported'."
37573167-13,37573167,13,Were the patients in the study in a clinical trial?,No,Not reported,"No — the samples and testing were from routine clinical practice, not a clinical trial.",True,False,"Model answers 'No' (not a clinical trial), matching original but not updated 'Not reported'."
37573167-14,37573167,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,"Yes — the cohort consists of drug-experienced individuals, many with prior ARV exposure.",True,False,"Model answers 'Yes' to prior ARV exposure, matching original but not updated 'Not reported'."
37540331-4,37540331,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported,True,True,"Model said none reported/not applicable, aligning with human “No” and updated “Not reported.”"
37540331-5,37540331,5,How many individuals had samples obtained for HIV sequencing?,0,Not reported,None (0),True,False,"Model stated zero, matching human “0” but not the updated “Not reported.”"
37540331-6,37540331,6,From which countries were the sequenced samples obtained?,No,Not reported,Not applicable — no sequencing was performed. The study was conducted in Iran.,True,True,"Model said not applicable/no sequencing, consistent with human “No” and updated “Not reported.”"
37540331-7,37540331,7,From what years were the sequenced samples obtained?,No,Not reported,Not applicable — no sequencing was performed. The trial was registered in 2019.,True,True,"Model marked not applicable, matching human “No” and updated “Not reported.”"
37540331-8,37540331,8,Were samples cloned prior to sequencing?,No,Not reported,Not applicable — no sequencing was performed,True,True,"Model answered not applicable (no sequencing), consistent with human “No” and updated “Not reported.”"
37540331-9,37540331,9,Which HIV genes were reported to have been sequenced?,No,Not reported,None — no HIV genes were sequenced or reported,True,True,"Model reported none/no genes sequenced, matching human “No” and updated “Not reported.”"
37540331-10,37540331,10,What method was used for sequencing?,No,Not reported,Not applicable — no sequencing was performed. Viral load was measured by PCR.,True,True,"Model said not applicable (no sequencing), aligning with human “No” and updated “Not reported.”"
37540331-11,37540331,11,What type of samples were sequenced?,No,Not reported,Not applicable — no sequencing was performed. Clinical laboratory samples (for viral load and CD4) were collected.,True,True,"Model said not applicable (no sequencing), aligning with human “No” and updated “Not reported.”"
37540331-12,37540331,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,No,True,False,"Model said “No,” matching human “No” but not the updated “Not reported.”"
37540331-13,37540331,13,Were the patients in the study in a clinical trial?,Yes,Not reported,Yes,True,False,"Model answered “Yes,” matching the original human answer but not the updated “Not reported.”"
37540331-14,37540331,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No sequences reported; participants were treatment-experienced and on ART,True,False,"Model said no sequences reported, matching human “No” but not updated “Not reported.”"
37540331-15,37540331,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,Not applicable for sequencing. Participants' baseline regimens mostly included two NRTIs and one NNRTI.,True,True,"Model marked not applicable and gave general regimen context, aligning with human “No” and updated “Not reported.”"
37540331-16,37540331,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Specific prior drugs are not specified; generally patients were on ART, mostly two NRTIs plus one NNRTI. Study drugs administered during the trial included TAF 25 mg (Altafir®) and dolutegravir 50 mg (Dolutegravir®).",True,False,"Model did not clearly state not applicable; it gave general info, matching human “No” but not updated “Not applicable.”"
37541705-1,37541705,1,Does the paper report HIV sequences from patient samples?,Yes,No,No — the paper does not report HIV sequences generated from patient samples.,False,True,"Model said no sequences reported, contradicting human “Yes” but matching updated “No.”"
37541705-2,37541705,2,Does the paper report in vitro drug susceptibility data?,No,No,No — the paper does not report in vitro phenotypic drug susceptibility data.,True,True,"Model said no in vitro susceptibility data, matching both human and updated “No.”"
37541705-3,37541705,3,Were sequences from the paper made publicly available?,No,No,No — sequence data were not made publicly available.,True,True,"Model said sequences not publicly available, matching human and updated “No.”"
37541705-4,37541705,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,Not applicable — the paper does not report any GenBank accession numbers.,True,True,"Model said not applicable/none, aligning with human “No” and updated “Not reported.”"
37541705-5,37541705,5,How many individuals had samples obtained for HIV sequencing?,0,0,Not applicable / zero — the study does not report obtaining samples for HIV sequencing.,True,True,"Model indicated zero/not applicable, matching both human and updated “0.”"
37541705-6,37541705,6,From which countries were the sequenced samples obtained?,"Botswana, South Africa, Thailand, and the U.S.",Not applicable,"Not applicable — no sequences were reported; participants were recruited from Botswana, South Africa, Thailand, and the U.S.",False,True,"Model said not applicable (no sequences), contradicting human country list but matching updated “Not applicable.”"
37541705-7,37541705,7,From what years were the sequenced samples obtained?,2020-2021,Not applicable,"Not applicable — no sequencing was reported; study enrollment occurred from September 9, 2020 through June 28, 2021 (last Week 24 visit December 14, 2021).",False,True,"Model said not applicable (no sequencing), contradicting human years but matching updated “Not applicable.”"
37541705-8,37541705,8,Were samples cloned prior to sequencing?,No,Not applicable,Not applicable — no sequencing or cloning methods are reported.,True,True,"Model said not applicable (no sequencing/cloning), consistent with human “No” and updated “Not applicable.”"
37541705-9,37541705,9,Which HIV genes were reported to have been sequenced?,RT,Not applicable,Not applicable — the paper does not report sequencing of any HIV genes.,False,True,"Model said not applicable/no genes sequenced, contradicting human “RT” but matching updated “Not applicable.”"
37541705-10,37541705,10,What method was used for sequencing?,No,Not applicable,Not applicable — no sequencing method is reported.,True,True,"Model marked not applicable (no method), aligning with human “No” and updated “Not applicable.”"
37541705-11,37541705,11,What type of samples were sequenced?,No,Not applicable,Not applicable — no sequencing was reported; the study collected pharmacokinetic plasma samples and monitored plasma HIV-1 RNA.,True,True,"Model said not applicable (no sequencing), matching human “No” and updated “Not applicable.”"
37541705-12,37541705,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No — the paper does not report any sequences from individuals with virologic failure.,True,False,"Model answered “No,” matching human “No” but not the updated “Not applicable.”"
23749954-3,23749954,3,Were sequences from the paper made publicly available?,No,No,Not reported — the paper does not provide GenBank accession numbers or state that newly generated sequences were deposited.,False,False,"Model said 'Not reported', while both annotations say 'No' (explicitly not made public)."
23749954-4,23749954,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported in the paper.,True,True,"Model said no accession numbers reported, matching both 'No' and 'Not reported'."
23749954-5,23749954,5,How many individuals had samples obtained for HIV sequencing?,0,0,None — no patient samples were obtained for sequencing in this study.,True,True,"Model explicitly states zero individuals were sequenced, matching '0'."
23749954-6,23749954,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable — the study did not sequence patient-derived samples from any countries.,True,True,"Model states not applicable due to no sequenced patient samples, aligning with both annotations."
23749954-7,23749954,7,From what years were the sequenced samples obtained?,No,Not applicable,Not applicable — no newly sequenced patient samples or associated collection years are reported.,True,True,"Model says not applicable because no samples were sequenced, matching both annotations."
23749954-8,23749954,8,Were samples cloned prior to sequencing?,No,Not applicable,Not applicable for patient samples; the authors did generate cloned NL4-3 plasmids with specific mutations in the laboratory.,True,True,"Model indicates not applicable (no patient sequencing), consistent with 'No' and 'Not applicable'."
23749954-9,23749954,9,Which HIV genes were reported to have been sequenced?,RT,Not applicable,"The study focused on the reverse transcriptase (RT) region (codons around positions 64/65, 70, 210, 219 and the K65R mutation).",True,False,"Model specifies RT, matching original 'RT' but contradicting updated 'Not applicable'."
23749954-10,23749954,10,What method was used for sequencing?,No,Not applicable,Not reported — the paper does not describe any sequencing methodology for newly generated sequences.,True,True,"Model says sequencing method not reported, consistent with no method provided/not applicable."
23749954-11,23749954,11,What type of samples were sequenced?,No,Not applicable,No new patient-derived samples were sequenced; the study used laboratory-generated NL4-3 mutant viruses and analyses of public database sequence alignments.,True,True,"Model states no patient samples were sequenced, aligning with both annotations."
23749954-12,23749954,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No — the study did not obtain or report sequences from individuals with virological failure.,True,True,"Model says no sequences from individuals with virological failure, matching both."
23749954-13,23749954,13,Were the patients in the study in a clinical trial?,No,Not applicable,No — there were no patients enrolled in this study; experiments used laboratory viruses and database sequences.,True,True,"Model notes no patients in the study, matching both annotations."
23749954-14,23749954,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,No — the paper does not report sequences from treated individuals; it analyzes laboratory-generated clones and database consensus sequences.,True,True,"Model says no sequences from treated individuals, aligning with both."
23749954-15,23749954,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable — there were no individuals sampled in this study.,True,True,"Model answers not applicable since no individuals were sampled, matching both."
23749954-16,23749954,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable — no human participants or their prior drug exposures were part of this study.,True,True,"Model answers not applicable (no participants), matching both."
24227862-1,24227862,1,Does the paper report HIV sequences from patient samples?,No,Not reported.,No.,True,False,"Model answers 'No', but updated says 'Not reported' (model does not convey unavailability)."
24227862-2,24227862,2,Does the paper report in vitro drug susceptibility data?,Yes,Not reported.,Yes.,True,False,"Model says 'Yes', matching original but not updated 'Not reported'."
24227862-3,24227862,3,Were sequences from the paper made publicly available?,No,Not reported.,No (no public sequence deposition is reported).,True,True,"Model says no deposition and clarifies it was not reported, matching both 'No' and 'Not reported'."
24227862-4,24227862,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported.,None reported.,True,True,"Model states none reported, matching both annotations."
24227862-5,24227862,5,How many individuals had samples obtained for HIV sequencing?,0,Not reported.,None — no patient-derived samples were sequenced.,True,False,Model states zero individuals; updated expects 'Not reported' rather than a value.
24227862-6,24227862,6,From which countries were the sequenced samples obtained?,No,Not reported.,"Not applicable — no patient-derived samples; laboratory materials and CBMCs (obtained in Montreal, Canada) were used.",True,False,Model says not applicable and mentions sources; updated says 'Not reported'.
24227862-7,24227862,7,From what years were the sequenced samples obtained?,No,Not reported.,Not applicable — no calendar years of sample collection or patient-derived sequences are reported.,True,True,"Model notes not applicable and explicitly that no years are reported, satisfying 'Not reported'."
24227862-8,24227862,8,Were samples cloned prior to sequencing?,No,Not reported.,Yes — site-directed cloning was performed to generate recombinant NL4.3 clones prior to sequencing for verification.,False,False,"Model says 'Yes' to cloning, contradicting both 'No' and 'Not reported'."
24227862-9,24227862,9,Which HIV genes were reported to have been sequenced?,RT,Not reported.,The reverse transcriptase (RT) coding sequences were sequenced/genotyped.,True,False,"Model specifies RT sequenced, matching original but not updated 'Not reported'."
24227862-10,24227862,10,What method was used for sequencing?,No,Not reported.,DNA sequencing (method not specified).,False,True,"Model gives 'method not specified' (i.e., not reported), contradicting original 'No' but matching updated."
24227862-11,24227862,11,What type of samples were sequenced?,No,Not reported.,Laboratory-derived recombinant HIV-1 NL4.3 proviral clones and viruses harvested from cell culture (in vitro selections); genotyping was performed on virus-containing culture media.,False,False,"Model provides specific sample types, conflicting with both 'No' and 'Not reported'."
37626789-1,37626789,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answered Yes, matching both annotations."
37626789-2,37626789,2,Does the paper report in vitro drug susceptibility data?,No,No,"No — the paper reports genotypic resistance from sequencing and interpretation via the Stanford HIVDB algorithm, not in vitro phenotypic susceptibility testing.",True,True,Model correctly states no phenotypic susceptibility testing was reported.
37626789-3,37626789,3,Were sequences from the paper made publicly available?,No,No,No — the paper does not report public deposition of sequences.,True,True,"Model says sequences were not publicly deposited, matching both."
37626789-4,37626789,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers are reported in the paper.,True,True,"Model states no GenBank accessions were reported, aligning with 'No'/'Not reported'."
37626789-5,37626789,5,How many individuals had samples obtained for HIV sequencing?,551,551,Not specified in the paper.,False,False,"Model says not specified, but the annotated count is 551."
37626789-6,37626789,6,From which countries were the sequenced samples obtained?,Ethiopia,Ethiopia,Ethiopia.,True,True,"Model identifies Ethiopia, matching both."
37626789-7,37626789,7,From what years were the sequenced samples obtained?,2007-2019,2007-2019,Samples were collected during the 2019 viral load testing period (March to September 2019) with a six-month follow-up for confirmation; the overall cohort follow-up covers 2007,False,False,Model gives only 2019 and vague cohort info; does not clearly state 2007–2019.
37626789-8,37626789,8,Were samples cloned prior to sequencing?,No,No,No cloning prior to sequencing is reported in the paper.,True,True,"Model says no cloning, matching both."
37626789-9,37626789,9,Which HIV genes were reported to have been sequenced?,Pol,Pol,The pol gene.,True,True,"Model specifies the pol gene, matching both."
37626789-10,37626789,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,An in-house amplification and Sanger sequencing assay using an ABI-3730 DNA genetic analyzer; sequences were edited using the web-based ReCall tool.,True,True,"Model describes Sanger sequencing, matching both."
37626789-11,37626789,11,What type of samples were sequenced?,Plasma,Plasma,Plasma extracted from whole blood samples.,True,True,"Model says plasma, matching both."
37626789-12,37626789,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both."
37626789-13,37626789,13,Were the patients in the study in a clinical trial?,No,No,No; they were part of an observational longitudinal national cohort study.,True,True,"Model notes observational cohort (not a trial), matching both."
37626789-14,37626789,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both."
37626789-15,37626789,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI","NRTI, NNRTI",Primarily nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs); protease inhibitors (PIs) were infrequently used.,False,False,"Model adds PIs, which are not included in the annotated classes (NRTI, NNRTI)."
37626789-16,37626789,16,Which drugs were received by individuals in the study before sample sequencing?,"AZT, 3TC, NVP, D4T, EFV, ABC, EFV, TDF","AZT, 3TC, NVP, D4T, EFV, ABC, TDF","Drugs included Zidovudine (AZT), Lamivudine (3TC), Nevirapine (NVP), Stavudine (D4T), Efavirenz (EFV), Abacavir (ABC), and Tenofovir (TDF); protease inhibitors such as nelfinavir (NFV) and others are mentioned as second-line options but were infrequently used.",True,True,"Model lists AZT, 3TC, NVP, D4T, EFV, ABC, TDF; matches annotated drugs despite extra note about PIs as options."
37632026-1,37632026,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes,True,False,"Model says Yes, matching original but not the updated 'Not reported'."
37632026-2,37632026,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No,True,False,"Model says No, matching original but not updated 'Not reported'."
37632026-3,37632026,3,Were sequences from the paper made publicly available?,Yes,Not reported,Yes,True,False,"Model says Yes, matching original but not updated 'Not reported'."
37632026-4,37632026,4,What were the GenBank accession numbers for sequenced HIV isolates?,MK580543-MK580618; JF273935-JF273965; JQ796152-JQ796169; MK867721-MK867755; OQ985493-OQ985958,Not reported,MK580543-MK580618; JF273935-JF273965; JQ796152-JQ796169; MK867721-MK867755; OQ985493-OQ985958,True,False,"Model provides accession numbers matching original list, contradicting updated 'Not reported'."
37632026-5,37632026,5,How many individuals had samples obtained for HIV sequencing?,759,Not reported,759 individuals,True,False,"Model gives 759, matching original but not updated 'Not reported'."
37632026-6,37632026,6,From which countries were the sequenced samples obtained?,Cameroon,Not reported,Cameroon,True,False,"Model says Cameroon, matching original but not updated 'Not reported'."
37632026-7,37632026,7,From what years were the sequenced samples obtained?,2011-2019,Not reported,November 2011 to August 2019,True,False,"Model gives 2011–2019, matching original but not updated 'Not reported'."
37632026-8,37632026,8,Were samples cloned prior to sequencing?,No,Not reported,No,True,False,"Model says No cloning, matching original but not updated 'Not reported'."
37632026-9,37632026,9,Which HIV genes were reported to have been sequenced?,Pol,Not reported,pol gene: protease and reverse-transcriptase regions,True,False,"Model says pol (PR and RT), matching original but not updated 'Not reported'."
37701387-5,37701387,5,How many individuals had samples obtained for HIV sequencing?,0,Not reported,30 individuals (the Rainbow study participants).,False,False,Model says 30; human says 0 and updated says not reported.
37701387-6,37701387,6,From which countries were the sequenced samples obtained?,No,Not reported,Italy.,False,False,Model gives Italy; humans indicate not reported.
37701387-7,37701387,7,From what years were the sequenced samples obtained?,No,Not reported,From 2020 to 2021.,False,False,Model provides 2020–2021; humans indicate not reported.
37701387-8,37701387,8,Were samples cloned prior to sequencing?,No,Not reported,Not reported / No indication of cloning prior to sequencing.,False,True,"Model says not reported; original says No, updated says Not reported."
37701387-9,37701387,9,Which HIV genes were reported to have been sequenced?,No,Not reported,Regions corresponding to NRTI-associated sites (reverse transcriptase) and INSTI-associated sites (integrase) were assessed.,False,False,Model lists RT/integrase; humans indicate not reported.
37701387-10,37701387,10,What method was used for sequencing?,No,Not reported,Not reported / method not specified in the paper.,True,True,Model says not reported; matches both original and updated.
37701387-11,37701387,11,What type of samples were sequenced?,Whole Blood,Not reported,Baseline clinical samples from study participants (baseline genotype was examined); exact specimen type is not specified.,False,True,"Model leaves specimen type unspecified; original says Whole Blood, updated says Not reported."
37701387-12,37701387,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,No — sequences were from ART‑naïve individuals and the study reported no virological failure-related ART interruptions.,True,False,Model answers No; updated says Not reported.
37701387-13,37701387,13,Were the patients in the study in a clinical trial?,Yes,Not reported,Yes — the Rainbow component was a phase IV clinical trial.,True,False,Model answers Yes; updated says Not reported.
37701387-14,37701387,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,No — the reported sequences/genotype data are from ART‑naïve individuals.,False,False,Model answers No; original says Yes and updated says Not reported.
37701387-15,37701387,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, PI, INSTI",Not reported,None — participants were ART‑naïve prior to sequencing.,False,False,Model says none/ART-naïve; original lists classes and updated says Not reported.
37701387-16,37701387,16,Which drugs were received by individuals in the study before sample sequencing?,"BIC, FTC, TAF, DRV",Not applicable,None — individuals were ART‑naïve before baseline sequencing.,False,False,Model says none; original lists drugs and updated says Not applicable.
37716367-1,37716367,1,Does the paper report HIV sequences from patient samples?,No,No,No.,True,True,"Model answers No, matching both."
37716367-2,37716367,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No.,True,False,Model answers No; updated says Not reported.
37716367-3,37716367,3,Were sequences from the paper made publicly available?,No,No,No (not applicable).,True,True,"Model answers No, matching both."
37716367-4,37716367,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported in this paper / Not applicable.,True,True,"Model indicates none reported/not applicable, matching unavailability."
37716367-5,37716367,5,How many individuals had samples obtained for HIV sequencing?,0,0,Not applicable / none reported.,True,True,"'None reported' corresponds to 0, matching both."
37716367-6,37716367,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable / not reported.,True,True,"Model states not applicable/not reported, matching both."
37716367-7,37716367,7,From what years were the sequenced samples obtained?,No,Not applicable,Not applicable / not reported.,True,True,"Model states not applicable/not reported, matching both."
37716367-8,37716367,8,Were samples cloned prior to sequencing?,No,Not applicable,Not applicable / not reported.,True,True,"Model states not applicable/not reported, consistent with no sequencing."
37716367-9,37716367,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,Not applicable / not reported.,True,True,"Model states not applicable/not reported, consistent with no sequencing."
37716367-10,37716367,10,What method was used for sequencing?,No,Not applicable,Not applicable / not reported.,True,True,"Model states not applicable/not reported, consistent with no sequencing."
37716367-11,37716367,11,What type of samples were sequenced?,No,Not applicable,Not applicable / not reported.,True,True,"Model states not applicable/not reported, consistent with no sequencing."
37716367-12,37716367,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,Not applicable / not reported.,True,True,"Model states not applicable/not reported, consistent with no sequencing."
37716367-13,37716367,13,Were the patients in the study in a clinical trial?,No,Not reported,No (the paper is a guideline; it does not report a clinical trial).,True,False,Model answers No; updated says Not reported.
37585352-8,37585352,8,Were samples cloned prior to sequencing?,No,Not reported,No,True,False,"Model said No, matching original; updated says Not reported, which the model did not convey."
37585352-9,37585352,9,Which HIV genes were reported to have been sequenced?,Pol,Not reported,The pol gene (near full-length HIV-1 pol sequences),True,False,"Model identified pol, matching original; updated says Not reported."
37585352-10,37585352,10,What method was used for sequencing?,Illumina sequencing,Not reported,Next-generation sequencing (Illumina MiSeq and HiSeq platforms),True,False,"Model gave Illumina (MiSeq/HiSeq), matching original; updated says Not reported."
37585352-11,37585352,11,What type of samples were sequenced?,No,Not reported,Proviral DNA (from participants),False,False,"Original says No, but model specifies proviral DNA; updated says Not reported, which model did not reflect."
37585352-12,37585352,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,No,True,False,"Model said No, matching original; updated says Not reported."
37585352-13,37585352,13,Were the patients in the study in a clinical trial?,Yes,Not reported,"Yes, participants were recruited from a large community HIV incidence trial (the Botswana Combination Prevention Project, registered NCT01965470)",True,False,"Model said Yes (clinical trial), matching original; updated says Not reported."
37585352-14,37585352,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes,True,False,"Model said Yes, matching original; updated says Not reported."
37585352-15,37585352,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI",Not reported,Primarily nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs); very few participants had exposure to integrase strand transfer inhibitors (INSTIs),True,False,"Model listed NRTI and NNRTI (plus note on rare INSTI), matching original classes; updated says Not reported."
37585352-16,37585352,16,Which drugs were received by individuals in the study before sample sequencing?,"EFV, FTC, TDF, 3TC, NVP, AZT",Not applicable,"Reported drugs include efavirenz, emtricitabine, tenofovir, lamivudine, nevirapine and zidovudine; INSTI exposure was very rare",True,False,"Model listed EFV/FTC/TDF/3TC/NVP/AZT, matching original; updated says Not applicable."
37593123-1,37593123,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes.,True,False,"Model said Yes, matching original; updated says Not reported."
37593123-2,37593123,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,"No — the study reports genotypic resistance inference, not in vitro phenotypic susceptibility testing.",True,False,"Model said No (no in vitro phenotyping), matching original; updated says Not reported."
37593123-3,37593123,3,Were sequences from the paper made publicly available?,No,Not reported,Yes — the analysis used sequences obtained from public databases (China CDC records and the Los Alamos HIV sequence database / GenBank annotations).,False,False,"Model said Yes (publicly available), contradicting original No; updated says Not reported."
37593123-4,37593123,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,Not reported in the paper.,True,True,"Model stated Not reported, aligning with original (unavailable) and updated Not reported."
37593123-5,37593123,5,How many individuals had samples obtained for HIV sequencing?,57902,Not reported,"57,902 individuals (ART-naïve).",True,False,"Model gave 57,902, matching original; updated says Not reported."
37593123-6,37593123,6,From which countries were the sequenced samples obtained?,China,Not reported,China.,True,False,"Model said China, matching original; updated says Not reported."
37593123-7,37593123,7,From what years were the sequenced samples obtained?,2004-2022,Not reported,2004 to 2022.,True,False,"Model gave 2004–2022, matching original; updated says Not reported."
37593123-8,37593123,8,Were samples cloned prior to sequencing?,No,Not reported,Not reported / No indication of cloning.,False,True,"Model said Not reported/no indication, conflicting with original No; matches updated Not reported."
37593123-9,37593123,9,Which HIV genes were reported to have been sequenced?,Pol,Not reported,"The pol gene region, specifically protease and the initial 238 amino acids of reverse transcriptase.",True,False,"Model specified pol (PR + first 238 aa of RT), matching original; updated says Not reported."
37593123-10,37593123,10,What method was used for sequencing?,No,Not reported,Not specified; sequences were obtained from public sequence databases and analyzed computationally (alignment with HIV-Trace and phylogenetics with IQ-Tree).,True,True,"Model said not specified (database sequences), aligning with original No and updated Not reported."
37593123-11,37593123,11,What type of samples were sequenced?,No,Not reported,"Not specified beyond being sequences from ART-naïve HIV-positive individuals; the sample type (e.g., plasma, PBMC) is not reported.",True,True,"Model said sample type not reported, aligning with original No and updated Not reported."
37593123-12,37593123,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,"No. All sequences were from ART-naïve individuals, so none were from persons failing treatment.",True,False,"Model said No (ART-naïve), matching original; updated says Not reported."
37593123-13,37593123,13,Were the patients in the study in a clinical trial?,No,Not reported,"No. The study used surveillance/research sequences from databases and describes observational sampling across PLADs, not enrollment in a clinical trial.",True,False,"Model said No clinical trial, matching original; updated says Not reported."
37593123-14,37593123,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No. The sequences were from ART-naïve individuals who had not previously received antiretroviral therapy.,True,False,"Model said No prior ARVs (ART-naïve), matching original; updated says Not reported."
37593123-15,37593123,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,None — individuals were ART-naïve and had not received antiretroviral drug classes prior to sampling.,True,False,"Model said None (ART-naïve), matching original; updated says Not reported."
37593123-16,37593123,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"None — the study population was ART-naïve, so no individual-level prior antiretroviral drugs are reported.",True,True,"Model said None (ART-naïve), aligning with original No and updated Not applicable."
37632026-10,37632026,10,What method was used for sequencing?,Sanger sequencing,Not reported,RT-PCR and nested PCR amplification followed by Sanger sequencing on an Applied Biosystems 3500 genetic analyzer; sequence assembly with SeqScape or Recall,True,False,"Model specifies Sanger sequencing (matches original), but not consistent with updated “Not reported.”"
37632026-11,37632026,11,What type of samples were sequenced?,Plasma,Not reported,Plasma samples (viral RNA extracted from plasma derived from whole blood),True,False,"Model states plasma samples, matching original, but contradicts updated “Not reported.”"
37632026-12,37632026,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,Yes,True,False,"Model says Yes, matching original; updated says Not reported."
37632026-13,37632026,13,Were the patients in the study in a clinical trial?,No,Not reported,No,True,False,"Model says No clinical trial, matching original; updated says Not reported."
37632026-14,37632026,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes,True,False,"Model says Yes sequences from ARV-experienced, matching original; updated says Not reported."
37632026-15,37632026,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI, PI",Not reported,"NRTIs (nucleoside/nucleotide RT inhibitors), NNRTIs (non-nucleoside RT inhibitors), and boosted protease inhibitors (PI/r); no integrase inhibitor exposure was reported",True,False,"Model lists NRTI, NNRTI, PI (matches original classes); updated says Not reported."
37632026-16,37632026,16,Which drugs were received by individuals in the study before sample sequencing?,"AZT, D4T, XTC, TDF, ATV, LPV, DRV",Not reported,"Reported drugs included zidovudine (AZT), stavudine (D4T), tenofovir (TDF), lamivudine/emtricitabine (3TC/FTC or XTC), abacavir (ABC), efavirenz (EFV), nevirapine (NVP), boosted protease inhibitors atazanavir/ritonavir (ATV/r), lopinavir/ritonavir (LPV/r), darunavir/ritonavir (DRV/r), and older PIs nelfinavir (NFV) and indinavir (IDV).",True,False,"Model includes AZT, D4T, XTC (3TC/FTC), TDF, ATV/r, LPV/r, DRV/r (matches original drugs) though adds others; updated says Not reported."
37632071-1,37632071,1,Does the paper report HIV sequences from patient samples?,No,No,No.,True,True,"Model says no patient sequences, matching both original and updated."
37632071-2,37632071,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,"Model says no in vitro susceptibility data, matching both."
37632071-3,37632071,3,Were sequences from the paper made publicly available?,No,No,No — no sequences are reported or deposited.,True,True,"Model says no sequences deposited, matching both."
37632071-4,37632071,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None — no GenBank accession numbers are reported.,True,True,"Model states no GenBank accessions reported, aligning with “No” and “Not reported.”"
37632071-5,37632071,5,How many individuals had samples obtained for HIV sequencing?,0,0,None — the study did not perform HIV sequencing.,True,True,"Model indicates zero individuals sequenced, matching both."
37632071-6,37632071,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable (no sequencing); the study was conducted in Italy.,True,True,"Model answers not applicable (no sequencing), aligning with original “No” and updated “Not applicable.”"
37632071-7,37632071,7,From what years were the sequenced samples obtained?,No,Not applicable,Not applicable (no sequencing); the clinical study period was 2019–2022.,True,True,"Model says not applicable (no sequencing), matching both; extra study period context is acceptable."
37632071-8,37632071,8,Were samples cloned prior to sequencing?,No,Not applicable,No — cloning and sequencing are not described in the paper.,True,True,"Model indicates no cloning/sequencing described, effectively not applicable; matches original “No” and updated N/A."
37632071-9,37632071,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,None — no HIV genes were sequenced or reported.,True,True,"Model says no genes sequenced/reported, matching both."
37632071-10,37632071,10,What method was used for sequencing?,No,Not applicable,Not applicable — no sequencing was performed or methods reported.,True,True,"Model says not applicable—no sequencing methods, matching both."
37632071-11,37632071,11,What type of samples were sequenced?,No,Not applicable,Not applicable — no samples were sequenced; the study measured plasma HIV RNA (plasma samples).,True,True,"Model states not applicable (no samples sequenced), matching both; added context doesn’t contradict."
37632071-12,37632071,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No — no sequences were obtained; the study largely included individuals with suppressed or low-level viremia prior to switch.,True,True,"Model says no sequences obtained, matching both (N/A)."
37632071-13,37632071,13,Were the patients in the study in a clinical trial?,No,Not Reported,No — this was a retrospective cohort study of routine clinical practice.,True,False,"Model says not a clinical trial (matches original), but updated says Not reported."
37632071-14,37632071,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,No — the paper does not report any HIV sequences; the study population were treatment-experienced individuals on antiretroviral therapy.,True,True,"Model says no sequences (thus none from ARV-experienced), matching both."
37632071-15,37632071,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,"Not applicable for sequencing, but prior to the switch individuals received NRTIs combined with INSTIs, NNRTIs, or PIs (e.g., 2 NRTI + INSTI, 2 NRTI + NNRTI, 2 NRTI + PI).",True,True,Model notes not applicable for sequencing; aligns with original “No” and updated N/A despite extra drug-class context.
37632071-16,37632071,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Specific prior drug names are not reported comprehensively; the paper reports the switch regimen (bictegravir, emtricitabine, tenofovir alafenamide) and references lamivudine, TAF, and FTC in discussion, but does not list prior individual drug names for the cohort beyond drug classes.",True,True,Model indicates specific prior drugs not comprehensively reported and treats sequencing context as N/A; matches both.
37649807-1,37649807,1,Does the paper report HIV sequences from patient samples?,No,No,No.,True,True,"Model says no patient sequences, matching both."
37649807-2,37649807,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,"Model says no in vitro susceptibility data, matching both."
37662576-12,37662576,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,"No — the study did not obtain or report sequences from individuals, including those with virological failure.",True,False,"Model answered No, matching original No but not updated Not reported."
37662576-13,37662576,13,Were the patients in the study in a clinical trial?,No,Not reported,No — there were no patients in this study.,True,False,"Model said No (no patients), matching original No but not updated Not reported."
37662576-14,37662576,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No — no individual-derived HIV sequences are reported.,True,False,"Model said No sequences from treated individuals, matching original No but not updated Not reported."
37662576-15,37662576,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,Not applicable — no individuals or pre-sequencing drug histories were reported.,True,False,"Model said Not applicable/none, aligning with original No; updated says Not reported."
37662576-16,37662576,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not reported,Not applicable — no individuals or their prior drug treatments were sampled or sequenced.,True,False,"Model said Not applicable/none, aligning with original No; updated says Not reported."
37674678-1,37674678,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answered Yes, matching both annotations."
37674678-2,37674678,2,Does the paper report in vitro drug susceptibility data?,No,No,"No — only genotypic (predicted) resistance analyses were reported, not in vitro phenotypic susceptibility assays.",True,True,"Model answered No in vitro susceptibility, matching both."
37674678-3,37674678,3,Were sequences from the paper made publicly available?,Yes,Yes,Not explicitly reported in the manuscript.,False,False,Model said not reported; both annotations say Yes (publicly available).
37674678-4,37674678,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers are reported in the paper.,True,True,"Model stated no GenBank numbers reported, matching original No and updated Not reported."
37674678-5,37674678,5,How many individuals had samples obtained for HIV sequencing?,1161 or 1393,Not reported,"1,161 sequences were successfully obtained and analyzed (from 1,393 enrolled individuals).",True,False,"Model gave 1,161 (from 1,393), matching human; updated says Not reported."
37674678-6,37674678,6,From which countries were the sequenced samples obtained?,China,China,"China (samples were obtained in Nanjing, China).",True,True,"Model answered China, matching both."
37674678-7,37674678,7,From what years were the sequenced samples obtained?,2019 to 2021,2019–2021,"From 2019 through 2021 (enrolled between January 1, 2019 and November 31, 2021).",True,True,"Model gave 2019–2021, matching both."
37674678-8,37674678,8,Were samples cloned prior to sequencing?,No,No,No — samples were amplified by nested PCR and PCR products were directly sequenced; no cloning is described.,True,True,"Model said no cloning, matching both."
37674678-9,37674678,9,Which HIV genes were reported to have been sequenced?,Pol,Pol,The pol gene (specifically HXB2 positions 2253–3312).,True,True,"Model identified pol, matching both."
37674678-10,37674678,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,Nested RT-PCR amplification followed by automatic Sanger sequencing on an ABI 3730XL instrument.,True,True,"Model specified Sanger sequencing, matching both."
37674678-11,37674678,11,What type of samples were sequenced?,Plasma,Plasma,Plasma-derived viral RNA from 200 μl plasma samples (plasma isolated from blood).,True,True,"Model identified plasma, matching both."
37674678-12,37674678,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,No — all participants were ART-naïve with no history of antiretroviral therapy.,True,True,"Model answered No (ART-naïve), matching both."
37674678-13,37674678,13,Were the patients in the study in a clinical trial?,No,No,"No — patients were enrolled observationally at voluntary counseling and testing clinics, not as part of a clinical trial.",True,True,"Model answered No clinical trial, matching both."
37674678-14,37674678,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,No,No — the sequences were from ART-naïve individuals with no history of antiretroviral therapy.,True,True,"Model answered No prior ARVs, matching both."
37674678-15,37674678,15,Which drug classes were received by individuals in the study before sample sequencing?,No,nan,None — individuals had not received antiretroviral therapy prior to sampling.,True,False,"Model said none, matching original No; updated is missing/NaN (treated as not reported)."
37674678-16,37674678,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,None — no antiretroviral drugs were received by participants prior to sequencing.,True,True,"Model said none received, aligning with original No and updated Not applicable."
37701387-1,37701387,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes — the paper reports baseline genotype/mutation data from patient samples.,True,False,"Model answered Yes, matching original but not updated Not reported."
37701387-2,37701387,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No — the paper does not report in vitro phenotypic drug susceptibility data.,True,False,"Model answered No, matching original but not updated Not reported."
37701387-3,37701387,3,Were sequences from the paper made publicly available?,No,Not reported,No — the paper does not report making sequences publicly available.,True,False,Model answered No; updated says Not reported.
37701387-4,37701387,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model said none reported, matching both original No and updated Not reported."
37775947-7,37775947,7,From what years were the sequenced samples obtained?,2009-2013,Not reported,Samples were obtained between April 2009 and December 2013.,True,False,"Model gives 2009–2013, matching original; conflicts with updated 'Not reported'."
37775947-8,37775947,8,Were samples cloned prior to sequencing?,No,Not reported,No — cloning is not reported; samples underwent RNA amplification followed by NGS.,True,False,"Model says no cloning, matching original; not compatible with updated 'Not reported'."
37775947-9,37775947,9,Which HIV genes were reported to have been sequenced?,Pol,Not reported,"pol gene covering protease (positions 1–99), reverse transcriptase (positions 100–659), and part of integrase (positions 660–935).",True,False,"Model specifies pol, matching original; conflicts with updated 'Not reported'."
37775947-10,37775947,10,What method was used for sequencing?,Illumina sequencing,Not reported,Next-generation sequencing (NGS) using Illumina MiSeq.,True,False,"Model states Illumina NGS, matching original; not matching updated 'Not reported'."
37775947-11,37775947,11,What type of samples were sequenced?,Plasma,Not reported,Stored plasma samples (baseline plasma taken within 60 days before enrolment).,True,False,"Model says plasma, matching original; conflicts with updated 'Not reported'."
37775947-12,37775947,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,No — baseline sequences were obtained from ART‑naïve participants prior to treatment; genotypic tests at time of failure were not conducted.,True,False,"Model says no sequences at virological failure, matching original; not matching updated 'Not reported'."
37775947-13,37775947,13,Were the patients in the study in a clinical trial?,Yes,Not reported,Yes — they were participants in the START randomized clinical trial.,True,False,"Model says patients were in a clinical trial, matching original; not matching updated 'Not reported'."
37775947-14,37775947,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No — the participants were ART‑naïve at baseline.,True,False,"Model says no prior ARVs, matching original; conflicts with updated 'Not reported'."
37775947-15,37775947,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,None — participants were ART‑naïve before sequencing.,True,False,"Model says none (ART-naïve), matching original 'No'; not matching updated 'Not reported'."
37775947-16,37775947,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,None — no antiretroviral drugs were received before baseline sampling because participants were ART‑naïve.,True,False,"Model says none, matching original 'No'; does not reflect updated 'Not applicable'."
37817087-1,37817087,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answers yes, matching both annotations."
37817087-2,37817087,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,"Model answers no, matching both annotations."
37817087-3,37817087,3,Were sequences from the paper made publicly available?,No,No,No — sequences are not publicly deposited; they are available from the corresponding author upon reasonable request.,True,True,"Model says not publicly available, matching both annotations."
37817087-4,37817087,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,Not provided in the paper.,True,True,"Model says not provided, aligning with lack of accession numbers."
37817087-5,37817087,5,How many individuals had samples obtained for HIV sequencing?,4559 and 3097,Not reported,PR/RT sequences were obtained from 4559 cases; PR/RT/IN sequences were obtained from 3097 cases.,True,False,"Model gives 4559 and 3097, matching original; conflicts with updated 'Not reported'."
37817087-6,37817087,6,From which countries were the sequenced samples obtained?,Germany,Not reported,Samples were obtained in Germany (national surveillance of new HIV diagnoses reported to the Robert Koch Institute).,True,False,"Model specifies Germany, matching original; conflicts with updated 'Not reported'."
37817087-7,37817087,7,From what years were the sequenced samples obtained?,2017-2020,Not reported,2017–2020.,True,False,"Model gives 2017–2020, matching original; conflicts with updated 'Not reported'."
37817087-8,37817087,8,Were samples cloned prior to sequencing?,No,No,No.,True,True,"Model answers no cloning, matching both annotations."
37817087-9,37817087,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN","PR, RT, IN","Protease (PR), reverse transcriptase (RT) and integrase (IN).",True,True,"Model lists PR, RT, IN, matching both annotations."
37817087-10,37817087,10,What method was used for sequencing?,Illumina sequencing,Not reported,Illumina next-generation sequencing (MiSeq) of PCR amplicons.,True,False,"Model provides Illumina NGS, matching original; not matching updated 'Not reported'."
37817087-11,37817087,11,What type of samples were sequenced?,"Serum, Plasma, DBS",Not reported,"Serum, plasma, or dried serum/plasma spots (spot elution from Whatman 903 filter paper).",False,False,"Model lists serum, plasma, and dried serum/plasma spots, which does not match original 'Serum, Plasma, DBS' and conflicts with updated 'Not reported'."
37817087-12,37817087,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,"No — sequences were from newly diagnosed cases (primary resistance); the study did not focus on individuals with virological failure on treatment, although the authors note they cannot fully exclude some treated cases diagnosed abroad.",True,False,"Model answers no sequences from VF on treatment, matching original; conflicts with updated 'Not reported'."
37817087-13,37817087,13,Were the patients in the study in a clinical trial?,No,Not reported,No.,True,False,"Model answers no clinical trial, matching original; conflicts with updated 'Not reported'."
37817087-14,37817087,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,"Generally no — sequences are from newly diagnosed (presumed treatment-naive) individuals, though the authors acknowledge they cannot completely exclude some cases that were previously treated abroad.",True,False,"Model says generally no prior ARVs (with caveat), aligning with original 'No'; not matching updated 'Not reported'."
37817087-15,37817087,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,"Not reported for individual patients; the paper reports resistance categories (NRTI, NNRTI, PI, INI) but does not provide data on which drug classes patients had personally received prior to sequencing.",False,True,"Model states 'Not reported' for drug classes received, which contradicts original 'No' but matches updated 'Not reported'."
37896785-11,37896785,11,What type of samples were sequenced?,Plasma,Plasma,Blood plasma samples.,True,True,"Model says blood plasma, matching 'Plasma' for both."
37896785-12,37896785,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both."
37896785-13,37896785,13,Were the patients in the study in a clinical trial?,No,No,No.,True,True,"Model answers No, matching both."
37896785-14,37896785,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both."
37896785-15,37896785,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,Primarily NRTIs and NNRTIs (first-line regimens); some patients may have received protease inhibitors as second-line therapy.,False,False,"Model provides drug classes, conflicting with human 'No' and updated 'Not reported'."
37896785-16,37896785,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Drugs mentioned as components of local regimens include stavudine (d4T), lamivudine (3TC), zidovudine (AZT), nevirapine (NVP), efavirenz (EFV); lopinavir/ritonavir is noted as recommended second-line therapy and other PIs (darunavir, fosamprenavir) are discussed in relation to resistance.",False,False,"Model lists specific drugs, conflicting with human 'No' and updated 'Not applicable'."
37896860-1,37896860,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes.,True,False,"Model says Yes, matching original but not updated 'Not reported'."
37896860-2,37896860,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No.,True,False,"Model says No, matching original but not updated 'Not reported'."
37896860-3,37896860,3,Were sequences from the paper made publicly available?,No,Not reported,No.,True,False,"Model says No, matching original but not updated 'Not reported'."
37896860-4,37896860,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model says 'None reported,' aligning with original 'No' and updated 'Not reported'."
37896860-5,37896860,5,How many individuals had samples obtained for HIV sequencing?,704,Not reported,106 participants had at least one drug resistance test result.,False,False,"Model gives 106, not 704, and not 'Not reported'."
37896860-6,37896860,6,From which countries were the sequenced samples obtained?,Kenya,Not reported,Kenya.,True,False,"Model says Kenya, matching original but not updated 'Not reported'."
37896860-7,37896860,7,From what years were the sequenced samples obtained?,2019-2020,Not reported,2019–2020.,True,False,"Model gives 2019–2020, matching original but not updated 'Not reported'."
37896860-8,37896860,8,Were samples cloned prior to sequencing?,No,Not reported,No.,True,False,"Model says No, matching original but not updated 'Not reported'."
37896860-9,37896860,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN",Not reported,Reverse transcriptase and protease (PI) regions of pol were sequenced; integrase was not routinely evaluated.,False,False,"Model lists RT and PR only (IN not sequenced), conflicting with human 'PR, RT, IN' and not 'Not reported'."
37896860-10,37896860,10,What method was used for sequencing?,Sanger sequencing,Not reported,Sanger sequencing using Applied Biosystems 3130xl and 3730xl Genetic Analyzers.,True,False,"Model gives Sanger sequencing, matching original but not updated 'Not reported'."
37896860-11,37896860,11,What type of samples were sequenced?,Plasma,Not reported,Plasma samples derived from whole blood.,True,False,"Model says plasma, matching original but not updated 'Not reported'."
37896860-12,37896860,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,Yes.,True,False,"Model says Yes, matching original but not updated 'Not reported'."
37896860-13,37896860,13,Were the patients in the study in a clinical trial?,Yes,Not reported,Yes; participants were enrolled in the Opt4Kids randomized controlled trial.,True,False,"Model says Yes (names the trial), matching original but not updated 'Not reported'."
37896860-14,37896860,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes.,True,False,"Model says Yes, matching original but not updated 'Not reported'."
37896860-15,37896860,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, PI, NNRTI, INSTI",Not reported,"NRTIs, NNRTIs, PIs, and INSTIs.",True,False,"Model lists NRTIs, NNRTIs, PIs, INSTIs, matching original but not updated 'Not reported'."
37896860-16,37896860,16,Which drugs were received by individuals in the study before sample sequencing?,"3TC, ABC, AZT, LPV, EFV, DTG",Not reported,"Lamivudine, abacavir, zidovudine, lopinavir/ritonavir, efavirenz, and dolutegravir (among others); resistance to drugs such as tenofovir, emtricitabine, rilpivirine, etravirine, and doravirine was also assessed.",True,False,"Model lists 3TC, ABC, AZT, LPV/r, EFV, DTG (plus extra context), matching original but not updated 'Not reported'."
37910452-1,37910452,1,Does the paper report HIV sequences from patient samples?,No,Not reported,No,True,False,"Model says No, matching original but not updated 'Not reported'."
37910452-2,37910452,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No,True,False,"Model says No, matching original but not updated 'Not reported'."
37910452-3,37910452,3,Were sequences from the paper made publicly available?,No,Not reported,No,True,False,"Model says No, matching original but not updated 'Not reported'."
37880705-2,37880705,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,"Model answered No, matching both annotations."
37880705-3,37880705,3,Were sequences from the paper made publicly available?,No,No,"Yes — sequences were obtained from public repositories (GenBank) when available, and authors were contacted for others.",False,False,"Model said Yes/public repositories, contradicting No in both annotations."
37880705-4,37880705,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,Not specified in the provided paper text.,True,True,"Model stated accession numbers not specified, aligning with not reported."
37880705-5,37880705,5,How many individuals had samples obtained for HIV sequencing?,1070,1070,1070 individuals (one sequence per individual were included).,True,True,"Model gave 1070, matching both."
37880705-6,37880705,6,From which countries were the sequenced samples obtained?,Ethiopia,Ethiopia,Ethiopia.,True,True,"Model listed Ethiopia, matching both."
37880705-7,37880705,7,From what years were the sequenced samples obtained?,2003-2018,2003-2018,Samples (sequences) were from studies conducted between 2003 and 2018.,True,True,"Model gave 2003–2018, matching both."
37880705-8,37880705,8,Were samples cloned prior to sequencing?,No,Not reported,Not reported (no mention of cloning prior to sequencing).,False,True,"Question is yes/no; model said Not reported, while original said No. Updated is Not reported."
37880705-9,37880705,9,Which HIV genes were reported to have been sequenced?,"PR, RT","PR, RT",Full protease (PR) and partial reverse transcriptase (RT) (first 230 codons).,True,True,"Model identified PR and RT, matching both."
37880705-10,37880705,10,What method was used for sequencing?,No,Not reported,Not specified in the provided paper text; sequences were retrieved from GenBank (original sequencing methods not reported).,True,True,"Model said not specified, aligning with not reported."
37880705-11,37880705,11,What type of samples were sequenced?,No,Not reported,Not specified in the provided paper text.,True,True,"Model said not specified, aligning with not reported."
37880705-12,37880705,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,No — sequences were from ART-naïve individuals; studies among ART-experienced individuals were excluded.,True,False,"Model asserted No (ART-naïve), but updated says not reported."
37880705-13,37880705,13,Were the patients in the study in a clinical trial?,No,Not reported,Not reported / No indication that patients were in a clinical trial.,False,True,Model indicated not reported; original said No.
37880705-14,37880705,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No — the sequences analyzed were from ART-naïve individuals.,True,False,"Model said No (ART-naïve), conflicting with updated not reported."
37880705-15,37880705,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,None — individuals were ART-naïve (no antiretroviral drug classes received prior to sampling).,True,False,"Model said None, while updated says not reported."
37880705-16,37880705,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,None — participants were ART-naïve and had not received antiretroviral drugs prior to sampling.,True,True,"Model said None/ART-naïve, which is equivalent to not applicable."
37896785-1,37896785,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answered Yes, matching both."
37896785-2,37896785,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,"Model answered No, matching both."
37896785-3,37896785,3,Were sequences from the paper made publicly available?,Yes,Yes,Yes.,True,True,"Model answered Yes, matching both."
37896785-4,37896785,4,What were the GenBank accession numbers for sequenced HIV isolates?,OQ215322-OQ215382,OQ215322–OQ215382,OQ215322–OQ215382.,True,True,Accession range OQ215322–OQ215382 matches both.
37896785-5,37896785,5,How many individuals had samples obtained for HIV sequencing?,61,61,61 individuals.,True,True,"Model gave 61, matching both."
37896785-6,37896785,6,From which countries were the sequenced samples obtained?,Vietnam,Vietnam,"Vietnam (Ho Chi Minh City, South Vietnam).",True,True,"Model listed Vietnam, matching both."
37896785-7,37896785,7,From what years were the sequenced samples obtained?,2021,2021,2021.,True,True,"Model gave 2021, matching both."
37896785-8,37896785,8,Were samples cloned prior to sequencing?,No,No,No.,True,True,"Model answered No, matching both."
37896785-9,37896785,9,Which HIV genes were reported to have been sequenced?,"PR, RT","PR, RT",A pol gene fragment encoding the protease (PR) and part of reverse transcriptase (RT).,True,True,"Model identified PR and part of RT, matching both."
37896785-10,37896785,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,Sanger sequencing (AmpliSens HIVResist-Seq kit) with analysis on an ABI Prism 3500 genetic analyzer.,True,True,"Model specified Sanger sequencing, matching both."
37716367-14,37716367,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,Not applicable / not reported.,False,True,"Model says not applicable/not reported, which conflicts with original 'No' but matches updated 'Not applicable'."
37716367-15,37716367,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable / not reported.,False,True,"Model indicates information unavailable, not listing classes; this conflicts with original 'No' but aligns with updated 'Not applicable'."
37716367-16,37716367,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable / not reported.,False,True,"Model reports not applicable/not reported, conflicting with original 'No' but matching updated 'Not applicable'."
37755428-1,37755428,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both annotations."
37755428-2,37755428,2,Does the paper report in vitro drug susceptibility data?,No,No,No — phenotypic in vitro susceptibility testing was not reported; resistance was predicted genotypically.,True,True,"Model states no phenotypic data, matching both 'No' annotations."
37755428-3,37755428,3,Were sequences from the paper made publicly available?,No,No,Not reported / No information provided on public sequence deposition.,False,False,"Model says not reported, but both annotations say 'No' (not made public)."
37755428-4,37755428,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model says none reported, consistent with original 'No' and updated 'Not reported' for accession numbers."
37755428-5,37755428,5,How many individuals had samples obtained for HIV sequencing?,143,143,"143 remnant specimens were available for HIVDR testing; 121 and 105 yielded successful genotypes for PR/RT and integrase, respectively.",True,True,"Model includes 143 as the number with samples obtained, matching both."
37755428-6,37755428,6,From which countries were the sequenced samples obtained?,Haiti,Haiti,Haiti.,True,True,"Model lists Haiti, matching both annotations."
37755428-7,37755428,7,From what years were the sequenced samples obtained?,2020-2021,2020-2021,Between April 2020 and March 2021.,True,True,"Model gives April 2020–March 2021, equivalent to 2020–2021."
37755428-8,37755428,8,Were samples cloned prior to sequencing?,No,No,No — cloning is not reported; Sanger sequencing was performed on extracted nucleic acids.,True,True,"Model indicates no cloning, matching both."
37755428-9,37755428,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN","PR, RT, IN",Protease/reverse transcriptase (PR/RT) and integrase regions.,True,True,"Model lists PR/RT and IN, matching both."
37755428-10,37755428,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,Sanger-based sequencing.,True,True,"Model states Sanger sequencing, matching both."
37755428-11,37755428,11,What type of samples were sequenced?,DBS,DBS,Remnant dried blood spot specimens collected at the time of HIV diagnosis.,True,True,"Model specifies dried blood spots, matching DBS."
37755428-12,37755428,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,No — sequences were from ART-naive infants; no drug resistance testing was done on the mother's virus despite maternal detectable viral load.,True,True,"Model says no sequences from individuals with virologic failure, matching both."
37755428-13,37755428,13,Were the patients in the study in a clinical trial?,No,No,"No — the data derive from a national surveillance survey, not a clinical trial.",True,True,"Model says not a clinical trial, matching both."
37755428-14,37755428,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,No,"Yes — although infants were ART-naive, the majority had prior exposure to antiretroviral drugs for PMTCT and some infants received postnatal prophylaxis (PNP).",False,False,"Model says Yes (prior ARV exposure), contradicting both 'No' annotations."
37755428-15,37755428,15,Which drug classes were received by individuals in the study before sample sequencing?,No,nan,NRTIs and INSTIs (mothers on DTG-based ART); NNRTIs were also referenced as commonly used for PNP historically.,False,False,"Model lists ARV classes, conflicting with original 'No'; updated answer is missing/undefined (nan)."
37755428-16,37755428,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Tenofovir/lamivudine/dolutegravir (mother(s)) and zidovudine-based postnatal prophylaxis (infant); the paper also refers to exposure histories involving 3TC/lamivudine, ABC (in resistance context), and historical NNRTIs (efavirenz/nevirapine) in the population.",False,False,"Model lists specific drugs, conflicting with original 'No' and updated 'Not applicable'."
37775947-1,37775947,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes.,True,False,"Model says Yes, matching original 'Yes' but not updated 'Not reported'."
37775947-2,37775947,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,"No — the paper reports genotypic predictions (GSS) based on sequence data, not in vitro phenotypic susceptibility assays.",True,False,"Model says no in vitro susceptibility, matching original 'No' but not updated 'Not reported'."
37775947-3,37775947,3,Were sequences from the paper made publicly available?,No,Not reported,Not reported / No indication in the paper that sequence data were made publicly available.,False,True,"Model says not reported, which conflicts with original 'No' but matches updated 'Not reported'."
37775947-4,37775947,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model says none reported, consistent with both original 'No' and updated 'Not reported' for accession numbers."
37775947-5,37775947,5,How many individuals had samples obtained for HIV sequencing?,1380 or 1819,Not reported,1819 participants had NGS data at ≥200 read depth; 1380 participants with sequencing and who started ART and had follow-up were included in the main analysis.,True,False,"Model provides both 1819 and 1380, matching original; conflicts with updated 'Not reported'."
37775947-6,37775947,6,From which countries were the sequenced samples obtained?,"South America, Africa, USA",Not reported,"The paper does not list specific countries; samples were from multiple regions including South America, Africa, the USA and Europe.",True,True,"Model mentions South America, Africa, USA (and notes no specific countries), matching original list and aligning with updated 'Not reported'."
34516245-13,34516245,13,Were the patients in the study in a clinical trial?,No,Not reported,No (no patients were involved).,True,False,"Model says No, matching original, but not the updated Not reported."
34516245-14,34516245,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No.,True,False,"Model answers No, matching original; updated says Not reported."
34516245-15,34516245,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,Not applicable—there were no individual patients; the study used laboratory viral strains (no drug exposure history of patients).,True,False,"Model conveys Not applicable/no patients, consistent with original No; not consistent with updated Not reported."
34516245-16,34516245,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Not applicable—no individuals received drugs; experimental viruses were exposed in vitro to EFdA and mutants were tested for susceptibility to EFdA, TDF, and FTC.",True,True,"Model states Not applicable (no individuals), matching original No and updated Not applicable."
35730213-1,35730213,1,Does the paper report HIV sequences from patient samples?,No,Not reported,No.,True,False,"Model says No, matching original; updated is Not reported."
35730213-2,35730213,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No.,True,False,"Model says No in vitro data, matching original; not matching updated Not reported."
35730213-3,35730213,3,Were sequences from the paper made publicly available?,No,Not reported,No (not applicable).,True,False,"Model says No (not applicable), matching original; updated is Not reported."
35730213-4,35730213,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported / Not applicable.,True,True,"Model says none reported / not applicable, which conveys unavailability; matches both original No and updated Not reported."
35730213-5,35730213,5,How many individuals had samples obtained for HIV sequencing?,0,Not reported,None; the paper did not obtain samples for HIV sequencing.,True,False,"Model says none (0), matching original 0; not matching updated Not reported."
35730213-6,35730213,6,From which countries were the sequenced samples obtained?,No,Not reported,Not applicable — no sequencing was performed; the study was conducted in Lesotho.,True,False,"Model says Not applicable (no sequencing), aligning with original No; updated is Not reported."
35730213-7,35730213,7,From what years were the sequenced samples obtained?,No,Not reported,Not applicable — no sequencing; study enrolment and follow-up occurred in 2020–2021.,True,False,"Model says Not applicable (no sequencing), matching original No; not matching updated Not reported."
35730213-8,35730213,8,Were samples cloned prior to sequencing?,No,Not reported,Not applicable — no sequencing was performed.,True,False,"Model says Not applicable (no sequencing), effectively No; updated is Not reported."
35730213-9,35730213,9,Which HIV genes were reported to have been sequenced?,No,Not reported,None — no HIV genes were reported as being sequenced.,True,True,"Model says none reported (no genes sequenced), matching original No and conveying Not reported for the updated."
35730213-10,35730213,10,What method was used for sequencing?,No,Not reported,Not applicable — no sequencing methods were reported.,True,True,"Model says no sequencing methods reported, matching original No and updated Not reported."
35730213-11,35730213,11,What type of samples were sequenced?,No,Not reported,Not applicable — no samples were sequenced. The study used questionnaire data and routine clinical measurements (including viral load data).,True,True,"Model states no samples were sequenced (information unavailable), matching original No and updated Not reported."
35730213-12,35730213,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,"No — no sequences were obtained; additionally, virological failure was rare in this cohort.",True,False,"Model says No sequences obtained, matching original No; not matching updated Not reported."
35730213-13,35730213,13,Were the patients in the study in a clinical trial?,No,Not reported,"No — they were enrolled in a prospective, registered cohort study (DO-REAL).",True,False,"Model says No (cohort study), matching original; updated is Not reported."
35730213-14,35730213,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No.,True,False,"Model answers No, matching original; not matching updated Not reported."
35730213-15,35730213,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,"The paper does not explicitly name drug classes; it reports specific drugs in prior regimens (TDF, 3TC, EFV).",False,True,"Model says drug classes not explicitly named (lists drugs), contradicting original No but aligns with updated Not reported."
35730213-16,35730213,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Participants were receiving tenofovir disoproxil fumarate (TDF), lamivudine (3TC), and efavirenz (EFV) prior to switching to DTG-based therapy.",False,False,"Model lists specific drugs, contradicting original No and updated Not applicable."
35913500-1,35913500,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,"No — the paper does not report HIV nucleotide sequences; it reports clinical resistance testing results (eg, an N155H mutation) but does not present sequence data.",False,False,"Model says No sequences reported, contradicting original Yes and not matching updated Not reported."
35913500-2,35913500,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No — the paper does not report any in vitro drug susceptibility assay data.,True,False,"Model says No in vitro data, matching original; not matching updated Not reported."
35913500-3,35913500,3,Were sequences from the paper made publicly available?,No,Not reported,No — the paper does not indicate that any sequences were deposited or made publicly available.,True,False,"Model says No public sequences, matching original; not matching updated Not reported."
35913500-4,35913500,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported / not applicable.,True,True,"Model says none reported/not applicable, conveying unavailability; matches both original No and updated Not reported."
35913500-5,35913500,5,How many individuals had samples obtained for HIV sequencing?,51,Not reported,Not specified / sequencing not reported; resistance testing was performed as clinically indicated and one baseline resistance mutation is reported.,False,True,"Model says sequencing not reported/not specified, contradicting original 51 but matching updated Not reported."
37941373-15,37941373,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI, INSTI",Not reported,"Integrase strand transfer inhibitors (INSTIs), nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), and non-nucleoside reverse transcriptase inhibitors (NNRTIs).",True,False,"Model lists INSTI, NRTI, NNRTI matching original; updated says not reported."
37941373-16,37941373,16,Which drugs were received by individuals in the study before sample sequencing?,"DTG, RPV, 3TC, TDF, EFV",Not reported,"Reported drugs included dolutegravir, rilpivirine, lamivudine, tenofovir, crizaline, and efavirenz; the paper also discusses prior use of raltegravir and elvitegravir among INSTI-treated patients.",False,False,Model includes correct drugs but also hallucinates “crizaline” and adds extras; updated says not reported.
37946329-1,37946329,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes.,True,False,"Model says Yes, matching original; updated is Not reported."
37946329-2,37946329,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No.,True,False,"Model says No, matching original; updated is Not reported."
37946329-3,37946329,3,Were sequences from the paper made publicly available?,No,Not reported,Not reported / No explicit public deposition is indicated in the paper.,False,True,"Model says not reported, which conflicts with original 'No' but matches updated 'Not reported'."
37946329-4,37946329,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,Not reported.,True,True,"Model states not reported, aligning with original 'No' (none provided) and updated 'Not reported'."
37946329-5,37946329,5,How many individuals had samples obtained for HIV sequencing?,921,Not reported,Partial pol sequences were successfully amplified from 921 individuals; integrase (INT) gene sequences were obtained from 751 individuals.,True,False,"Model provides 921 (plus extra detail), matching original; updated says not reported."
37946329-6,37946329,6,From which countries were the sequenced samples obtained?,China,Not reported,China (Henan Province).,True,False,"Model gives China (Henan), matching original; updated says not reported."
37946329-7,37946329,7,From what years were the sequenced samples obtained?,2018-2022,Not reported,From June 2018 to April 2022.,True,False,"Model states 2018–2022, matching original; updated says not reported."
37946329-8,37946329,8,Were samples cloned prior to sequencing?,No,Not reported,Not reported / No evidence of cloning prior to sequencing is provided.,False,True,"Model says not reported/no evidence, which conflicts with original 'No' but matches updated 'Not reported'."
37946329-9,37946329,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN",Not reported,Partial pol gene and complete integrase (INT) gene.,True,False,"Model’s 'partial pol (PR/RT) and complete integrase' matches PR, RT, IN; updated says not reported."
37946329-10,37946329,10,What method was used for sequencing?,No,Not reported,PCR amplification of target gene regions followed by sequencing (genotypic drug resistance testing as described previously); the specific sequencing platform/technique is not specified in the paper.,False,False,"Model asserts a sequencing method rather than indicating it was not reported, conflicting with both original and updated."
37946329-11,37946329,11,What type of samples were sequenced?,Plasma,Not reported,Plasma samples.,True,False,"Model says plasma, matching original; updated says not reported."
37946329-12,37946329,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,Yes.,True,False,"Model says Yes, matching original; updated says not reported."
37946329-13,37946329,13,Were the patients in the study in a clinical trial?,No,Not reported,"No — they were treatment-experienced patients assessed in an observational study, not described as a clinical trial.",True,False,"Model says No (observational), matching original; updated says not reported."
37946329-14,37946329,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes.,True,False,"Model says Yes, matching original; updated says not reported."
37946329-15,37946329,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI, PI, INSTI",Not reported,"Nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), and integrase strand transfer inhibitors (INSTIs/INIs).",True,False,"Model lists NRTI, NNRTI, PI, INSTI matching original; updated says not reported."
37946329-16,37946329,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Various individual drugs across classes were mentioned, including lamivudine (3TC), abacavir (ABC), tenofovir (TDF), emtricitabine (FTC), stavudine (D4T), nevirapine (NVP), efavirenz (EFV), etravirine (ETR), atazanavir/ritonavir (ATV/r), lopinavir/ritonavir (LPV/r), fosamprenavir/r (FPV/r), saquinavir/r (SQV/r), raltegravir (RAL), dolutegravir (DTG), bictegravir (BIC), cabotegravir (CAB), and elvitegravir (EVG).",False,False,"Model lists many drugs, conflicting with original 'No' and updated 'Not applicable'."
37957382-1,37957382,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes.,True,False,"Model says Yes, matching original; updated says not reported."
37957382-2,37957382,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No — the paper reports genotypic susceptibility scoring and ARV drug level testing but does not report in vitro phenotypic drug susceptibility assays.,True,False,"Model says No and clarifies, matching original; updated says not reported."
37957382-3,37957382,3,Were sequences from the paper made publicly available?,Yes,Not reported,Yes.,True,False,"Model says Yes, matching original; updated says not reported."
37957382-4,37957382,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,The paper provides a GenBank BioProject identifier (PRJNA973660) but does not list individual GenBank accession numbers for specific isolates.,True,True,"Model indicates no individual accession numbers (only BioProject), aligning with original 'No' and updated 'Not reported'."
37957382-5,37957382,5,How many individuals had samples obtained for HIV sequencing?,8,Not reported,Eight participants.,True,False,"Model says eight, matching original; updated says not reported."
37957382-6,37957382,6,From which countries were the sequenced samples obtained?,No,Not reported,"The paper does not explicitly state the countries of origin for the sequenced samples; it reports institutional cohorts (for example, Brigham and Women's Hospital HEAL cohort, ACTG, and the Ragon Institute) but does not list countries.",True,True,"Model says country not stated, matching original 'No' and updated 'Not reported'."
37957382-7,37957382,7,From what years were the sequenced samples obtained?,No,Not reported,The paper does not report the calendar years when samples were obtained.,True,True,"Model says years not reported, matching both original 'No' and updated 'Not reported'."
37938856-6,37938856,6,From which countries were the sequenced samples obtained?,Kenya,Kenya,Kenya.,True,True,"Model answers Kenya, matching both annotations."
37938856-7,37938856,7,From what years were the sequenced samples obtained?,2019-2022,2019–2022,"Samples were obtained during the intervention enrolment and follow-up period (October 7, 2019 to December 31, 2021).",False,False,"Model gives 2019–2021, but annotations say 2019–2022."
37938856-8,37938856,8,Were samples cloned prior to sequencing?,No,No,No cloning is reported.,True,True,"Model states no cloning, matching both."
37938856-9,37938856,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN","PR, RT, IN",The reverse transcriptase (RT) region (implied by reported NRTI and NNRTI mutations).,False,False,"Model mentions only RT, while annotations list PR, RT, and IN."
37938856-10,37938856,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,Sanger sequencing.,True,True,"Model states Sanger sequencing, matching both."
37938856-11,37938856,11,What type of samples were sequenced?,No,Not reported,"Samples from participants with viral load ≥1000 copies/ml (i.e., viraemic clinical samples used for DRM testing).",False,False,"Model specifies a sample type, whereas annotations indicate it was not reported."
37938856-12,37938856,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both."
37938856-13,37938856,13,Were the patients in the study in a clinical trial?,No,No,"No; this was a prospective pre/post-intervention cohort study, not a randomized clinical trial.",True,True,"Model correctly says not a clinical trial, matching both."
37938856-14,37938856,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,Yes.,True,True,"Model affirms prior ARV exposure, matching both."
37938856-15,37938856,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI, PI, INSTI","NRTI, NNRTI, PI, INSTI","NRTIs, NNRTIs, protease inhibitors (PIs), and integrase strand transfer inhibitors (INSTIs).",True,True,"Model lists NRTIs, NNRTIs, PIs, and INSTIs, matching both."
37938856-16,37938856,16,Which drugs were received by individuals in the study before sample sequencing?,"3TC, TDF, EFV, DTG, ATV","3TC, TDF, EFV, DTG, ATV","Lamivudine, tenofovir, efavirenz, dolutegravir, and atazanavir/ritonavir (among others referenced in standard regimens).",True,True,"Model lists 3TC, TDF, EFV, DTG, and ATV/r (equivalent to ATV), matching both."
37941373-1,37941373,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes.,True,False,"Model says Yes, matching original; updated marks as not reported."
37941373-2,37941373,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,"No — only genotypic (sequence-based) resistance interpretation was reported, not in vitro phenotypic susceptibility assays.",True,False,"Model says No (genotypic only), matching original; contradicts updated not reported."
37941373-3,37941373,3,Were sequences from the paper made publicly available?,No,Not reported,No — sequences were not publicly deposited; data are available from the first author on request.,True,False,"Model says not publicly deposited, matching original; conflicts with updated not reported."
37941373-4,37941373,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported in the paper.,True,True,"Model states none reported, aligning with both 'No' and 'Not reported'."
37941373-5,37941373,5,How many individuals had samples obtained for HIV sequencing?,1080 or 1032,Not reported,Samples were harvested from 1080 patients; successful IN gene amplification/sequencing was achieved for 1032 samples.,True,False,"Model gives 1080 and 1032, matching original; updated says not reported."
37941373-6,37941373,6,From which countries were the sequenced samples obtained?,China,Not reported,"China (Chongqing, China).",True,False,"Model states China, matching original; updated says not reported."
37941373-7,37941373,7,From what years were the sequenced samples obtained?,2019-2022,Not reported,From July 2019 to August 2022.,True,False,"Model gives July 2019–August 2022, matching original; updated says not reported."
37941373-8,37941373,8,Were samples cloned prior to sequencing?,No,Not reported,No — no cloning step is described; nested PCR and Sanger sequencing were used.,True,False,"Model says no cloning, matching original; updated says not reported."
37941373-9,37941373,9,Which HIV genes were reported to have been sequenced?,IN,Not reported,The integrase (IN) region of the HIV-1 pol gene.,True,False,"Model identifies IN, matching original; updated says not reported."
37941373-10,37941373,10,What method was used for sequencing?,Sanger sequencing,Not reported,Sanger (dideoxy) sequencing following nested RT‑PCR (in-house method).,True,False,"Model states Sanger sequencing, matching original; updated says not reported."
37941373-11,37941373,11,What type of samples were sequenced?,Plasma,Not reported,Plasma samples (HIV-RNA extracted from plasma).,True,False,"Model specifies plasma, matching original; updated says not reported."
37941373-12,37941373,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,Yes.,True,False,"Model answers Yes, matching original; updated says not reported."
37941373-13,37941373,13,Were the patients in the study in a clinical trial?,No,Not reported,No.,True,False,"Model answers No, matching original; updated says not reported."
37941373-14,37941373,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes.,True,False,"Model answers Yes, matching original; updated says not reported."
37993493-3,37993493,3,Were sequences from the paper made publicly available?,No,Not reported,No — the paper does not report public deposition of sequences; data are available upon request from the authors/DUCS platform.,True,False,"Model said sequences were not publicly available (matches No), not that it was unreported."
37993493-4,37993493,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"""None reported"" matches both No and Not reported."
37993493-5,37993493,5,How many individuals had samples obtained for HIV sequencing?,33,Not reported,"33 individuals had samples eligible for genotyping; of these, 31/33 were successfully genotyped in at least one region, 23 samples yielded protease/RT sequences and 30 yielded integrase sequences; 22 samples were fully genotyped in all three regions.",True,False,"Model gave 33, matching original; not compatible with Not reported."
37993493-6,37993493,6,From which countries were the sequenced samples obtained?,Tanzania,Not reported,Tanzania (Dar es Salaam).,True,False,Model named Tanzania; this contradicts Not reported.
37993493-7,37993493,7,From what years were the sequenced samples obtained?,2023,Not reported,Samples were obtained in 2023 (February to May 2023).,True,False,Model gave 2023; not Not reported.
37993493-8,37993493,8,Were samples cloned prior to sequencing?,No,Not reported,No — samples were not cloned; sequencing was performed by Sanger capillary sequencing of PCR products and sequences were assembled and edited with RECall.,True,False,Model said No cloning; not Not reported.
37993493-9,37993493,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN",Not reported,"Protease, reverse transcriptase (RT), and integrase.",True,False,Model listed PR/RT/IN; not Not reported.
37993493-10,37993493,10,What method was used for sequencing?,Sanger sequencing,Not reported,"Sanger-style capillary sequencing using an Applied Biosystems 3500xL genetic analyser, with sequence assembly/editing by RECall and interpretation via Stanford HIVDB.",True,False,Model specified Sanger sequencing; not Not reported.
37993493-11,37993493,11,What type of samples were sequenced?,Plasma,Not reported,Plasma (derived from venous whole blood) samples.,True,False,Model said plasma; not Not reported.
37993493-12,37993493,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,"Yes — sequences were obtained from individuals with unsuppressed viral load (≥ 1000 copies/mL), i.e., virological failure while on ART.",True,False,Model said Yes for virological failure; not Not reported.
37993493-13,37993493,13,Were the patients in the study in a clinical trial?,No,Not reported,"No — patients were part of a cross-sectional survey of treatment-experienced adults in an urban cohort study, not a clinical trial.",True,False,Model said not a clinical trial; not Not reported.
37993493-14,37993493,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes — all participants were treatment-experienced and had been receiving antiretroviral therapy for at least one year prior to inclusion.,True,False,Model said Yes for prior ARVs; not Not reported.
37993493-15,37993493,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, PI, INSTI",Not reported,"Nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), integrase strand transfer inhibitors (INSTIs, e.g., dolutegravir), and protease inhibitors (PIs) in some patients.",False,False,"Model added NNRTI, which was not in the human-labeled classes; thus overinclusive and not Not reported."
37993493-16,37993493,16,Which drugs were received by individuals in the study before sample sequencing?,"TDF, 3TC, DTG, ABC, LPV, ATV, EFV",Not applicable,"Specific drugs mentioned include tenofovir (TDF), lamivudine (3TC), dolutegravir (DTG), abacavir (ABC), lopinavir/ritonavir (LPV/r), atazanavir/ritonavir (ATV/r), and efavirenz (EFV) as a previously used drug.",True,False,Model’s drug list matches original; contradicts Not applicable.
38005921-1,38005921,1,Does the paper report HIV sequences from patient samples?,No,No,Yes. The study used amino acid sequences of HIV proteins derived from clinical samples (Stanford HIV Drug Resistance Database).,False,False,Model said Yes sequences from patient samples; humans said No.
38005921-2,38005921,2,Does the paper report in vitro drug susceptibility data?,No,No,Yes. The datasets include phenotypic resistance measurements determined by the PhenoSense™ test system.,False,False,Model said Yes phenotypic data; humans said No.
38005921-3,38005921,3,Were sequences from the paper made publicly available?,Yes,No,Yes. The datasets used for building the models are provided in the Supplementary Materials and the web service is freely available.,True,False,Model said Yes publicly available; updated says No.
38005921-4,38005921,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,The paper does not report any GenBank accession numbers.,True,True,"Model stated no GenBank accessions reported, matching both."
38005921-5,38005921,5,How many individuals had samples obtained for HIV sequencing?,0,0,"The paper does not specify the number of individuals; it reports sample counts per drug class (1958 PI, 1707 NRTI, 1819 NNRTI samples).",False,False,Model said number not specified; humans annotated 0 individuals.
38005921-6,38005921,6,From which countries were the sequenced samples obtained?,No,Not applicable,The paper does not specify the countries of origin for the sequences.,True,False,"Model said countries not specified (aligns with original No), not Not applicable."
38005921-7,38005921,7,From what years were the sequenced samples obtained?,No,Not applicable,The paper does not give exact sample collection years; it uses a publication-year threshold (≤2018 vs >2018) to construct training and test sets.,True,False,"Model said years not given (aligns with original No), not Not applicable."
38005921-8,38005921,8,Were samples cloned prior to sequencing?,No,Not applicable,Not reported. The paper does not describe any cloning of samples prior to sequencing.,False,False,"Model said Not reported, not No or Not applicable."
38005921-9,38005921,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,Protease and reverse transcriptase (HIV-1 protease and reverse transcriptase) sequences were used.,False,False,"Model named PR/RT sequences, contradicting No/Not applicable."
38005921-10,38005921,10,What method was used for sequencing?,No,Not applicable,Not applicable / Not reported. The paper used existing amino acid sequence data from the Stanford HIV Drug Resistance Database and does not describe sequencing methods.,True,True,"Model conveyed no sequencing method (Not applicable/Not reported), matching both annotations’ intent."
38005921-11,38005921,11,What type of samples were sequenced?,No,Not applicable,Amino acid sequences of HIV-1 protease and reverse transcriptase derived from clinical samples/isolates (genotype–phenotype datasets).,False,False,"Model described clinical sample–derived sequences, contradicting No/Not applicable."
37973713-1,37973713,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes — the paper reports HIV sequences (genotyping) from patient samples.,True,False,"Model says sequences were reported, matching original Yes but contradicting updated Not reported."
37973713-2,37973713,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No — the paper does not report in vitro phenotypic drug susceptibility testing data.,True,True,"Model says no in vitro susceptibility data were reported, matching original No and conveying not reported for the updated."
37973713-3,37973713,3,Were sequences from the paper made publicly available?,No,Not reported,Yes — sequences were submitted to the Stanford University HIV Drug Resistance Database.,False,False,"Model claims sequences were submitted publicly, contradicting both original No and updated Not reported."
37973713-4,37973713,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers are reported in the paper.,True,True,"Model states no GenBank accessions reported, matching original No and updated Not reported."
37973713-5,37973713,5,How many individuals had samples obtained for HIV sequencing?,117,Not reported,83 individuals had genotyping results (117 recruited minus 34 excluded for missing genotyping results).,False,False,"Model gives 83, conflicting with original 117 and not aligning with updated Not reported."
37973713-6,37973713,6,From which countries were the sequenced samples obtained?,"Ukraine, Poland",Not reported,"Samples were from Poland and eastern countries including Ukraine, Belarus, Georgia, and Kazakhstan.",False,False,Model lists additional countries beyond Ukraine and Poland; does not match original and not Not reported.
37973713-7,37973713,7,From what years were the sequenced samples obtained?,2020-2022,Not reported,Samples were obtained during 2020–2022.,True,False,"Model gives 2020–2022, matching original but not updated Not reported."
37973713-8,37973713,8,Were samples cloned prior to sequencing?,No,Not reported,No — the paper describes Sanger population sequencing and does not report cloning prior to sequencing.,True,False,"Model answers No (no cloning), matching original No but not the updated Not reported."
37973713-9,37973713,9,Which HIV genes were reported to have been sequenced?,"PR, RT",Not reported,The protease (PR) and reverse transcriptase (RT) coding regions (parts of pol) were sequenced.,True,False,"Model lists PR and RT, matching original but not updated Not reported."
37973713-10,37973713,10,What method was used for sequencing?,Sanger sequencing,Not reported,Sanger sequencing using the commercially available ViroSeq HIV-1 Genotyping System (Abbott Molecular).,True,False,"Model specifies Sanger sequencing (ViroSeq), matching original but not updated Not reported."
37973713-11,37973713,11,What type of samples were sequenced?,Plasma,Not reported,"The paper does not explicitly state the biological sample type used for sequencing (e.g., plasma or whole blood) though viral load was measured in peripheral blood.",False,True,"Model says sample type not explicitly stated, contradicting original Plasma and matching updated Not reported."
37973713-12,37973713,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,"No — sequences were obtained from ART-naïve, newly diagnosed patients, not from individuals with virological failure on treatment.",True,False,"Model says no sequences from virological failure, matching original No but not updated Not reported."
37973713-13,37973713,13,Were the patients in the study in a clinical trial?,Yes,Not reported,"The study was a registered, multi-center prospective observational cross-sectional study (registered on clinicaltrials.gov, NCT04636736), not an interventional randomized clinical trial.",False,False,"Model describes an observational study (not an interventional clinical trial), contradicting original Yes and not matching updated Not reported."
37973713-14,37973713,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No — the paper reports sequences from individuals with no history of antiretroviral therapy (ART-naïve).,True,False,"Model says ART-naïve only, matching original No prior ARVs but not updated Not reported."
37973713-15,37973713,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,None — individuals were ART-naïve and had not received antiretroviral drug classes prior to sequencing.,True,False,"Model says none (no drug classes), matching original No but not updated Not reported."
37973713-16,37973713,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not reported,None — no specific antiretroviral drugs were received before sequencing (participants were ART-naïve).,True,False,"Model says none (no specific drugs), matching original No but not updated Not reported."
37976080-1,37976080,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both original and updated Yes."
37976080-2,37976080,2,Does the paper report in vitro drug susceptibility data?,No,No,"No — the paper reports genotypic resistance analysis, not in vitro phenotypic drug susceptibility testing.",True,True,"Model answers No in vitro phenotypic data, matching both original and updated No."
37976080-3,37976080,3,Were sequences from the paper made publicly available?,No,No,Not reported / Not clearly stated in the paper.,False,False,"Model says not reported/unclear, while both original and updated say No."
37976080-4,37976080,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers are reported in the paper.,True,True,"Model says no GenBank accessions reported, matching original No and updated Not reported."
37976080-5,37976080,5,How many individuals had samples obtained for HIV sequencing?,2568,2568,2568 participants had PDR testing / sequencing results.,True,True,"Model states 2568, matching both."
37976080-6,37976080,6,From which countries were the sequenced samples obtained?,China,China,China.,True,True,"Model gives China, matching both."
37976080-7,37976080,7,From what years were the sequenced samples obtained?,2022,2022,2022.,True,True,"Model gives 2022, matching both."
37976080-8,37976080,8,Were samples cloned prior to sequencing?,No,No,No — cloning is not described; PCR amplification followed by Sanger sequencing of the PCR products was used.,True,True,"Model answers No cloning, matching both."
37976080-9,37976080,9,Which HIV genes were reported to have been sequenced?,"PR, RT","PR, RT",The pol gene region covering the protease (PR) region and the partial reverse transcriptase (RT) region.,True,True,"Model lists PR and RT, matching both."
37649807-3,37649807,3,Were sequences from the paper made publicly available?,No,No,No — the paper does not report any sequences or GenBank deposits.,True,True,"Model states no sequences/public deposits, matching both annotations."
37649807-4,37649807,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model says none reported, aligning with human 'No' and updated 'Not reported'."
37649807-5,37649807,5,How many individuals had samples obtained for HIV sequencing?,0,0,Zero — no samples were obtained for sequencing in this study.,True,True,"Model says zero samples sequenced, matching both '0' answers."
37649807-6,37649807,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable (no sequences); the analyzed data derive from Kenya.,True,True,"Model answers not applicable due to no sequencing, matching updated N/A and consistent with human 'No'."
37649807-7,37649807,7,From what years were the sequenced samples obtained?,No,Not applicable,Not applicable (no sequences); the analyzed viral load data span January 2015 to December 2021.,True,True,"Model answers not applicable due to no sequencing, matching updated N/A and consistent with human 'No'."
37649807-8,37649807,8,Were samples cloned prior to sequencing?,No,Not applicable,Not applicable — no sequencing was performed.,True,True,"Model answers not applicable (no sequencing), matching updated N/A and consistent with human 'No'."
37649807-9,37649807,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,None — no HIV genes were sequenced or reported.,True,True,"Model states no genes were sequenced, matching both annotations."
37649807-10,37649807,10,What method was used for sequencing?,No,Not applicable,Not applicable — no sequencing methods are described.,True,True,"Model says not applicable (no sequencing methods), matching updated N/A and consistent with human 'No'."
37649807-11,37649807,11,What type of samples were sequenced?,No,Not applicable,Not applicable — no sequencing was performed; viral load testing used plasma samples.,True,True,"Model says not applicable (no sequencing), matching updated N/A and consistent with human 'No'."
37649807-12,37649807,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No — no sequences were obtained; the paper does report virologic failure based on viral load criteria.,True,True,Model says no sequences obtained; aligns with human 'No' and updated N/A.
37649807-13,37649807,13,Were the patients in the study in a clinical trial?,No,Not reported,No — patients were part of routine programmatic care and the analysis used retrospective routinely collected data.,True,False,Model asserts 'No' trial participation; human says 'No' but updated says 'Not reported'.
37649807-14,37649807,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,"No — the paper does not report sequences; however, the cohort included many individuals with prior ARV exposure.",True,True,Model notes no sequences (thus N/A) and aligns with human 'No' and updated N/A.
37649807-15,37649807,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,"Not applicable for sequencing; reported antiretroviral classes in the cohort include NRTIs (TDF with 3TC or FTC), NNRTIs, INSTIs (DTG), and protease inhibitors (PIs).",True,True,Model marks not applicable for sequencing; matches updated N/A and is consistent with human 'No'.
37649807-16,37649807,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Not applicable for sequencing; the paper reports exposure to tenofovir disoproxil fumarate (TDF), lamivudine (3TC) or emtricitabine (FTC), dolutegravir (DTG), NNRTIs (class reported but individual NNRTI names not specified), and protease inhibitors (PIs).",True,True,Model marks not applicable for sequencing; matches updated N/A and is consistent with human 'No'.
37662576-1,37662576,1,Does the paper report HIV sequences from patient samples?,No,Not reported,No.,True,False,"Model says 'No', matching human but not updated 'Not reported'."
37662576-2,37662576,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No.,True,False,"Model says 'No', matching human but not updated 'Not reported'."
37662576-3,37662576,3,Were sequences from the paper made publicly available?,No,Not reported,No — the paper used public PDB structures rather than depositing new sequence data.,True,False,"Model says 'No' (used PDB), aligning with human but contradicting updated 'Not reported'."
37662576-4,37662576,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model says none reported, matching both human 'No' and updated 'Not reported'."
37662576-5,37662576,5,How many individuals had samples obtained for HIV sequencing?,0,Not reported,None — no individual patient samples were obtained or sequenced.,True,False,Model states no individuals/sequencing; matches human '0' but not updated 'Not reported'.
37662576-6,37662576,6,From which countries were the sequenced samples obtained?,No,Not reported,Not applicable — no patient-derived sequences or sample collection locations were reported.,True,False,Model answers not applicable/none reported; aligns with human 'No' but not updated 'Not reported'.
37662576-7,37662576,7,From what years were the sequenced samples obtained?,No,Not reported,Not applicable — no sequencing of samples was performed or reported.,True,False,Model says not applicable (no sequencing); matches human 'No' but not updated 'Not reported'.
37662576-8,37662576,8,Were samples cloned prior to sequencing?,No,Not reported,Not applicable — no sequencing or cloning of samples was performed.,True,False,Model says not applicable (no sequencing/cloning); matches human 'No' but not updated 'Not reported'.
37662576-9,37662576,9,Which HIV genes were reported to have been sequenced?,No,Not reported,None were sequenced; the study analyzed the HIV-1 protease protein (PR) structures.,True,False,Model asserts none sequenced; matches human 'No' but not updated 'Not reported'.
37662576-10,37662576,10,What method was used for sequencing?,No,Not reported,Not applicable — no sequencing method was used or reported.,True,False,Model says not applicable/no method used; matches human 'No' but not updated 'Not reported'.
37662576-11,37662576,11,What type of samples were sequenced?,No,Not reported,Not applicable — no samples were sequenced.,True,False,Model says not applicable (no samples sequenced); matches human 'No' but not updated 'Not reported'.
37358226-14,37358226,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,"No; the paper does not report HIV sequences, although the cohort consisted of treatment-experienced individuals who had received ARV drugs.",True,False,"Model answered No, matching the original. Updated says Not reported, which the model did not convey."
37358226-15,37358226,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,Participants had received NNRTIs and NRTIs (no sequencing was performed).,False,False,"Question asks for classes; model listed NNRTIs/NRTIs, while original and updated indicate no info reported."
37358226-16,37358226,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Participants received efavirenz or nevirapine (NNRTIs) and NRTIs including abacavir (ABC), zidovudine (ZDV), tenofovir disoproxil fumarate (TDF) together with lamivudine (3TC); many were on efavirenz-containing ART prior to transition.",False,False,Model listed specific drugs; original says No and updated says Not applicable.
37376649-1,37376649,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes.,True,False,"Model said Yes, matching original; updated says Not reported."
37376649-2,37376649,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No.,True,False,"Model said No, matching original; updated says Not reported."
37376649-3,37376649,3,Were sequences from the paper made publicly available?,No,Not reported,No explicit public sequence deposition is reported.,False,True,"Model said not explicitly reported (i.e., unavailable), which matches updated Not reported but not the original No."
37376649-4,37376649,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None are reported in the paper.,True,True,"Model said none/not reported, matching both the implication of the original and the updated Not reported."
37376649-5,37376649,5,How many individuals had samples obtained for HIV sequencing?,734,Not reported,Retrospective proviral DNA testing was performed on baseline samples from 734 participants.,True,False,"Model gave 734, matching original; updated says Not reported."
37376649-6,37376649,6,From which countries were the sequenced samples obtained?,No,Not reported,Not specified in the paper.,False,True,"Model said not specified, matching updated Not reported but not the original No."
37376649-7,37376649,7,From what years were the sequenced samples obtained?,No,Not reported,The years when samples were obtained are not reported in the paper.,False,True,"Model stated years not reported, matching updated but not the original No."
37376649-8,37376649,8,Were samples cloned prior to sequencing?,No,Not reported,No indication of cloning; samples were analyzed by NGS without mention of cloning.,False,True,"Model indicated no mention of cloning (i.e., not reported), matching updated but not a firm No."
37376649-9,37376649,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN",Not reported,The HIV-1 polymerase (pol) region was sequenced.,True,False,"Model said pol region, which covers PR/RT/IN, matching original; updated says Not reported."
37376649-10,37376649,10,What method was used for sequencing?,Illumina sequencing,Not reported,Next-generation sequencing (NGS) using the GenoSure Archive assay.,False,False,"Model gave NGS/GenoSure Archive, not the original Illumina, and not Not reported per the updated."
37376649-11,37376649,11,What type of samples were sequenced?,Whole Blood,Not reported,Participants' baseline whole blood samples (proviral DNA) were used.,True,False,"Model said whole blood/proviral DNA, matching original; updated says Not reported."
37376649-12,37376649,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,"No — participants with prior virologic failure were excluded, and the baseline sequencing was performed in participants without previous virologic failure.",True,False,"Model answered No and gave rationale, matching original; updated says Not reported."
37376649-13,37376649,13,Were the patients in the study in a clinical trial?,Yes,Not reported,"Yes — they were participants in the randomized TANGO clinical trial (ClinicalTrials.gov, NCT03446573).",True,False,"Model said Yes (TANGO trial), matching original; updated says Not reported."
37376649-14,37376649,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes.,True,False,"Model answered Yes, matching original; updated says Not reported."
37376649-15,37376649,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, INSTI",Not reported,"Participants had prior exposure to NRTIs, NNRTIs, protease inhibitors (PIs), and integrase strand transfer inhibitors (INSTIs).",False,False,"Model listed NRTI, INSTI plus NNRTI and PI, which does not match the original limited set and contradicts updated Not reported."
37376649-16,37376649,16,Which drugs were received by individuals in the study before sample sequencing?,"Lamivudine (3TC), Tenofovir (TAF), Dolutegravir (DTG)",Not applicable,The manuscript primarily reports prior regimens as tenofovir alafenamide (TAF)-based regimens and discusses study drugs dolutegravir (DTG) and lamivudine (3TC); no comprehensive list of all individual prior drugs for participants is provided.,True,False,"Model referenced DTG, 3TC, and TAF as prior drugs, aligning with original; updated is Not applicable."
37381002-1,37381002,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model said Yes, matching both original and updated."
37381002-2,37381002,2,Does the paper report in vitro drug susceptibility data?,No,No,No — the paper reports genotypic resistance analysis/predictions rather than in vitro phenotypic susceptibility testing.,True,True,"Model said No phenotypic data, matching both annotations."
37381002-3,37381002,3,Were sequences from the paper made publicly available?,No,No,Not reported in the paper.,False,False,"Model said not reported, while both annotations say No."
37381002-4,37381002,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,Not provided / Not reported in the paper.,True,True,"Model said not provided/not reported, matching both the original implication and the updated Not reported."
37381002-5,37381002,5,How many individuals had samples obtained for HIV sequencing?,398,398,398 individuals (pol gene sequences successfully sequenced).,True,True,"Model gave 398, matching both annotations."
37381002-6,37381002,6,From which countries were the sequenced samples obtained?,China,China,China.,True,True,"Model answered China, matching both annotations."
38005921-12,38005921,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,Not specified. The paper does not state whether sequences came from individuals with virological failure.,False,True,"Model said not specified (information unavailable), which contradicts original 'No' but matches updated 'Not applicable' per unavailability rule."
38005921-13,38005921,13,Were the patients in the study in a clinical trial?,No,Not reported,"No. The paper used sequences compiled from the Stanford HIV Drug Resistance Database and studies, not from a clinical trial conducted by the authors.",True,False,"Model answered 'No', matching original; does not convey 'not reported' for the updated answer."
38005921-14,38005921,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,Not specified. The paper does not explicitly state the prior treatment histories of individuals whose sequences were used.,False,True,"Model said not specified (unavailable), not 'No'; aligns with updated 'Not applicable' per unavailability rule."
38005921-15,38005921,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,"Not specified for individuals; however, the datasets and models encompass protease inhibitors (PI), nucleoside reverse transcriptase inhibitors (NRTI), and non-nucleoside reverse transcriptase inhibitors (NNRTI).",False,True,"Model states information not specified for individuals (unavailable), not a list; matches updated NA but not original 'No'."
38005921-16,38005921,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Not specified. The paper does not report individual treatment histories, although models and results include many specific drugs (e.g., zidovudine, lamivudine, stavudine, etravirine, rilpivirine, efavirenz, nevirapine, etc.).",False,True,Model indicates not specified (unavailable) though mentions example drugs; matches updated NA but not original 'No'.
38020274-1,38020274,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes.,True,False,"Model said 'Yes', matching original; not compatible with updated 'Not reported'."
38020274-2,38020274,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No.,True,False,"Model said 'No', matching original; not 'Not reported'."
38020274-3,38020274,3,Were sequences from the paper made publicly available?,No,Not reported,Not reported / No evidence of public deposition.,False,True,"Model said 'Not reported / No evidence', which does not equal 'No' but matches updated 'Not reported'."
38020274-4,38020274,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers are reported in the paper.,True,True,"Model stated no GenBank numbers reported, consistent with both 'No' and 'Not reported'."
38020274-5,38020274,5,How many individuals had samples obtained for HIV sequencing?,311,Not reported,"Sequencing was performed on participants with PVL 2,000 copies/ml with sample counts reported as approximately 56 at enrolment (T1), 96 at 6 months (T2), and 60 at 12 months (T3).",False,False,Model gave different counts and not 311; also not indicating unavailability.
38020274-6,38020274,6,From which countries were the sequenced samples obtained?,Cameroon,Not reported,Cameroon.,True,False,"Model answered 'Cameroon', matching original; not 'Not reported'."
38020274-7,38020274,7,From what years were the sequenced samples obtained?,2018-2020,Not reported,2018 to 2020.,True,False,"Model provided '2018–2020', matching original; not 'Not reported'."
38020274-8,38020274,8,Were samples cloned prior to sequencing?,No,Not reported,No cloning is reported.,False,True,"Model said 'No cloning is reported' (unavailability), which does not assert 'No' but matches updated 'Not reported'."
38020274-9,38020274,9,Which HIV genes were reported to have been sequenced?,No,Not reported,HIV-1 polymerase and reverse transcriptase gene regions (pol/RT).,False,False,"Model named pol/RT, contradicting original 'No' and not conveying 'Not reported'."
38020274-10,38020274,10,What method was used for sequencing?,No,Not reported,"An in-house genotypic resistance testing protocol was used; specific sequencing technology (e.g., Sanger or NGS) is not specified.",False,True,"Model said specific technology not specified (unavailable), which matches updated 'Not reported' but not original 'No'."
38020274-11,38020274,11,What type of samples were sequenced?,Plasma,Not reported,"Blood-derived plasma samples (blood samples stored at -80°C from participants with plasma viral load ≥1,000 copies/ml).",True,False,"Model specified plasma, matching original; not 'Not reported'."
38020274-12,38020274,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,Yes.,True,False,"Model said 'Yes', matching original; not 'Not reported'."
38020274-13,38020274,13,Were the patients in the study in a clinical trial?,No,Not reported,"No; they were participants in a prospective cohort study, not a clinical trial.",True,False,"Model said 'No; cohort study', matching original; not 'Not reported'."
38020274-14,38020274,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes.,True,False,"Model said 'Yes', matching original; not 'Not reported'."
38020274-15,38020274,15,Which drug classes were received by individuals in the study before sample sequencing?,"RTI, PI",Not reported,Reverse transcriptase inhibitor-based regimens (NRTIs/NNRTIs) as first-line and ritonavir-boosted protease inhibitors (PI/r) as second-line.,True,False,"Model listed RTIs and PIs, matching original 'RTI, PI'; not 'Not reported'."
38020274-16,38020274,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Reported drugs include TDF, AZT, ABC, 3TC, d4T, NVP (representative NNRTIs), and ritonavir-boosted protease inhibitors LPV/r, ATV/r, and DRV/r; participants were generally not exposed to integrase inhibitors (e.g., Dolutegravir) prior to sequencing.",False,False,"Model listed multiple drugs, contradicting original 'No' and not indicating unavailability for updated NA."
38022124-1,38022124,1,Does the paper report HIV sequences from patient samples?,No,No,No — the paper does not report HIV sequences from patient samples.,True,True,"Model answered 'No', matching both original and updated."
38022124-2,38022124,2,Does the paper report in vitro drug susceptibility data?,No,No,No — the paper does not report in vitro drug susceptibility data.,True,True,"Model answered 'No', matching both original and updated."
38022124-3,38022124,3,Were sequences from the paper made publicly available?,No,No,No — sequences were not reported or deposited; no public sequence data are provided.,True,True,"Model answered 'No', matching both original and updated."
38022124-4,38022124,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,Not applicable / Not reported — no GenBank accession numbers are provided.,True,True,"Model said no accession numbers provided (not reported), matching both original 'No' and updated 'Not reported'."
37872202-9,37872202,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,"Env (gp120/gp41, gp140/SOSIP) sequences were the focus and were sequenced/used.",False,False,"Model claims env was sequenced, but human/updated indicate sequencing not applicable."
37872202-10,37872202,10,What method was used for sequencing?,No,Not applicable,Automated DNA sequencing.,False,False,Model specifies a sequencing method despite sequencing being not applicable.
37872202-11,37872202,11,What type of samples were sequenced?,No,Not applicable,"Cloned env expression plasmids / Env expressors (engineered plasmid constructs such as codon-optimized JR-FL env, previously reported Env plasmids, and mutated Env expressors) were sequenced.",False,False,"Model describes sequenced plasmids, contradicting human/updated that sequencing was not applicable."
37872202-12,37872202,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No — there is no mention of sequences from individuals with virological failure on treatment.,True,False,"Model answers No, matching original, but not the updated Not applicable."
37872202-13,37872202,13,Were the patients in the study in a clinical trial?,No,Not reported,"No — the paper references a cohort study (RV217 Early Capture HIV Cohort Study), not a clinical trial.",True,False,"Model says No (cohort), matching original, but updated says Not reported."
37872202-14,37872202,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,No — the paper does not report sequences from individuals with prior antiretroviral treatment.,True,False,"Model answers No, aligning with original, but updated says Not applicable."
37872202-15,37872202,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,Not reported / none reported.,True,True,"Model states not reported/none reported, matching lack of data/not applicable."
37872202-16,37872202,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,Not reported / none reported.,True,True,"Model states not reported/none reported, matching lack of data/not applicable."
37878637-1,37878637,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both."
37878637-2,37878637,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,"Model answers No, matching both."
37878637-3,37878637,3,Were sequences from the paper made publicly available?,No,No,Not explicitly reported (no public sequence accession numbers provided).,True,True,"Model notes no public accessions reported, effectively No."
37878637-4,37878637,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers are provided in the paper.,True,True,"Model states no GenBank accessions provided, matching both."
37878637-5,37878637,5,How many individuals had samples obtained for HIV sequencing?,141,141,141 participants.,True,True,"Model gives 141, matching both."
37878637-6,37878637,6,From which countries were the sequenced samples obtained?,Cameroon,Cameroon,Cameroon.,True,True,"Model lists Cameroon, matching both."
37878637-7,37878637,7,From what years were the sequenced samples obtained?,2018-2020,2018–2020,2018–2020.,True,True,"Model gives 2018–2020, matching both."
37878637-8,37878637,8,Were samples cloned prior to sequencing?,No,No,No evidence of cloning; PCR products were directly sequenced.,True,True,"Model indicates no cloning (direct PCR sequencing), matching No."
37878637-9,37878637,9,Which HIV genes were reported to have been sequenced?,"PR, RT","PR, RT",Protease and reverse transcriptase regions of the pol gene.,True,True,"Model specifies protease and reverse transcriptase, matching PR, RT."
37878637-10,37878637,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,Sanger sequencing of PCR products using an Applied Biosystems 3500 genetic analyzer (population sequencing).,True,True,"Model specifies Sanger sequencing, matching both."
37878637-11,37878637,11,What type of samples were sequenced?,Plasma,Plasma,Plasma (viral RNA extracted from plasma aliquots).,True,True,"Model indicates plasma, matching both."
37878637-12,37878637,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Yes,Yes; sequences were obtained from participants experiencing virological failure (PVL ≥ 1000 copies/mL) who were on ART.,True,True,"Model answers Yes with detail on VF on ART, matching both."
37878637-13,37878637,13,Were the patients in the study in a clinical trial?,No,No,"No; this was a cohort study, not a clinical trial.",True,True,"Model answers No (cohort, not trial), matching both."
37878637-14,37878637,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,Yes; participants were receiving antiretroviral therapy (first- or second-line) for at least six months prior to inclusion.,True,True,"Model answers Yes; sequences from ART-experienced individuals, matching both."
37878637-15,37878637,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI, PI","NRTI, NNRTI, PI",Reverse transcriptase inhibitors (NRTIs and NNRTIs) and protease inhibitors (ritonavir-boosted PIs).,True,True,"Model lists NRTIs, NNRTIs, and PIs, matching both."
37878637-16,37878637,16,Which drugs were received by individuals in the study before sample sequencing?,"TDF, 3TC, EFV","TDF, 3TC, EFV","Commonly a TDF + 3TC + EFV first-line regimen (tenofovir [TDF], lamivudine [3TC], efavirenz [EFV]) and ritonavir-boosted protease inhibitor regimens for second-line therapy.",True,True,"Model includes TDF, 3TC, EFV (and notes boosted PIs), matching required drugs."
37880705-1,37880705,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model answers Yes, matching both."
38058846-8,38058846,8,Were samples cloned prior to sequencing?,No,Not reported,Not reported.,False,True,"Model said 'Not reported', whereas original said 'No'; matches the updated 'Not reported'."
38058846-9,38058846,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN",Not reported,Not specified in the paper.,False,True,"Model said genes were not specified, conflicting with original PR/RT/IN; aligns with updated 'Not reported'."
38058846-10,38058846,10,What method was used for sequencing?,No,Not reported,Not reported.,False,True,"Model reported 'Not reported', not the original 'No'; matches the updated 'Not reported'."
38058846-11,38058846,11,What type of samples were sequenced?,No,Not reported,Not specified.,False,True,"Model stated 'Not specified', conflicting with original 'No'; matches updated 'Not reported'."
38058846-12,38058846,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,Yes — resistance testing/sequencing was performed in individuals experiencing virological failure while on ART (notably DTG-containing regimens).,True,False,"Model answered 'Yes', matching the original; updated says 'Not reported'."
38058846-13,38058846,13,Were the patients in the study in a clinical trial?,No,Not reported,"No — they were managed in clinical care and included in a case series, not enrolled in a clinical trial.",True,False,"Model answered 'No' (not a clinical trial), matching original; updated is 'Not reported'."
38058846-14,38058846,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes — at least two of the three individuals had prior antiretroviral drug exposure before the resistance testing.,True,False,"Model answered 'Yes' to prior ARVs, matching original; updated is 'Not reported'."
38058846-15,38058846,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI, PI, INSTI",Not reported,"Nucleoside reverse transcriptase inhibitors (NRTIs), non‑nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs) and an integrase strand transfer inhibitor (INSTI; dolutegravir).",True,False,"Model listed NRTI, NNRTI, PI, INSTI, matching original classes; updated is 'Not reported'."
38058846-16,38058846,16,Which drugs were received by individuals in the study before sample sequencing?,"3TC, ABC, LPV, AZT, DTG, FTC, TDF, DRV, EFV, NVP",Not applicable,"Reported drugs include lamivudine, abacavir, lopinavir/ritonavir, zidovudine, dolutegravir (DTG), emtricitabine, tenofovir, efavirenz, darunavir/ritonavir and combinations thereof (e.g., tenofovir/emtricitabine/efavirenz; tenofovir/emtricitabine/darunavir/ritonavir); TLD (tenofovir/lamivudine/dolutegravir) or equivalent combinations were also used.",False,False,Model omitted nevirapine (NVP) from the drug list; updated said 'Not applicable'.
38072961-1,38072961,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes,True,True,"Model said 'Yes', matching both original and updated."
38072961-2,38072961,2,Does the paper report in vitro drug susceptibility data?,No,No,No,True,True,"Model said 'No', matching both original and updated."
38072961-3,38072961,3,Were sequences from the paper made publicly available?,No,No,No (not reported),True,True,"Model said 'No (not reported)', consistent with 'No' for both annotations."
38072961-4,38072961,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported / Not provided,True,True,"Model said none reported/not provided, matching lack of accession numbers and updated 'Not reported'."
38072961-5,38072961,5,How many individuals had samples obtained for HIV sequencing?,1,Not reported,One individual,True,False,"Model said one individual, matching original; updated is 'Not reported'."
38072961-6,38072961,6,From which countries were the sequenced samples obtained?,China,Not reported,China,True,False,"Model answered China, matching original; updated is 'Not reported'."
38072961-7,38072961,7,From what years were the sequenced samples obtained?,2022,Not reported,2022,True,False,"Model answered 2022, matching original; updated is 'Not reported'."
38072961-8,38072961,8,Were samples cloned prior to sequencing?,No,Not reported,No (no cloning reported),True,False,"Model answered 'No', matching original; updated is 'Not reported'."
38072961-9,38072961,9,Which HIV genes were reported to have been sequenced?,"PR, RT",Not reported,Protease and reverse transcriptase (pol region),True,False,"Model listed PR and RT, matching original; updated is 'Not reported'."
38072961-10,38072961,10,What method was used for sequencing?,"Sanger sequencing, NGS",Not reported,Sanger sequencing,False,False,"Model gave Sanger only, missing NGS from the original; updated says 'Not reported'."
38072961-11,38072961,11,What type of samples were sequenced?,"CSF, Plasma",Not reported,Cerebrospinal fluid (CSF) and plasma samples,True,False,"Model listed CSF and plasma, matching original; updated is 'Not reported'."
38072961-12,38072961,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,Yes,True,False,"Model answered 'Yes', matching original; updated is 'Not reported'."
38072961-13,38072961,13,Were the patients in the study in a clinical trial?,No,Not reported,No,True,False,"Model answered 'No', matching original; updated is 'Not reported'."
38072961-14,38072961,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes,True,False,"Model answered 'Yes', matching original; updated is 'Not reported'."
38072961-15,38072961,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI, PI",Not reported,"Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitor (NNRTI), and protease inhibitor (PI)",True,False,"Model listed NRTI, NNRTI, PI, matching original; updated is 'Not reported'."
38072961-16,38072961,16,Which drugs were received by individuals in the study before sample sequencing?,"TDF, 3TC, LPV, EFV",Not applicable,"Tenofovir, lamivudine, efavirenz, and lopinavir/ritonavir",True,False,"Model listed TDF, 3TC, LPV/r, EFV (equivalent names), matching original; updated is 'Not applicable'."
37817087-16,37817087,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,Not reported for individual patients.,False,False,"Model said information was not reported; original said No (none), updated said Not applicable. Does not match either."
37823653-1,37823653,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes,True,False,"Model answered Yes, matching original, not matching updated Not reported."
37823653-2,37823653,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No,True,False,"Model answered No, matching original, not matching updated Not reported."
37823653-3,37823653,3,Were sequences from the paper made publicly available?,No,Not reported,Not reported / No explicit statement of public deposition,False,True,"Model said not reported/no explicit statement, which matches updated Not reported, not original No."
37823653-4,37823653,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported in the paper,True,True,"Model stated no accession numbers reported, matching both original (none) and updated (not reported)."
37823653-5,37823653,5,How many individuals had samples obtained for HIV sequencing?,6078,Not reported,"6,078 participants",True,False,"Model gave 6,078, matching original; updated says Not reported."
37823653-6,37823653,6,From which countries were the sequenced samples obtained?,Botswana,Not reported,Botswana,True,False,"Model answered Botswana, matching original; updated says Not reported."
37823653-7,37823653,7,From what years were the sequenced samples obtained?,2013-2018,Not reported,Enrolled between 2013 and 2018,True,False,"Model indicated 2013–2018, matching original; updated says Not reported."
37823653-8,37823653,8,Were samples cloned prior to sequencing?,No,Not reported,No,True,False,"Model answered No, matching original; updated says Not reported."
37823653-9,37823653,9,Which HIV genes were reported to have been sequenced?,"NFLG, gp120",Not reported,gp120 (part of the HIV envelope gene),False,False,"Model only mentioned gp120, omitting NFLG; does not match original or updated."
37823653-10,37823653,10,What method was used for sequencing?,Illumina sequencing,Not reported,Next-generation sequencing (NGS) using Illumina MiSeq and HiSeq after a long-range HIV genotyping PCR,True,False,"Model specified Illumina NGS, matching original; updated says Not reported."
37823653-11,37823653,11,What type of samples were sequenced?,No,Not reported,Proviral DNA templates (from participants' samples),False,False,"Model provided a sample type (proviral DNA), conflicting with original No and updated Not reported."
37823653-12,37823653,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,Yes,True,False,"Model answered Yes, matching original; updated says Not reported."
37823653-13,37823653,13,Were the patients in the study in a clinical trial?,Yes,Not reported,"Yes — they were enrolled in the Botswana Combination Prevention Project (BCPP), a registered study (ClinicalTrials.gov NCT01965470)",True,False,"Model answered Yes (clinical trial), matching original; updated says Not reported."
37823653-14,37823653,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes,True,False,"Model answered Yes, matching original; updated says Not reported."
37823653-15,37823653,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI",Not reported,Non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens (efavirenz or nevirapine) and later dolutegravir-based (integrase inhibitor) regimens were mentioned,False,False,Model mentioned NNRTI and INSTI; original required NRTI and NNRTI; updated Not reported. Mismatch.
37823653-16,37823653,16,Which drugs were received by individuals in the study before sample sequencing?,"EFV, NVP",Not applicable,Efavirenz and nevirapine were the predominant drugs; dolutegravir-based regimens are noted as later first-line implementation,True,False,"Model listed efavirenz and nevirapine (matches EFV, NVP) though added DTG context; updated says Not applicable."
37872202-1,37872202,1,Does the paper report HIV sequences from patient samples?,No,No,Yes — the paper uses a transmitted/founder Env derived from a participant (patient-derived sequence) and previously reported patient-derived Env plasmids.,False,False,"Model said Yes (patient-derived sequences), contradicting both original and updated No."
37872202-2,37872202,2,Does the paper report in vitro drug susceptibility data?,Yes,Not reported,Yes.,True,False,"Model answered Yes, matching original; updated says Not reported."
37872202-3,37872202,3,Were sequences from the paper made publicly available?,No,No,No — the paper reports deposition of structural data (PDB/EMDB) but does not report deposition of nucleotide sequence data to public sequence databases in the Data availability statement.,True,True,"Model said No public sequence deposition, matching both original and updated No."
37872202-4,37872202,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers are reported in this paper.,True,True,"Model stated no GenBank accessions reported, matching both original and updated."
37872202-5,37872202,5,How many individuals had samples obtained for HIV sequencing?,0,0,One individual is explicitly mentioned (participant 40100) as the source of the transmitted/founder T/F100 Env; other Envs used were previously reported plasmids but the paper does not enumerate additional individuals sampled in this study.,False,False,"Model implied one individual, contradicting both original and updated 0."
37872202-6,37872202,6,From which countries were the sequenced samples obtained?,No,Not applicable,Thailand is explicitly mentioned as the source of the transmitted/founder T/F100 Env; other sample origins are not explicitly stated in this paper.,False,False,Model gave a country (Thailand); original says No and updated Not applicable.
37872202-7,37872202,7,From what years were the sequenced samples obtained?,No,Not applicable,The paper does not report the years when the samples were obtained.,True,True,"Model explicitly said years not reported, aligning with unavailable information for both original (No) and updated (Not applicable)."
37872202-8,37872202,8,Were samples cloned prior to sequencing?,No,Not applicable,Yes — Env sequences were cloned into expression plasmids and mutations were introduced into Env expressors; the presence of mutations was confirmed by automated DNA sequencing.,False,False,"Model answered Yes (cloned), contradicting original No and updated Not applicable."
37910452-4,37910452,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None / Not applicable,True,True,No accession numbers were reported; model says none/not applicable.
37910452-5,37910452,5,How many individuals had samples obtained for HIV sequencing?,0,Not reported,None / Not applicable,True,False,"Human says 0; model’s none/NA matches zero, but updated says not reported, which the model does not state."
37910452-6,37910452,6,From which countries were the sequenced samples obtained?,No,Not reported,None / Not applicable (studies were conducted in Ghana),True,True,No countries since no sequencing; model answers none/NA (notes Ghana context).
37910452-7,37910452,7,From what years were the sequenced samples obtained?,No,Not reported,Not applicable (no sequencing); included studies were conducted between 2013 and 2022,True,True,No sequencing years; model says not applicable (extra context doesn’t conflict).
37910452-8,37910452,8,Were samples cloned prior to sequencing?,No,Not reported,No / Not applicable,True,True,No cloning/not applicable due to no sequencing; matches both.
37910452-9,37910452,9,Which HIV genes were reported to have been sequenced?,No,Not reported,None / Not applicable,True,True,No genes reported; model says none/NA.
37910452-10,37910452,10,What method was used for sequencing?,No,Not reported,Not applicable (no sequencing reported),True,True,No sequencing method; model says not applicable.
37910452-11,37910452,11,What type of samples were sequenced?,No,Not reported,Not applicable (no sequencing reported),True,True,No sample type since no sequencing; model says not applicable.
37910452-12,37910452,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,No / Not applicable,True,True,No sequences from VF; model says no/not applicable.
37910452-13,37910452,13,Were the patients in the study in a clinical trial?,No,Not reported,Some were — the review included randomized controlled trials among other designs,False,False,"Model claims some were in trials, contradicting human ‘No’ and not conveying not reported."
37910452-14,37910452,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No,True,False,"Model says No, aligning with human; updated expects not reported."
37910452-15,37910452,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,Not applicable; participants were on antiretroviral therapy (ART) but no specific drug classes are reported,True,True,No drug classes reported/NA; model explicitly states none reported.
37910452-16,37910452,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not reported,Not applicable; participants received antiretroviral therapy (ART) but no specific drug names are reported,True,True,No drug names reported/NA; model explicitly states none reported.
37914679-1,37914679,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes,True,False,"Model says Yes (matches human), but not compatible with updated ‘Not reported’."
37914679-2,37914679,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No,True,False,"Model says No, matching human; updated is ‘Not reported’."
37914679-3,37914679,3,Were sequences from the paper made publicly available?,No,Not reported,No (not reported),True,True,"Model answers No and notes not reported, satisfying both readings."
37914679-4,37914679,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,Not reported,True,True,Accession numbers not reported; model says not reported.
37914679-5,37914679,5,How many individuals had samples obtained for HIV sequencing?,76,Not reported,76 individuals,True,False,Model gives 76 (matches human); updated says not reported.
37914679-6,37914679,6,From which countries were the sequenced samples obtained?,No,Not reported,China,False,False,Human/updated indicate not reported; model asserts China.
37914679-7,37914679,7,From what years were the sequenced samples obtained?,2018 to 2020,Not reported,"January 1, 2018 to December 31, 2020",True,False,Model provides 2018–2020 matching human; updated says not reported.
37914679-8,37914679,8,Were samples cloned prior to sequencing?,No,Not reported,No (not reported),True,True,Model says No and notes not reported; acceptable for both.
37914679-9,37914679,9,Which HIV genes were reported to have been sequenced?,"PR, RT, IN",Not reported,Regions encoding drug resistance associated with NNRTI and NRTI (reverse transcriptase) and evidence of PI and INSTI resistance (implying protease and integrase regions) were sequenced (genes not explicitly named).,True,False,"Model implies PR, RT, IN, matching human; conflicts with updated ‘Not reported’."
37914679-10,37914679,10,What method was used for sequencing?,"Sanger sequencing, Illumina sequencing",Not reported,MiSeq second-generation sequencing platform (Illumina),False,False,Human lists Sanger and Illumina; model mentions only Illumina (missing Sanger) and contradicts updated ‘Not reported’.
37914679-11,37914679,11,What type of samples were sequenced?,Plasma,Not reported,Baseline plasma samples,True,False,"Model says plasma, matching human; updated says not reported."
37914679-12,37914679,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,Yes — baseline sequences were obtained from individuals who subsequently were classified as virological failures,False,False,"Model says Yes, contradicting human ‘No’ and not conveying not reported."
38140553-10,38140553,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,Sanger-based (BigDye Terminator v3.1) sequencing of PCR-amplified pol gene fragments; ViroSeq HIV-1 Genotyping System and ViroSeq software were used for some samples.,True,True,"Model specifies Sanger sequencing (with BigDye/ViroSeq), matching the Sanger answer."
38140553-11,38140553,11,What type of samples were sequenced?,Plasma; PBMC; Whole Blood,Plasma; PBMC; Whole Blood,"Blood plasma, peripheral blood mononuclear cells (lymphocytes), and frozen whole blood.",True,True,"Model lists plasma, PBMC, and whole blood, matching the annotated sample types."
38140553-12,38140553,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,"Not specifically reported; sequences came from patients both receiving ART and not on ART, but virological failure status is not stated.",False,False,"Model says status not reported, whereas annotation says No."
38140553-13,38140553,13,Were the patients in the study in a clinical trial?,No,No,No.,True,True,"Model answers No, matching the annotations."
38140553-14,38140553,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,No,"Yes; the study included sequences from individuals receiving ART at the time of sampling, though past treatment histories were not fully known for all patients.",False,False,"Model says Yes (prior/ongoing ART), but annotations say No."
38140553-15,38140553,15,Which drug classes were received by individuals in the study before sample sequencing?,No,nan,"Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and protease inhibitors (PIs).",False,False,"Model lists ARV classes, but human says No; updated answer is missing (nan)."
38140553-16,38140553,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"The paper mentions use of efavirenz (EFV) and the NRTIs lamivudine (3TC) and emtricitabine (FTC) as main components of preferred first-line regimens in Russia (i.e., drugs likely received by individuals).",False,False,"Model lists specific drugs, but annotation indicates none/not applicable."
38140649-1,38140649,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model says Yes, matching both annotations."
38140649-2,38140649,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,"Model says No, matching both annotations."
38140649-3,38140649,3,Were sequences from the paper made publicly available?,Yes,Yes,Yes.,True,True,"Model says Yes, matching both annotations."
38140649-4,38140649,4,What were the GenBank accession numbers for sequenced HIV isolates?,"OR605755-OR606279, OR613869-OR613875","OR605755-OR606279, OR613869-OR613875",OR605755-OR606279 and OR613869-OR613875.,True,True,Model gives the same accession ranges as annotated.
38140649-5,38140649,5,How many individuals had samples obtained for HIV sequencing?,270,270,270 individuals.,True,True,"Model states 270 individuals, matching annotations."
38140649-6,38140649,6,From which countries were the sequenced samples obtained?,Croatia,Croatia,"Croatia (samples collected from patients entering care at the University Hospital for Infectious Diseases, Zagreb, Croatia).",True,True,"Model specifies Croatia, matching annotations."
38140649-7,38140649,7,From what years were the sequenced samples obtained?,2019-2022,2019-2022,2019 to 2022.,True,True,"Model lists 2019–2022, matching annotations."
38140649-8,38140649,8,Were samples cloned prior to sequencing?,No,No,No.,True,True,"Model says No cloning, matching annotations."
38140649-9,38140649,9,Which HIV genes were reported to have been sequenced?,Pol,Pol,"The pol gene: HIV-1 protease (PR), partial reverse transcriptase (RT), and integrase (IN) regions.",True,True,"Model specifies pol (PR, RT, IN), matching the annotated gene."
38140649-10,38140649,10,What method was used for sequencing?,"Sanger sequencing, Illumina sequencing",Sanger sequencing; Illumina (NGS),Sanger sequencing (BigDye Terminator v3.1) for standard genotyping and next-generation sequencing (Illumina MiniSeq) for deep sequencing.,True,True,"Model lists Sanger and Illumina NGS, matching annotations."
38140649-11,38140649,11,What type of samples were sequenced?,Plasma,Plasma,Patient plasma samples containing HIV-1 RNA.,True,True,"Model says plasma, matching annotations."
38140649-12,38140649,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,No.,True,True,"Model answers No, matching annotations."
38140649-13,38140649,13,Were the patients in the study in a clinical trial?,No,No,No.,True,True,"Model answers No, matching annotations."
38140649-14,38140649,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,No,No.,True,True,"Model answers No prior ARVs, matching annotations."
38140649-15,38140649,15,Which drug classes were received by individuals in the study before sample sequencing?,No,nan,None; individuals were antiretroviral treatment-naïve.,True,False,"Model says none (ART-naïve), matching original 'No'; updated answer is missing (nan)."
38140649-16,38140649,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,None; individuals were antiretroviral treatment-naïve.,True,True,"Model states none/ART-naïve, aligning with 'Not applicable'."
38140667-1,38140667,1,Does the paper report HIV sequences from patient samples?,No,No,No,True,True,"Model says No sequences from patient samples, matching annotations."
38140667-2,38140667,2,Does the paper report in vitro drug susceptibility data?,No,No,No,True,True,"Model says No in vitro susceptibility data, matching annotations."
38090027-1,38090027,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes. The paper reports genotypic resistance testing (GRT) results obtained from patient samples (plasma HIV-RNA and PBMC HIV-DNA) in cases of virological failure.,True,False,"Model says sequences were reported; original says Yes, updated says Not reported."
38090027-2,38090027,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No. The paper reports genotypic resistance testing results but does not present in vitro (phenotypic) drug susceptibility data.,True,False,"Model says no in vitro susceptibility data; original No matches, updated Not reported does not."
38090027-3,38090027,3,Were sequences from the paper made publicly available?,No,Not reported,No. The paper does not report deposition of sequences or provide public accession numbers.,True,False,"Model says sequences not made public; original No matches, updated Not reported does not."
38090027-4,38090027,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported. The paper does not provide any GenBank accession numbers.,True,True,"Model states no GenBank accessions reported, matching both original No and updated Not reported."
38090027-5,38090027,5,How many individuals had samples obtained for HIV sequencing?,5,Not reported,Five individuals had genotypic resistance testing evaluable at virological failure.,True,False,"Model gives 5 individuals, matching original; updated is Not reported."
38090027-6,38090027,6,From which countries were the sequenced samples obtained?,Italy,Not reported,Italy.,True,False,"Model says Italy, matching original; updated is Not reported."
38090027-7,38090027,7,From what years were the sequenced samples obtained?,2019-2020,Not reported,"Samples/sequencing were obtained during the study period when patients switched to BFTAF from June 2019 to June 2021, with follow-up (and consequent genotypic testing at virological failure) through data freezing on 31 August 2022.",False,False,"Model gives 2019–2021 with follow-up to 2022, conflicting with original 2019–2020 and not aligning with Not reported."
38090027-8,38090027,8,Were samples cloned prior to sequencing?,No,Not reported,No indication of cloning is reported.,False,True,"Model says no indication of cloning is reported, which aligns with Not reported rather than a definitive No."
38090027-9,38090027,9,Which HIV genes were reported to have been sequenced?,"RT, IN",Not reported,"Genes corresponding to targets of PIs, NRTIs (reverse transcriptase), and integrase inhibitors were analysed (protease, reverse transcriptase, and integrase regions).",False,False,"Model lists PR, RT, IN; original only RT and IN; updated is Not reported—so both not matched."
38090027-10,38090027,10,What method was used for sequencing?,No,Not reported,"A validated in-house genotypic resistance testing (GRT) method was used to identify resistance-associated mutations on plasma HIV-RNA and PBMC HIV-DNA, with interpretation using the Stanford HIV Drug Resistance Database.",False,False,Model asserts an in-house GRT method; original and updated indicate no method reported.
38090027-11,38090027,11,What type of samples were sequenced?,"Plasma, PBMC",Not reported,Plasma HIV-RNA and peripheral blood mononuclear cell (PBMC) HIV-DNA samples were used for genotypic resistance testing/sequencing.,True,False,"Model specifies plasma and PBMC, matching original; updated is Not reported."
38090027-12,38090027,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,Yes. Genotypic resistance tests were evaluable at virological failure in five patients.,True,False,"Model says Yes at virological failure; original Yes, updated Not reported."
38090027-13,38090027,13,Were the patients in the study in a clinical trial?,No,Not reported,"No. The study was a retrospective cohort conducted in clinical practice; although a small number later enrolled in clinical trials, the cohort itself was not a clinical trial.",True,False,"Model says not a clinical trial; matches original No, not updated Not reported."
38090027-14,38090027,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,"Yes. The cohort consisted of treatment-experienced individuals with long prior ART exposure, and GRTs were performed in some of these individuals.",True,False,"Model says sequences from treatment-experienced individuals; matches original Yes, not updated Not reported."
38090027-15,38090027,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, NNRTI, PI, INSTI",Not reported,"Individuals had previously received integrase strand transfer inhibitor-based regimens (InSTIs), protease inhibitor-based regimens (PIs), non-nucleoside reverse transcriptase inhibitor-based regimens (NNRTIs), and nucleoside reverse transcriptase inhibitors (NRTIs).",True,False,"Model lists NRTI, NNRTI, PI, INSTI; matches original, not updated Not reported."
38090027-16,38090027,16,Which drugs were received by individuals in the study before sample sequencing?,"BIC, FTC, TAF, EVG",Not reported,"Reported prior drugs/regimens include elvitegravir/cobicistat/FTAF (ECFTAF), other integrase inhibitor regimens, protease inhibitor regimens (e.g., darunavir/cobicistat/FTAF mentioned as a switch), dolutegravir (DTG), rilpivirine (RPV), emtricitabine, and tenofovir alafenamide (TAF).",False,False,"Model lists multiple drugs (e.g., DTG, RPV, DRV) beyond the original BIC, FTC, TAF, EVG and not Not reported."
38140553-1,38140553,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,Model Yes matches both original and updated Yes.
38140553-2,38140553,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,Model No matches both original and updated No.
38140553-3,38140553,3,Were sequences from the paper made publicly available?,Yes,Yes,Yes.,True,True,Model Yes matches both original and updated Yes.
38140553-4,38140553,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,GenBank accession numbers for the newly sequenced isolates are not reported; only the HXB-2 reference GenBank accession (K03455) is cited.,True,True,"Model clearly states no new accession numbers reported, matching original No and updated Not reported."
38140553-5,38140553,5,How many individuals had samples obtained for HIV sequencing?,3178,3178,3178 individuals.,True,True,"Model gives 3178, matching both."
38140553-6,38140553,6,From which countries were the sequenced samples obtained?,Russia,Russia,Russia (Russian Federation).,True,True,Model says Russia; matches both.
38140553-7,38140553,7,From what years were the sequenced samples obtained?,2011-2020,2011-2020,2011 to 2020.,True,True,Model says 2011–2020; matches both.
38140553-8,38140553,8,Were samples cloned prior to sequencing?,No,No,No evidence of cloning; samples were amplified by nested PCR and sequenced directly by Sanger methods.,True,True,Model indicates no cloning (direct Sanger); matches both No.
38140553-9,38140553,9,Which HIV genes were reported to have been sequenced?,Pol,Pol,The protease (PR) and part of the reverse transcriptase (RT) regions of the pol gene (PR-RT).,True,True,Model specifies PR-RT regions of pol; aligns with Pol in both.
37914679-13,37914679,13,Were the patients in the study in a clinical trial?,No,Not reported,No — this was a retrospective observational study (not a clinical trial),True,False,"Model answered No, matching the original, but not the updated Not reported."
37914679-14,37914679,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No — the study enrolled ART-naïve patients,True,False,"Model said No (ART-naïve), matching original No but contradicting updated Not reported."
37914679-15,37914679,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,None prior to sequencing — participants were ART-naïve,True,False,"Model said none prior to sequencing, aligning with original No but not with updated Not reported."
37914679-16,37914679,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,No antiretroviral drugs were received before sequencing (participants were ART-naïve),True,False,"Model stated no drugs received, matching original No but not the updated Not applicable."
37920909-1,37920909,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes,True,True,"Model said Yes, matching both annotations."
37920909-2,37920909,2,Does the paper report in vitro drug susceptibility data?,No,No,No,True,True,"Model said No, matching both annotations."
37920909-3,37920909,3,Were sequences from the paper made publicly available?,No,No,No (not reported),True,True,"Model said No (not reported), matching both original and updated No."
37920909-4,37920909,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported in the paper,True,True,"Model said none reported, matching original No and updated Not reported."
37920909-5,37920909,5,How many individuals had samples obtained for HIV sequencing?,601 or 629,Not reported,629 individuals had samples obtained; sequencing was successful for 601 cases,True,False,"Model provided 629 (and 601 sequenced), matching original '601 or 629' but not updated Not reported."
37920909-6,37920909,6,From which countries were the sequenced samples obtained?,China,China,China,True,True,"Model answered China, matching both."
37920909-7,37920909,7,From what years were the sequenced samples obtained?,2020-2023,2020-2023,"Between January 1, 2020 and April 1, 2023",True,True,"Model gave 2020–2023 range, matching both."
37920909-8,37920909,8,Were samples cloned prior to sequencing?,No,No,Not reported (no cloning stated),False,False,"Model said not reported, while both annotations say No."
37920909-9,37920909,9,Which HIV genes were reported to have been sequenced?,IN,IN,The HIV-1 integrase gene,True,True,"Model identified integrase (IN), matching both."
37920909-10,37920909,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,An in-house genotyping method and standard Sanger sequencing,True,True,"Model included Sanger sequencing, matching both."
37920909-11,37920909,11,What type of samples were sequenced?,Whole Blood,Whole Blood,Blood-derived RNA (5 mL blood collected from participants),True,True,"Model described blood-derived RNA from blood, consistent with whole blood."
37920909-12,37920909,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,No,True,True,"Model said No, matching both."
37920909-13,37920909,13,Were the patients in the study in a clinical trial?,No,No,No,True,True,"Model said No, matching both."
37920909-14,37920909,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,No,No,True,True,"Model said No, matching both."
37920909-15,37920909,15,Which drug classes were received by individuals in the study before sample sequencing?,No,nan,None (participants were ART-naïve),True,False,"Model said none (ART-naïve), matching original No; updated value is nan/not reported."
37920909-16,37920909,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,None (no specific antiretroviral drugs were received prior to sampling),True,False,"Model said none, matching original No but not updated Not applicable."
37938856-1,37938856,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model said Yes, matching both."
37938856-2,37938856,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,"Model said No, matching both."
37938856-3,37938856,3,Were sequences from the paper made publicly available?,No,No,No (not reported).,True,True,"Model said No (not reported), matching both."
37938856-4,37938856,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model said none reported, matching original No and updated Not reported."
37938856-5,37938856,5,How many individuals had samples obtained for HIV sequencing?,820,820,46 successful DRM tests (sequenced samples) were obtained.,False,False,"Model reported 46 sequenced/DRM tests, not 820 as in both annotations."
38140667-3,38140667,3,Were sequences from the paper made publicly available?,No,No,No,True,True,"Model answered 'No,' matching both original and updated answers."
38140667-4,38140667,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported,True,True,"Model said 'None reported,' consistent with both 'No' and 'Not reported.'"
38140667-5,38140667,5,How many individuals had samples obtained for HIV sequencing?,0,0,Not reported / not applicable to this paper,False,False,Correct answer is 0; model said not reported/not applicable.
38140667-6,38140667,6,From which countries were the sequenced samples obtained?,No,Not applicable,"Studies summarized included samples from multiple countries including France, Canada, Spain, Tanzania, Malawi, Brazil, Nigeria, Mozambique, Botswana, South Africa, Italy, Germany, Ukraine, and Poland.",False,False,"No sequencing was applicable; model listed countries, which is incorrect."
38140667-7,38140667,7,From what years were the sequenced samples obtained?,No,Not applicable,"Across included studies spanning roughly 2013–2023 (publications and congress data from 2013 to 2023); individual studies reported various years (e.g., 2012–2014, 2019–2022, 2017–2022).",False,False,"No sequencing years apply; model provided years, which is incorrect."
38140667-8,38140667,8,Were samples cloned prior to sequencing?,No,Not applicable,Not reported,False,True,"Model said not reported (information unavailable), which matches updated 'Not applicable' but not original 'No.'"
38140667-9,38140667,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,"Primarily the integrase gene (INSTI/integrase) and, in many studies, reverse transcriptase and protease (RT and PR) genes were also reported.",False,False,Model listed genes despite none applicable; contradicts both annotations.
38140667-10,38140667,10,What method was used for sequencing?,No,Not applicable,Not specified in this review,False,True,"Model said not specified (unavailable), aligning with updated 'Not applicable' but not original 'No.'"
38140667-11,38140667,11,What type of samples were sequenced?,No,Not applicable,Primarily plasma samples (viral RNA/genotypes from viremic individuals) were sequenced in the cited studies.,False,False,"Model asserted plasma samples; there were no sequences, so this is incorrect."
38140667-12,38140667,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,Yes,False,False,Model said 'Yes' though sequencing was not applicable.
38140667-13,38140667,13,Were the patients in the study in a clinical trial?,No,Not reported,"No — the paper focuses on real-world observational studies and cohorts (though it references some clinical trials elsewhere), and the review itself did not enroll patients in a trial.",True,False,"Model answered 'No,' matching the original but not the updated 'Not reported.'"
38140667-14,38140667,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,Yes,False,False,Model said 'Yes' though sequencing was not applicable.
38140667-15,38140667,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,"Individuals had prior exposure to multiple antiretroviral classes including integrase strand transfer inhibitors (INSTIs), nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and protease inhibitors (PIs).",False,False,Model listed prior drug classes despite no sequencing; incorrect.
38140667-16,38140667,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Specific drugs mentioned in the included studies include dolutegravir (DTG), raltegravir (RAL), elvitegravir (EVG), tenofovir disoproxil fumarate (TDF), lamivudine (3TC), abacavir (ABC), emtricitabine (FTC), rilpivirine (RPV), and combinations such as TLD (TDF/3TC/DTG) and DTG/3TC/ABC.",False,False,Model listed specific drugs despite no sequencing; incorrect.
38142692-1,38142692,1,Does the paper report HIV sequences from patient samples?,No,No,No.,True,True,"Model answered 'No,' matching both."
38142692-2,38142692,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No.,True,False,"Model said 'No,' matching original but not updated 'Not reported.'"
38142692-3,38142692,3,Were sequences from the paper made publicly available?,No,No,No.,True,True,"Model answered 'No,' matching both."
38142692-4,38142692,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None / Not applicable — no sequences were reported.,True,True,"Model said none/not applicable, consistent with both annotations."
38142692-5,38142692,5,How many individuals had samples obtained for HIV sequencing?,0,0,Zero — no individuals had samples sequenced for HIV resistance in this study.,True,True,"Model stated zero, matching both."
38142692-6,38142692,6,From which countries were the sequenced samples obtained?,No,Not applicable,None — no sequencing was done. The study population was from South Africa.,True,True,Model correctly noted no sequencing (none) and the cohort location; aligns with both.
38142692-7,38142692,7,From what years were the sequenced samples obtained?,No,Not applicable,"Not applicable — no sequences were obtained; study participants were switched between Dec 1, 2019, and Nov 30, 2020.",True,True,Model said not applicable (no sequences) and gave study dates; matches both.
38142692-8,38142692,8,Were samples cloned prior to sequencing?,No,Not applicable,Not applicable — no sequencing was performed.,False,True,"Model said not applicable (no sequencing), matching updated but not original 'No.'"
38142692-9,38142692,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,None — no HIV genes were sequenced or reported in this study.,True,True,"Model said none were sequenced, aligning with both."
38142692-10,38142692,10,What method was used for sequencing?,No,Not applicable,Not applicable — no sequencing method was used or reported.,False,True,"Model said not applicable (no sequencing), matching updated but not original 'No.'"
38142692-11,38142692,11,What type of samples were sequenced?,No,Not applicable,Not applicable — no samples were sequenced. The study used routine viral load testing data.,False,True,"Model said not applicable (no sequencing), matching updated but not original 'No.'"
38142692-12,38142692,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,"No — no sequences were obtained, although the cohort consisted of individuals with virological failure.",True,False,"Model answered No, matching the original, but the updated answer is Not applicable, not a definitive No."
38142692-13,38142692,13,Were the patients in the study in a clinical trial?,No,Not reported,"No — this was a retrospective observational cohort study using routine-care data, not a clinical trial.",True,False,"Model stated No (not a clinical trial), aligning with the original, but the updated answer is Not reported."
38142692-14,38142692,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,"No — the paper does not report HIV sequences from any individuals, including those who had previously received ARV drugs.",True,False,"Model said No sequences reported, matching the original; updated says Not applicable, which the model did not convey."
38142692-15,38142692,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,Participants had received nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs).,False,False,"Model listed NRTI/NNRTI, while the original said No and updated is Not applicable."
38142692-16,38142692,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Participants had been receiving tenofovir disoproxil fumarate (TDF), emtricitabine or lamivudine (XTC), efavirenz (EFV), and nevirapine (NVP) as first-line therapy.",False,False,Model listed specific drugs; original said No and updated is Not applicable.
38152686-1,38152686,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,Yes.,True,False,"Model said Yes, agreeing with original; updated is Not reported."
38152686-2,38152686,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No.,True,False,"Model said No, matching original; updated is Not reported."
38152686-3,38152686,3,Were sequences from the paper made publicly available?,No,Not reported,No (not publicly deposited); data are available upon request.,True,False,"Model said No public deposition, matching original; updated is Not reported."
38152686-4,38152686,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model said none reported, which matches both the original No and updated Not reported."
38152686-5,38152686,5,How many individuals had samples obtained for HIV sequencing?,1,Not reported,One individual (single case report).,True,False,"Model said one individual, matching original 1; updated is Not reported."
38152686-6,38152686,6,From which countries were the sequenced samples obtained?,No,Not reported,Not explicitly stated.,True,True,"Model said not stated, matching original No and updated Not reported."
38152686-7,38152686,7,From what years were the sequenced samples obtained?,No,Not reported,Not stated (no calendar years reported).,True,True,"Model said not stated, matching original No and updated Not reported."
38152686-8,38152686,8,Were samples cloned prior to sequencing?,No,Not reported,Not reported / not specified.,False,True,"Model said not reported; original said No (a definitive answer), but updated is Not reported."
38152686-9,38152686,9,Which HIV genes were reported to have been sequenced?,IN,Not reported,Integrase and reverse transcriptase.,False,False,Model listed integrase and RT; original had only IN and updated is Not reported.
38152686-10,38152686,10,What method was used for sequencing?,No,Not reported,Only 'genotyping' is reported; the specific sequencing method is not stated.,True,True,"Model indicated the method was not stated, matching both original No and updated Not reported."
38152686-11,38152686,11,What type of samples were sequenced?,Plasma,Not reported,Not specified.,False,True,"Model said not specified, contradicting original Plasma; matches updated Not reported."
38152686-12,38152686,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,Yes.,True,False,"Model said Yes, matching original; updated is Not reported."
38152686-13,38152686,13,Were the patients in the study in a clinical trial?,No,Not reported,"No; this is a single-patient case report, not a clinical trial.",True,False,"Model said No trial (case report), matching original; updated is Not reported."
38152686-14,38152686,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes.,True,False,"Model said Yes, matching original; updated is Not reported."
38152686-15,38152686,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, INSTI",Not reported,"Nucleoside reverse transcriptase inhibitors (NRTIs), an integrase strand transfer inhibitor (INSTI), and a non-nucleoside reverse transcriptase inhibitor (NNRTI).",False,False,"Model added NNRTI beyond the original NRTI, INSTI and the updated is Not reported."
38152686-16,38152686,16,Which drugs were received by individuals in the study before sample sequencing?,"TDF, 3TC, DTG",Not applicable,"Tenofovir (TDF), Lamivudine (3TC), Dolutegravir (DTG), and Efavirenz (EFZ).",False,False,"Model added efavirenz beyond original TDF, 3TC, DTG; updated is Not applicable."
38314093-1,38314093,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,"Model said Yes, matching both original and updated."
38314093-2,38314093,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,"Model said No, matching both original and updated."
38314093-3,38314093,3,Were sequences from the paper made publicly available?,No,No,Not explicitly reported / not clearly made publicly available.,False,False,"Model said not explicitly reported/not clear, which is not a definitive No as in both human and updated answers."
38314093-4,38314093,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,No GenBank accession numbers are reported in the paper.,True,True,"Model said no GenBank accessions reported, matching both original No and updated Not reported."
37957382-8,37957382,8,Were samples cloned prior to sequencing?,Yes,Not reported,No — sequencing was performed using endpoint dilution single-genome approaches rather than cloning.,False,False,"Model said samples were not cloned, contradicting original Yes and not matching updated Not reported."
37957382-9,37957382,9,Which HIV genes were reported to have been sequenced?,"Full genome, NFLG",Not reported,"Near-full-length proviral genomes were sequenced, including pol and env (pol–env 6.7 kb amplicon); the 5′ leader/gag region was also sequenced, and individual genes (e.g., nef, pol, gag, env) were analyzed.",True,False,"Model described near-full-length (pol/env/gag etc.), consistent with full genome/NFLG; not compatible with updated Not reported."
37957382-10,37957382,10,What method was used for sequencing?,Illumina sequencing,Not reported,Single-genome near-full-length PCR (endpoint dilution NFL-seq) with Illumina barcoded library construction and MiSeq sequencing; sequence assembly used UltraCycler and alignments used MAFFT and MEGA.,True,False,"Model specified Illumina (MiSeq) sequencing, matching original; not matching updated Not reported."
37957382-11,37957382,11,What type of samples were sequenced?,"Plasma, PBMC",Not reported,Plasma HIV-1 RNA and proviral DNA extracted from peripheral blood mononuclear cells (PBMCs)/CD4+ T cells.,True,False,"Model listed plasma RNA and PBMC/CD4 DNA, matching original; not matching updated Not reported."
37957382-12,37957382,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,Yes,Not reported,Sequences were obtained from individuals on antiretroviral therapy who had persistent low-level (non-suppressible) viremia while on ART; the paper does not characterize these as classic high-level virologic failure but as non-suppressible viremia despite ART.,True,False,"Model indicated sequences from ART patients with persistent viremia (virological failure), aligning with Yes; not matching updated Not reported."
37957382-13,37957382,13,Were the patients in the study in a clinical trial?,No,Not reported,No — the study was observational and used historic comparator cohorts.,True,False,"Model said observational (not a clinical trial), matching original; not matching updated Not reported."
37957382-14,37957382,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes.,True,False,"Model answered Yes, matching original; not matching updated Not reported."
37957382-15,37957382,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, PI, INSTI",Not reported,"Participants received multiple classes including nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), and integrase (IN) inhibitors.",True,False,"Model included NRTI, PI, and INSTI (plus NNRTI), covering the original classes; not matching updated Not reported."
37957382-16,37957382,16,Which drugs were received by individuals in the study before sample sequencing?,"DTG, DRV, TFV, FTC",Not applicable,"The paper reports specific drugs in participant regimens and testing, including dolutegravir, darunavir (DRV/r), atazanavir/ritonavir (ATV/r), tenofovir disoproxil fumarate (TDF), tenofovir alafenamide (TAF), emtricitabine (FTC), and rilpivirine (RPV), among others.",True,False,"Model listed DTG, DRV, TFV/TDF/TAF, FTC among others, covering the original drugs; not matching updated Not applicable."
37966701-1,37966701,1,Does the paper report HIV sequences from patient samples?,No,No,No — the paper does not report HIV sequences from patient samples.,True,True,"Model said no patient HIV sequences were reported, matching both."
37966701-2,37966701,2,Does the paper report in vitro drug susceptibility data?,No,No,No — the paper does not report in vitro drug susceptibility data.,True,True,"Model said no in vitro susceptibility data, matching both."
37966701-3,37966701,3,Were sequences from the paper made publicly available?,No,No,No — no sequences were made publicly available.,True,True,"Model said no sequences were made public, matching both."
37966701-4,37966701,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported — no GenBank accession numbers are provided.,True,True,"Model stated none reported GenBank accessions, matching original No and updated Not reported."
37966701-5,37966701,5,How many individuals had samples obtained for HIV sequencing?,0,0,None — the study did not obtain or report samples for HIV sequencing.,True,True,"Model indicated zero individuals sequenced, matching both."
37966701-6,37966701,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable — no sequencing was performed; the study cohort and data are from the United States.,True,True,"Model said not applicable due to no sequencing, matching original No and updated Not applicable."
37966701-7,37966701,7,From what years were the sequenced samples obtained?,No,Not applicable,Not applicable — no sequencing was performed; study treatment initiation occurred between 21 January 2021 and 28 February 2022 with continuation injections by 15 March 2022.,True,True,"Model said not applicable due to no sequencing, matching both."
37966701-8,37966701,8,Were samples cloned prior to sequencing?,No,Not applicable,No — samples were not cloned prior to sequencing because no sequencing was performed.,True,True,"Model explained no cloning because no sequencing, aligning with original No and updated Not applicable."
37966701-9,37966701,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,None — the paper does not report sequencing of any HIV genes.,True,True,"Model said no genes were sequenced, matching both."
37966701-10,37966701,10,What method was used for sequencing?,No,Not applicable,Not applicable — no sequencing was performed and no sequencing methods are reported.,True,True,"Model said not applicable; no sequencing methods, matching both."
37966701-11,37966701,11,What type of samples were sequenced?,No,Not applicable,Not applicable — no biological samples were sequenced; the study used routine clinical electronic health record data and viral load measurements.,True,True,"Model said not applicable; no samples sequenced, matching both."
37966701-12,37966701,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No — no sequences were obtained; the paper does report four confirmed virologic failures but notes resistance data were not available.,True,True,"Model said no sequences were obtained, aligning with original No and updated Not applicable."
37966701-13,37966701,13,Were the patients in the study in a clinical trial?,No,Not Reported,"No — the patients were part of an observational real-world cohort (OPERA) receiving routine clinical care, not a clinical trial.",True,False,"Model said not a clinical trial, matching original No but contradicting updated Not reported."
37966701-14,37966701,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,"No — the paper does not report HIV sequences from any individuals, though participants had prior antiretroviral exposure (they were initiating CAB + RPV LA, often after stable ART).",True,True,"Model said no sequences from any individuals, matching original No and updated Not applicable."
37966701-15,37966701,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable — no sequencing was performed and the paper does not report prior antiretroviral drug classes; the regimen under study was cabotegravir + rilpivirine LA.,True,True,"Model said not applicable due to no sequencing, matching both."
37966701-16,37966701,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Not applicable — no sequencing was performed; participants received cabotegravir + rilpivirine long-acting injectable as the regimen under study, and prior ART regimens are not specified in the paper.",True,True,"Model said not applicable due to no sequencing, matching both."
38427738-14,38427738,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No. The paper does not report sequences from treated individuals; all sequences were obtained from viruses propagated experimentally under antiretroviral pressure in cell culture.,True,False,"Model answered No, matching original. Updated says Not reported, which the model did not convey."
38427738-15,38427738,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,"Not applicable — there were no human individuals whose drug histories were sequenced. (In the experimental system, cultures were exposed to antiretrovirals, primarily the INSTI dolutegravir (DTG) and the NRTTI EFdA.)",True,False,"Model said Not applicable/none, aligning with original 'No'. Updated is Not reported, which was not conveyed."
38427738-16,38427738,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Not applicable for human individuals. In the experimental (cell culture) system, viruses were exposed to antiretroviral drugs including the INSTI dolutegravir (DTG) and the NRTTI islatravir (EFdA); other ARVs (e.g., RAL, CAB, FTC, RPV, EFV, DRV, NFV, T-20, BMS-378806, BI-224436, LEN) were used in drug-sensitivity assays.",True,True,"Model stated Not applicable (with context), matching both the original intent and the updated Not applicable."
38864613-1,38864613,1,Does the paper report HIV sequences from patient samples?,No,Yes,No,True,False,"Model said No, matching original; updated says Yes."
38864613-2,38864613,2,Does the paper report in vitro drug susceptibility data?,Yes,Not reported,Yes,True,False,"Model said Yes, matching original; updated says Not reported."
38864613-3,38864613,3,Were sequences from the paper made publicly available?,Yes,Yes,Yes,True,True,"Model said Yes, matching both original and updated."
38864613-4,38864613,4,What were the GenBank accession numbers for sequenced HIV isolates?,PP827803-PP828572,PP827803-PP828572,PP827803 -- PP828572,True,True,Accession range PP827803–PP828572 matches both.
38864613-5,38864613,5,How many individuals had samples obtained for HIV sequencing?,0,Not reported,0 (no individuals; sequences derived from in vitro experiments),True,False,"Model gave 0 individuals, matching original; updated says Not reported."
38864613-6,38864613,6,From which countries were the sequenced samples obtained?,No,Not reported,Not applicable / Not reported,True,True,"Model conveyed not applicable/not reported, aligning with original 'No' (none) and updated Not reported."
38864613-7,38864613,7,From what years were the sequenced samples obtained?,No,Not reported,Not applicable / Not reported,True,True,"Model conveyed not applicable/not reported, aligning with original 'No' (none) and updated Not reported."
38864613-8,38864613,8,Were samples cloned prior to sequencing?,No,Not reported,No,True,False,"Model answered No, matching original; updated says Not reported."
38864613-9,38864613,9,Which HIV genes were reported to have been sequenced?,"RT, CA",Not reported,Capsid (CA) and reverse transcriptase (RT),True,False,"Model listed RT and CA, matching original; updated says Not reported."
38864613-10,38864613,10,What method was used for sequencing?,Sanger sequencing,Not reported,Population-based Sanger sequencing of one-step RT-PCR amplicons (automated population-based full-length sequencing),True,False,"Model indicated Sanger sequencing, matching original; updated says Not reported."
38864613-11,38864613,11,What type of samples were sequenced?,No,Not reported,Viral RNA from culture supernatant of wells with viral breakthrough (in vitro cell culture supernatant),False,False,"Model provided a specific sample type, which conflicts with original 'No' and updated Not reported."
38864613-12,38864613,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,No,True,False,"Model answered No, matching original; updated says Not reported."
38864613-13,38864613,13,Were the patients in the study in a clinical trial?,No,Not reported,No (no patients were involved),True,False,"Model answered No (no patients), matching original; updated says Not reported."
38864613-14,38864613,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not reported,No,True,False,"Model answered No, matching original; updated says Not reported."
38864613-15,38864613,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,Not applicable / None,True,False,"Model said Not applicable/None, aligning with original 'No'; updated says Not reported."
38864613-16,38864613,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,Not applicable / None,True,True,"Model said Not applicable/None, matching both original intent and updated Not applicable."
38314093-5,38314093,5,How many individuals had samples obtained for HIV sequencing?,37,37,37 individuals.,True,True,"Model states 37, matching both annotations."
38314093-6,38314093,6,From which countries were the sequenced samples obtained?,China,China,China.,True,True,"Model says China, matching both annotations."
38314093-7,38314093,7,From what years were the sequenced samples obtained?,2008-2019,2008-2019,Samples were collected between May 2008 and December 2019 (study period).,True,True,Model’s May 2008–Dec 2019 matches 2008–2019.
38314093-8,38314093,8,Were samples cloned prior to sequencing?,No,No,No — cloning is not reported.,True,True,Model answers No; aligns with both annotations.
38314093-9,38314093,9,Which HIV genes were reported to have been sequenced?,"PR, RT","PR, RT",Protease and reverse transcriptase (PR-RT / Pro-RT).,True,True,"Protease and RT (PR, RT) match both annotations."
38314093-10,38314093,10,What method was used for sequencing?,NGS,NGS,PCR amplification of cDNA followed by high-throughput sequencing.,True,True,High-throughput sequencing corresponds to NGS.
38314093-11,38314093,11,What type of samples were sequenced?,Serum,Serum,Serum samples.,True,True,"Model says serum, matching both."
38314093-12,38314093,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,No — the sequenced samples were from untreated patients.,True,True,Model says No; matches both.
38314093-13,38314093,13,Were the patients in the study in a clinical trial?,No,No,No.,True,True,Model says No; matches both.
38314093-14,38314093,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,No,No — the reported sequences were from untreated individuals.,True,True,Model says No; matches both.
38314093-15,38314093,15,Which drug classes were received by individuals in the study before sample sequencing?,No,nan,None — the sequenced individuals were untreated.,True,False,"Model says None (untreated), matching original ‘No’. Updated answer is missing (nan), so it does not match."
38314093-16,38314093,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,None — no specific antiretroviral drugs were reported as received prior to sequencing for the sequenced individuals.,True,True,Model says none; consistent with original ‘No’ and updated ‘Not applicable’ given no prior drugs.
38427738-1,38427738,1,Does the paper report HIV sequences from patient samples?,No,Yes,"No. The sequences reported were derived from in vitro–propagated laboratory and primary viral isolates in cell culture, not from patient samples.",True,False,"Model says No (not patient samples), matching original ‘No’ but contradicting updated ‘Yes’."
38427738-2,38427738,2,Does the paper report in vitro drug susceptibility data?,Yes,Yes,Yes.,True,True,Model says Yes; matches both.
38427738-3,38427738,3,Were sequences from the paper made publicly available?,No,No,No public sequence accession is reported; sequences are presented in the paper and/or Supplementary Materials and materials are available upon request.,True,True,Model indicates no public accessions; matches both ‘No’ annotations.
38427738-4,38427738,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None are provided in the paper; no GenBank accession numbers are reported.,True,True,Model states no GenBank accessions reported; matches both.
38427738-5,38427738,5,How many individuals had samples obtained for HIV sequencing?,0,Not reported,Zero individuals; sequencing was performed on virus propagated in cell culture rather than samples from human individuals.,True,False,"Model says zero individuals, matching original ‘0’ but not updated ‘Not reported’."
38427738-6,38427738,6,From which countries were the sequenced samples obtained?,No,Not reported,"Not applicable — sequences were from laboratory and experimentally propagated viral strains in cell culture, not from human subjects in specific countries.",True,True,Model says not applicable (no human samples); aligns with original ‘No’ and conveys unavailability for updated ‘Not reported’.
38427738-7,38427738,7,From what years were the sequenced samples obtained?,No,Not reported,"Not applicable / not reported. The paper reports durations of in vitro passaging (e.g., 'nearly 1 year') but does not report calendar years of sample collection.",True,True,Model says not applicable/not reported; matches original ‘No’ and updated ‘Not reported’.
38427738-8,38427738,8,Were samples cloned prior to sequencing?,No,Not reported,"Both approaches were used: bulk sequencing of PCR amplicons from genomic DNA was performed, and env amplicons were cloned into plasmids to construct infectious molecular clones which were then Sanger-sequenced/verified.",False,False,Model claims cloning was used; conflicts with original ‘No’ and updated ‘Not reported’.
38427738-9,38427738,9,Which HIV genes were reported to have been sequenced?,"Gag, Pol, Env, Nef, vpu","Gag, Pol, Env, Nef, Vpu","gag, pol (including RT and IN regions), env, vpu, and nef (regions of Gag, Pol, Env, Vpu, and Nef were amplified/sequenced); specific focus on NC (within Gag), RT, and IN mutations is reported.",True,True,"Model lists Gag, Pol, Env, Vpu, Nef (with RT/IN subregions); matches both lists."
38427738-10,38427738,10,What method was used for sequencing?,No,Not reported,Sanger sequencing of PCR amplicons performed by commercial sequencing providers (Psomagen or Poochon Scientific); constructed plasmids were verified by Sanger DNA sequencing.,False,False,"Model specifies Sanger sequencing, contradicting original ‘No’ and updated ‘Not reported’."
38427738-11,38427738,11,What type of samples were sequenced?,No,Not reported,Genomic DNA extracted from infected cell cultures (infected SupT1 or SupT1huR5 cells) and PCR amplicons derived from those cultures; env amplicons were cloned into plasmids and sequenced/verified.,False,False,Model specifies cell-culture DNA/plasmids; contradicts original ‘No’ and updated ‘Not reported’.
38427738-12,38427738,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,No. The study did not report sequencing of samples from individuals with virological failure; analyses were performed on viruses passaged in vitro under drug pressure.,True,False,Model says No virological-failure patient sequences; matches original ‘No’ but not updated ‘Not reported’.
38427738-13,38427738,13,Were the patients in the study in a clinical trial?,No,Not reported,No — there were no patients in this study; experiments used cell lines and laboratory/primary viral clones.,True,False,Model says No patients/clinical trial; matches original ‘No’ but not updated ‘Not reported’.
37976080-10,37976080,10,What method was used for sequencing?,Sanger sequencing,Sanger sequencing,Sanger sequencing.,True,True,Matches Sanger sequencing.
37976080-11,37976080,11,What type of samples were sequenced?,Plasma,Plasma,Plasma samples (viral RNA extracted from 200 µL plasma).,True,True,Identifies plasma samples.
37976080-12,37976080,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,Not specifically reported; the study sampled individuals starting or restarting ART and reports prior ARV exposure but does not report sequencing from individuals with documented virological failure.,False,False,Model says not reported; humans say No.
37976080-13,37976080,13,Were the patients in the study in a clinical trial?,No,No,"No — this was a multicenter observational cross-sectional study, not a clinical trial.",True,True,States not a clinical trial.
37976080-14,37976080,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,"Yes — some participants (3.2%, n=81) had prior ARV drug exposure, and they were included in the sequencing/PDR analysis.",True,True,Affirms prior ARV exposure.
37976080-15,37976080,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,Not specified in the paper.,False,True,"Model says not specified, aligning with Not reported, not with 'No'."
37976080-16,37976080,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Not reported/specified for the participants; the paper does list the 12 WHO-recommended drugs analyzed for resistance, but it does not state which specific drugs individual participants had received previously.",False,True,"Model conveys info not reported, consistent with Not applicable but not with 'No'."
37976185-1,37976185,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,Confirms patient sequences reported.
37976185-2,37976185,2,Does the paper report in vitro drug susceptibility data?,No,No,No.,True,True,States no in vitro susceptibility data.
37976185-3,37976185,3,Were sequences from the paper made publicly available?,No,No,No (not reported).,True,True,Indicates sequences not publicly available.
37976185-4,37976185,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,False,True,"Says none reported, matching Not reported, not 'No'."
37976185-5,37976185,5,How many individuals had samples obtained for HIV sequencing?,4246,4246,"4,246 individuals had a genotype obtained within 30 days of diagnosis and comprised the analytic population.",True,True,"Matches 4,246 individuals."
37976185-6,37976185,6,From which countries were the sequenced samples obtained?,USA,USA,"United States (New York City, USA).",True,True,Specifies USA.
37976185-7,37976185,7,From what years were the sequenced samples obtained?,2015-2022,2015-2022,2015--2022.,True,True,Matches 2015–2022.
37976185-8,37976185,8,Were samples cloned prior to sequencing?,No,No,Not reported / No evidence of cloning.,False,False,"Hedged as not reported/no evidence, not a clear 'No'."
37976185-9,37976185,9,Which HIV genes were reported to have been sequenced?,RT,RT,The paper does not explicitly name a gene; it reports genotypes identifying the M184I/V and K65R resistance-associated mutations.,False,False,Does not specify RT; claims not explicitly named.
37976185-10,37976185,10,What method was used for sequencing?,"Sanger sequencing, NGS","Sanger sequencing, NGS",Sanger sequencing and next-generation sequencing (reported as consensus sequences when NGS was conducted).,True,True,Lists Sanger and NGS.
37976185-11,37976185,11,What type of samples were sequenced?,Plasma,Plasma,Clinical baseline diagnostic specimens used for HIV genotyping (baseline genotypes obtained within 30 days of diagnosis); plasma viral load is referenced as the specimen source for testing capacity.,True,True,Indicates plasma as specimen source.
37976185-12,37976185,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,No,"No — sequences were from people with newly diagnosed HIV (baseline genotypes), not described as from individuals with virological failure on ART.",True,True,Says No virological failure sequences.
37976185-13,37976185,13,Were the patients in the study in a clinical trial?,No,No,No.,True,True,States not a clinical trial.
37976185-14,37976185,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Yes,Yes — some individuals had prior antiretroviral exposure via PrEP (TDF/TAF with FTC) before diagnosis and sequencing.,True,True,Notes prior ARV exposure via PrEP.
37976185-15,37976185,15,Which drug classes were received by individuals in the study before sample sequencing?,NRTI,NRTI,Nucleos(t)ide reverse transcriptase inhibitor drugs used for PrEP (tenofovir disoproxil fumarate or tenofovir alafenamide plus emtricitabine).,True,True,Identifies NRTI class.
37976185-16,37976185,16,Which drugs were received by individuals in the study before sample sequencing?,"TDF, FTC","TDF, FTC",Tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide (TAF) with emtricitabine (FTC).,False,False,"Adds TAF, which is not in human answers."
37993493-1,37993493,1,Does the paper report HIV sequences from patient samples?,Yes,Yes,Yes.,True,True,Confirms patient-derived sequences.
37993493-2,37993493,2,Does the paper report in vitro drug susceptibility data?,No,No,No — the paper reports genotypic predictions and genotypic susceptibility scores rather than in vitro phenotypic susceptibility assays.,True,True,States no phenotypic susceptibility data.
37340869-5,37340869,5,How many individuals had samples obtained for HIV sequencing?,1651,1651,"Up to 1,431 participants had complete baseline records (including genotypic factors) used for analyses; BFAs included 1,363 and 1,431 unique participants in the single-regimen and all-regimens models, respectively.",False,False,"Model gave 1,363/1,431 participants, not 1,651."
37340869-6,37340869,6,From which countries were the sequenced samples obtained?,No,Not reported,Specific countries are not comprehensively listed in the main text; Russia is explicitly mentioned (11 participants with CVF were from Russia).,False,False,"Countries were annotated as not reported; model mentions Russia, implying a country detail."
37340869-7,37340869,7,From what years were the sequenced samples obtained?,No,Not reported,Not reported — the paper does not provide calendar years of sample collection in the main text.,True,True,"Model states not reported for years, matching both annotations."
37340869-8,37340869,8,Were samples cloned prior to sequencing?,No,Not reported,Not reported — there is no mention in the paper of cloning prior to sequencing.,False,True,"Model says not reported; original said No, updated says Not reported."
37340869-9,37340869,9,Which HIV genes were reported to have been sequenced?,RT,RT,"Genotypic data pertain to integrase (L74I) and reverse transcriptase (RPV resistance-associated mutations), i.e., integrase and RT regions.",False,False,"Model lists integrase and RT, but only RT was reported."
37340869-10,37340869,10,What method was used for sequencing?,No,Not reported,"Not specified in the main text; the paper refers to a ""retrospective proviral DNA analysis"" for RPV RAMs and notes that full genotypic/phenotypic methodology has been published separately (Supplementary page 1).",True,True,"Model says sequencing method not specified, matching not reported."
37340869-11,37340869,11,What type of samples were sequenced?,No,Not reported,Proviral DNA (retrospective proviral DNA analysis) was used for identifying RPV RAMs; participants were virologically suppressed (plasma HIV-1 RNA <50 copies/mL) at randomization.,False,False,"Model asserts proviral DNA, but annotations indicate type not reported."
37340869-12,37340869,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,"Yes — genotypic/subtype data are reported for participants who experienced confirmed virologic failure (CVF); for example, participants with CVF had RPV RAMs and subtype A6/A1 was observed among CVF cases.",False,False,"Model says sequences from CVF cases were obtained, contradicting both annotations."
37340869-13,37340869,13,Were the patients in the study in a clinical trial?,Yes,Not reported,"Yes — participants were enrolled in randomized, multicenter, open-label phase 3/3b clinical trials (FLAIR, ATLAS, ATLAS-2M).",True,False,Model correctly states participants were in clinical trials; updated says not reported.
37340869-14,37340869,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,Not reported,Yes — the study participants were virologically suppressed on antiretroviral therapy prior to randomization and retrospective proviral DNA analyses (identifying RPV RAMs) reflect prior ARV exposure/history.,True,False,"Model answers Yes (prior ARV exposure), matching original but not updated Not reported."
37340869-15,37340869,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not reported,The paper references exposure and/or relevance of INSTIs (integrase strand transfer inhibitors) and NNRTIs (non-nucleoside reverse-transcriptase inhibitors); study drugs included an INSTI (cabotegravir) and an NNRTI (rilpivirine).,False,False,"Model provides drug classes (INSTI, NNRTI) though annotations say not reported."
37340869-16,37340869,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,The paper does not provide a detailed list of specific prior ARV drugs received by participants; it focuses on drug classes and on the study drugs cabotegravir and rilpivirine and reports mutations relevant to rilpivirine (RPV RAMs) and integrase (L74I/K103N mentioned as relevant).,True,False,"Model says specific prior drugs were not listed (i.e., not reported), matching original No but not updated Not applicable."
37358226-1,37358226,1,Does the paper report HIV sequences from patient samples?,No,Not reported,No.,True,False,Model says No; updated expects an explicit not reported/unavailable statement.
37358226-2,37358226,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No.,True,False,Model says No; updated marked Not reported.
37358226-3,37358226,3,Were sequences from the paper made publicly available?,No,Not reported,No.,True,False,Model says No availability; updated says Not reported.
37358226-4,37358226,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model says none reported, matching both annotations."
37358226-5,37358226,5,How many individuals had samples obtained for HIV sequencing?,0,Not reported,None; the study did not obtain samples for HIV sequencing.,True,False,Model indicates zero sequencing; updated says Not reported.
37358226-6,37358226,6,From which countries were the sequenced samples obtained?,No,Not reported,Not applicable — no sequences were obtained; the study population was from Lesotho.,True,True,"Model states not applicable (no sequences), clearly conveying unavailability of countries."
37358226-7,37358226,7,From what years were the sequenced samples obtained?,No,Not reported,Not applicable — no sequencing was done. The study included transitions to DTG before 30 October 2021 and data closure was 1 May 2023.,True,True,"Model states not applicable (no sequencing), aligning with not reported years."
37358226-8,37358226,8,Were samples cloned prior to sequencing?,No,Not reported,No — not applicable because no sequencing was performed.,True,False,"Model says No (not applicable), matching original but not updated Not reported."
37358226-9,37358226,9,Which HIV genes were reported to have been sequenced?,No,Not reported,None — no HIV genes were sequenced or reported.,True,False,"Model says none sequenced; updated says Not reported (expects unavailability, not a definitive none)."
37358226-10,37358226,10,What method was used for sequencing?,No,Not reported,Not applicable — no sequencing was performed or reported.,True,True,"Model says not applicable due to no sequencing, matching both."
37358226-11,37358226,11,What type of samples were sequenced?,No,Not reported,Not applicable — no samples were sequenced.,True,True,"Model says not applicable due to no sequencing, matching both."
37358226-12,37358226,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not reported,No; no sequences were obtained. The cohort did include individuals with pretransition viremia (>999 copies/mL).,True,False,Model says No sequences from VF because no sequencing was done; updated says Not reported.
37358226-13,37358226,13,Were the patients in the study in a clinical trial?,No,Not reported,"No; they were participants in a prospective open cohort (routine care), not a clinical trial.",True,False,Model says not a clinical trial; updated says Not reported.
38022124-5,38022124,5,How many individuals had samples obtained for HIV sequencing?,0,0,Not applicable / Not reported — sequencing was not performed; the study included 116 patients overall.,True,True,"Model clearly indicates no sequencing was performed, equivalent to 0 individuals."
38022124-6,38022124,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable / Not reported — no sequencing was done; the study was conducted in Turkey.,True,True,Model states not applicable/not reported due to no sequencing; aligns with both annotations.
38022124-7,38022124,7,From what years were the sequenced samples obtained?,No,Not applicable,Not applicable / Not reported — sequencing not performed; the clinical data/samples were from June 2020 to June 2022.,True,True,Model says not applicable/not reported because no sequencing; matches both.
38022124-8,38022124,8,Were samples cloned prior to sequencing?,No,Not applicable,Not applicable / Not reported — no cloning or sequencing procedures are described.,True,True,"Model indicates no cloning/sequencing described, i.e., not applicable; matches both."
38022124-9,38022124,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,Not applicable / Not reported — no HIV genes were sequenced in this study.,True,True,Model states no HIV genes were sequenced (N/A); matches both.
38022124-10,38022124,10,What method was used for sequencing?,No,Not applicable,Not applicable / Not reported — no sequencing method is described.,True,True,Model says no sequencing method described (N/A); matches both.
38022124-11,38022124,11,What type of samples were sequenced?,No,Not applicable,Not applicable / Not reported — no sequencing was performed; the study reported clinical measures such as HIV-1 RNA (viral load) but did not specify sample types for sequencing.,True,True,Model states no sequencing performed; no sample type for sequencing (N/A); matches both.
38022124-12,38022124,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,Not applicable / Not reported — no sequences were obtained; the study reports virological suppression outcomes but not sequencing from virological failures.,True,True,Model notes no sequences obtained (N/A); matches both.
38022124-13,38022124,13,Were the patients in the study in a clinical trial?,No,Not reported,"No — the patients were part of a retrospective, real-life observational study rather than a clinical trial.",True,False,"Model answers ‘No (observational study)’, matching original ‘No’ but contradicts updated ‘Not reported’."
38022124-14,38022124,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,"No — the paper does not report HIV sequences from previously treated individuals (sequencing was not performed); however, the cohort did include previously treated patients.",True,True,"Model says no sequences were reported and notes no sequencing done, which conveys N/A; matches both."
38022124-15,38022124,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,"Sequencing was not performed, but prior regimens reported include integrase inhibitor–containing regimens plus nucleoside reverse transcriptase inhibitor backbones (e.g., EVG/c/FTC/TAF and DTG+TDF/FTC).",True,True,"Model explicitly notes no sequencing (N/A), aligning with both; extra regimen details don’t change correctness."
38022124-16,38022124,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Sequencing was not performed, but the paper reports prior use of EVG/c/FTC/TAF (elvitegravir/cobicistat/emtricitabine/TAF) in 93.9% of experienced patients and DTG+TDF/FTC (dolutegravir plus tenofovir disoproxil fumarate/emtricitabine) in 4.5%.",True,True,Model notes no sequencing (N/A) and lists prior drugs; aligns with both annotations.
38031075-1,38031075,1,Does the paper report HIV sequences from patient samples?,No,No,No,True,True,Model says no sequences reported; matches both.
38031075-2,38031075,2,Does the paper report in vitro drug susceptibility data?,No,No,No,True,True,Model says no in vitro susceptibility data; matches both.
38031075-3,38031075,3,Were sequences from the paper made publicly available?,No,No,No,True,True,Model says no sequences made public; matches both.
38031075-4,38031075,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported,True,True,Model states none reported; matches both ‘No’ and ‘Not reported’.
38031075-5,38031075,5,How many individuals had samples obtained for HIV sequencing?,0,0,Zero (no sequencing performed),True,True,Model states zero; matches both.
38031075-6,38031075,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable (no sequencing); study samples were from Sierra Leone,True,True,Model says not applicable due to no sequencing; matches both.
38031075-7,38031075,7,From what years were the sequenced samples obtained?,No,Not applicable,Not applicable (no sequencing); samples were collected between August 2022 and January 2023,True,True,Model says not applicable due to no sequencing; matches both.
38031075-8,38031075,8,Were samples cloned prior to sequencing?,No,Not applicable,Not applicable (no sequencing performed),True,True,Model says not applicable (no sequencing); matches both.
38031075-10,38031075,10,What method was used for sequencing?,No,Not applicable,Not applicable (no sequencing performed),True,True,Model says not applicable (no sequencing); matches both.
38031075-11,38031075,11,What type of samples were sequenced?,No,Not applicable,Not applicable (no sequencing performed); blood/plasma samples were collected for viral load testing,True,True,Model says not applicable (no sequencing); matches both.
38031075-12,38031075,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No (no sequences were obtained),True,True,"Model says no sequences obtained, which conveys N/A; matches both."
38031075-13,38031075,13,Were the patients in the study in a clinical trial?,No,Not reported,No,True,False,"Model answers ‘No’, matching original but not the updated ‘Not reported’."
38031075-14,38031075,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,No,True,False,Model answers ‘No’ without indicating N/A; conflicts with updated ‘Not applicable’ though it matches original ‘No’.
38031075-15,38031075,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,Dolutegravir-based regimens and efavirenz/NNRTI-based regimens (note: no sequencing was performed),False,False,Model listed ART classes despite no sequencing; human/updated indicate not applicable.
38031075-16,38031075,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Tenofovir, lamivudine, dolutegravir, and efavirenz",False,False,Model listed specific drugs despite no sequencing; human/updated indicate not applicable.
38033131-1,38033131,1,Does the paper report HIV sequences from patient samples?,No,No,No,True,True,"Model answered No, matching both annotations."
38033131-2,38033131,2,Does the paper report in vitro drug susceptibility data?,No,No,No,True,True,"Model answered No, matching both annotations."
38033131-3,38033131,3,Were sequences from the paper made publicly available?,No,No,No,True,True,"Model answered No, matching both annotations."
38033131-4,38033131,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,Not applicable — no sequences reported,True,True,"Model indicated not applicable/no sequences, aligning with no accession numbers reported."
38033131-5,38033131,5,How many individuals had samples obtained for HIV sequencing?,0,0,Zero — no sequencing was performed,True,True,Model said zero; matches both.
38033131-6,38033131,6,From which countries were the sequenced samples obtained?,No,Not applicable,Not applicable — no sequences; study was conducted in Ethiopia,True,True,Model said not applicable due to no sequences; aligns with annotations.
38033131-7,38033131,7,From what years were the sequenced samples obtained?,No,Not applicable,"Not applicable — no sequences; study data cover January 1, 2015 to December 31, 2019",True,True,Model said not applicable due to no sequences; aligns with annotations.
38033131-8,38033131,8,Were samples cloned prior to sequencing?,No,Not applicable,Not applicable — no sequencing or cloning reported,True,True,"Model stated not applicable/no sequencing, consistent with No/Not applicable."
38033131-9,38033131,9,Which HIV genes were reported to have been sequenced?,No,Not applicable,Not applicable — no HIV genes were sequenced or reported,True,True,Model stated not applicable/no genes sequenced; matches annotations.
38033131-10,38033131,10,What method was used for sequencing?,No,Not applicable,Not applicable — no sequencing method reported,True,True,Model stated not applicable/no method reported; matches annotations.
38033131-11,38033131,11,What type of samples were sequenced?,No,Not applicable,Not applicable — no samples were sequenced,True,True,Model stated not applicable/no samples sequenced; matches annotations.
38033131-12,38033131,12,Were any sequences obtained from individuals with virological failure on a treatment regimen?,No,Not applicable,No — no sequences obtained,True,True,Model answered No and clarified no sequences; aligns with both annotations.
38033131-13,38033131,13,Were the patients in the study in a clinical trial?,No,Not reported,No,True,False,"Model answered No, matching original, but updated says Not reported."
38033131-14,38033131,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,No,Not applicable,No,True,True,"Model answered No (no such sequences reported), consistent with not applicable due to no sequencing."
38033131-15,38033131,15,Which drug classes were received by individuals in the study before sample sequencing?,No,Not applicable,"Not applicable for sequencing; participants received NNRTI-based ART and prophylactic agents (cotrimoxazole, isoniazid)",True,True,"Model conveyed not applicable for sequencing (despite extra context), aligning with annotations."
38033131-16,38033131,16,Which drugs were received by individuals in the study before sample sequencing?,No,Not applicable,"Not applicable for sequencing; drugs received included nevirapine-based ART, cotrimoxazole, and isoniazid (and some had PMTCT history)",True,True,"Model conveyed not applicable for sequencing (despite extra context), aligning with annotations."
38058846-1,38058846,1,Does the paper report HIV sequences from patient samples?,Yes,Not reported,No — the paper reports HIV drug resistance testing results but does not present raw HIV sequences.,False,False,"Model said No, conflicting with original Yes and with updated Not reported."
38058846-2,38058846,2,Does the paper report in vitro drug susceptibility data?,No,Not reported,No — the paper does not report any in vitro phenotypic drug susceptibility testing.,True,False,"Model said No, matching original but not the updated Not reported."
38058846-3,38058846,3,Were sequences from the paper made publicly available?,No,Not reported,No — the paper does not indicate that sequences were deposited in public repositories.,True,False,"Model said No, matching original but not the updated Not reported."
38058846-4,38058846,4,What were the GenBank accession numbers for sequenced HIV isolates?,No,Not reported,None reported.,True,True,"Model said none reported, aligning with both."
38058846-5,38058846,5,How many individuals had samples obtained for HIV sequencing?,3,Not reported,Three individuals.,True,False,"Model gave a count (three), matching original but contradicting updated Not reported."
38058846-6,38058846,6,From which countries were the sequenced samples obtained?,No,Not reported,South Africa.,False,False,"Model specified South Africa, contradicting both original No and updated Not reported."
38058846-7,38058846,7,From what years were the sequenced samples obtained?,No,Not reported,Not explicitly stated for the time of sequencing; the paper presents clinical timelines spanning 2018–2023 but does not give explicit calendar years for when resistance tests/sequencing were performed.,True,True,"Model stated not explicitly stated, matching lack of reported years in both annotations."
